No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 3k3aI, 1.0000, 0.00, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH OSELTAMIVIR
2, 3k3aP, 0.9999, 0.06, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH OSELTAMIVIR
3, 3k3aO, 0.9999, 0.05, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH OSELTAMIVIR
4, 3k3aN, 0.9999, 0.05, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH OSELTAMIVIR
5, 3k3aM, 0.9999, 0.05, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH OSELTAMIVIR
6, 3k3aL, 0.9999, 0.05, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH OSELTAMIVIR
7, 3k3aK, 0.9999, 0.03, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH OSELTAMIVIR
8, 3k3aJ, 0.9999, 0.05, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH OSELTAMIVIR
9, 3k3aH, 0.9999, 0.05, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH OSELTAMIVIR
10, 3k3aG, 0.9999, 0.05, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH OSELTAMIVIR
11, 3k3aF, 0.9999, 0.05, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH OSELTAMIVIR
12, 3k3aE, 0.9999, 0.05, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH OSELTAMIVIR
13, 3k3aD, 0.9999, 0.05, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH OSELTAMIVIR
14, 3k3aC, 0.9999, 0.04, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH OSELTAMIVIR
15, 3k3aB, 0.9999, 0.05, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH OSELTAMIVIR
16, 3k3aA, 0.9999, 0.04, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH OSELTAMIVIR
17, 3k38P, 0.9994, 0.17, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT
18, 3k38O, 0.9994, 0.17, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT
19, 3k38N, 0.9994, 0.17, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT
20, 3k38M, 0.9994, 0.17, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT
21, 3k38L, 0.9994, 0.17, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT
22, 3k38K, 0.9994, 0.17, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT
23, 3k38J, 0.9994, 0.17, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT
24, 3k38I, 0.9994, 0.16, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT
25, 3k38H, 0.9994, 0.17, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT
26, 3k38G, 0.9994, 0.17, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT
27, 3k38F, 0.9994, 0.17, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT
28, 3k38E, 0.9994, 0.17, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT
29, 3k38D, 0.9994, 0.17, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT
30, 3k38C, 0.9994, 0.17, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT
31, 3k38B, 0.9994, 0.16, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT
32, 3k38A, 0.9994, 0.17, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT
33, 4cplB, 0.9992, 0.20, 0.969, 390, 389, STRUCTURE OF THE NEURAMINIDASE FROM THE B/BRISBANE/60/2008 VIRUS.
34, 4cplA, 0.9991, 0.20, 0.969, 390, 389, STRUCTURE OF THE NEURAMINIDASE FROM THE B/BRISBANE/60/2008 VIRUS.
35, 3k39P, 0.9991, 0.21, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH PERAMIVIR
36, 3k39N, 0.9991, 0.21, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH PERAMIVIR
37, 3k39J, 0.9991, 0.21, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH PERAMIVIR
38, 3k39I, 0.9991, 0.21, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH PERAMIVIR
39, 3k39H, 0.9991, 0.21, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH PERAMIVIR
40, 3k39G, 0.9991, 0.21, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH PERAMIVIR
41, 3k39D, 0.9991, 0.21, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH PERAMIVIR
42, 3k39O, 0.9990, 0.22, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH PERAMIVIR
43, 3k39M, 0.9990, 0.21, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH PERAMIVIR
44, 3k39L, 0.9990, 0.22, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH PERAMIVIR
45, 3k39K, 0.9990, 0.22, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH PERAMIVIR
46, 3k39F, 0.9990, 0.21, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH PERAMIVIR
47, 3k39E, 0.9990, 0.22, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH PERAMIVIR
48, 3k39C, 0.9990, 0.22, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH PERAMIVIR
49, 3k39B, 0.9990, 0.22, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH PERAMIVIR
50, 3k39A, 0.9990, 0.21, 1.000, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH PERAMIVIR
51, 4cpzC, 0.9989, 0.23, 0.964, 390, 389, STRUCTURE OF THE NEURAMINIDASE FROM THE B/LYON/CHU/15.216/2011 VIRUS IN COMPLEX WITH ZANAMIVIR
52, 4cpzA, 0.9989, 0.23, 0.964, 390, 389, STRUCTURE OF THE NEURAMINIDASE FROM THE B/LYON/CHU/15.216/2011 VIRUS IN COMPLEX WITH ZANAMIVIR
53, 4cpzD, 0.9988, 0.24, 0.964, 390, 389, STRUCTURE OF THE NEURAMINIDASE FROM THE B/LYON/CHU/15.216/2011 VIRUS IN COMPLEX WITH ZANAMIVIR
54, 4cpzB, 0.9988, 0.24, 0.964, 390, 389, STRUCTURE OF THE NEURAMINIDASE FROM THE B/LYON/CHU/15.216/2011 VIRUS IN COMPLEX WITH ZANAMIVIR
55, 4cpyB, 0.9988, 0.24, 0.964, 390, 389, STRUCTURE OF THE NEURAMINIDASE FROM THE B/LYON/CHU/15.216/ 2011 VIRUS IN COMPLEX WITH OSELTAMIVIR
56, 4cpoA, 0.9988, 0.24, 0.964, 390, 389, STRUCTURE OF THE NEURAMINIDASE FROM THE B/LYON/CHU/15.216/ 2011  VIRUS
57, 4cpnB, 0.9988, 0.24, 0.969, 390, 389, STRUCTURE OF THE NEURAMINIDASE FROM THE B/BRISBANE/60/2008 VIRUS IN COMPLEX WITH ZANAMIVIR
58, 3k37B, 0.9988, 0.24, 0.997, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE IN COMPLEX WITH PERAMIVIR
59, 3k37A, 0.9988, 0.24, 0.997, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE IN COMPLEX WITH PERAMIVIR
60, 1nscB, 0.9988, 0.24, 0.954, 390, 389, INFLUENZA B VIRUS NEURAMINIDASE CAN SYNTHESIZE ITS OWN INHIBITOR
61, 1a4qB, 0.9988, 0.25, 0.954, 390, 389, INFLUENZA VIRUS B/BEIJING/1/87 NEURAMINIDASE COMPLEXED WITH DIHYDROPYRAN-PHENETHYL-PROPYL-CARBOXAMIDE
62, 4cpzE, 0.9987, 0.26, 0.964, 390, 389, STRUCTURE OF THE NEURAMINIDASE FROM THE B/LYON/CHU/15.216/2011 VIRUS IN COMPLEX WITH ZANAMIVIR
63, 4cpyA, 0.9987, 0.25, 0.964, 390, 389, STRUCTURE OF THE NEURAMINIDASE FROM THE B/LYON/CHU/15.216/ 2011 VIRUS IN COMPLEX WITH OSELTAMIVIR
64, 4cpoB, 0.9987, 0.25, 0.964, 390, 389, STRUCTURE OF THE NEURAMINIDASE FROM THE B/LYON/CHU/15.216/ 2011  VIRUS
65, 4cpnA, 0.9987, 0.25, 0.969, 390, 389, STRUCTURE OF THE NEURAMINIDASE FROM THE B/BRISBANE/60/2008 VIRUS IN COMPLEX WITH ZANAMIVIR
66, 4cpmA, 0.9987, 0.26, 0.969, 390, 389, STRUCTURE OF THE NEURAMINIDASE FROM THE B/BRISBANE/60/2008 VIRUS IN COMPLEX WITH OSELTAMIVIR
67, 1nsdB, 0.9987, 0.25, 0.954, 390, 389, INFLUENZA B VIRUS NEURAMINIDASE CAN SYNTHESIZE ITS OWN INHIBITOR
68, 1nsdA, 0.9987, 0.25, 0.954, 390, 389, INFLUENZA B VIRUS NEURAMINIDASE CAN SYNTHESIZE ITS OWN INHIBITOR
69, 1nscA, 0.9987, 0.25, 0.954, 390, 389, INFLUENZA B VIRUS NEURAMINIDASE CAN SYNTHESIZE ITS OWN INHIBITOR
70, 1nsbB, 0.9987, 0.25, 0.954, 390, 389, THE 2.2 ANGSTROMS RESOLUTION CRYSTAL STRUCTURE OF INFLUENZA B NEURAMINIDASE AND ITS COMPLEX WITH SIALIC ACID
71, 4cpzF, 0.9986, 0.26, 0.964, 390, 389, STRUCTURE OF THE NEURAMINIDASE FROM THE B/LYON/CHU/15.216/2011 VIRUS IN COMPLEX WITH ZANAMIVIR
72, 4cpmB, 0.9986, 0.26, 0.969, 390, 389, STRUCTURE OF THE NEURAMINIDASE FROM THE B/BRISBANE/60/2008 VIRUS IN COMPLEX WITH OSELTAMIVIR
73, 1nsbA, 0.9986, 0.26, 0.954, 390, 389, THE 2.2 ANGSTROMS RESOLUTION CRYSTAL STRUCTURE OF INFLUENZA B NEURAMINIDASE AND ITS COMPLEX WITH SIALIC ACID
74, 1a4gA, 0.9986, 0.26, 0.954, 390, 389, INFLUENZA VIRUS B/BEIJING/1/87 NEURAMINIDASE COMPLEXED WITH ZANAMIVIR
75, 3k36B, 0.9985, 0.27, 0.997, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE
76, 3k36A, 0.9985, 0.27, 0.997, 389, 389, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE
77, 1a4gB, 0.9985, 0.27, 0.954, 390, 389, INFLUENZA VIRUS B/BEIJING/1/87 NEURAMINIDASE COMPLEXED WITH ZANAMIVIR
78, 4cpzG, 0.9984, 0.29, 0.964, 390, 389, STRUCTURE OF THE NEURAMINIDASE FROM THE B/LYON/CHU/15.216/2011 VIRUS IN COMPLEX WITH ZANAMIVIR
79, 4cpzH, 0.9982, 0.30, 0.964, 390, 389, STRUCTURE OF THE NEURAMINIDASE FROM THE B/LYON/CHU/15.216/2011 VIRUS IN COMPLEX WITH ZANAMIVIR
80, 1a4qA, 0.9982, 0.30, 0.954, 390, 389, INFLUENZA VIRUS B/BEIJING/1/87 NEURAMINIDASE COMPLEXED WITH DIHYDROPYRAN-PHENETHYL-PROPYL-CARBOXAMIDE
81, 1vcjA, 0.9973, 0.39, 0.936, 389, 389, INFLUENZA B VIRUS NEURAMINIDASE COMPLEXED WITH 1-(4-CARBOXY-2-(3- PENTYLAMINO)PHENYL)-5-AMINOMETHYL-5-HYDROXYMETHYL-PYRROLIDIN-2-ONE
82, 1invA, 0.9972, 0.40, 0.936, 390, 389, A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES
83, 1b9sA, 0.9972, 0.40, 0.936, 390, 389, NOVEL AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE MAKE SELECTIVE INTERACTIONS WITH CONSERVED RESIDUES AND WATER MOLECULES IN THE ACTIVE SITE
84, 1b9vA, 0.9971, 0.40, 0.936, 390, 389, NOVEL AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE MAKE SELECTIVE INTERACTIONS WITH CONSERVED RESIDUES AND WATER MOLECULES IN TEH ACTIVE SITE
85, 1b9tA, 0.9971, 0.40, 0.936, 390, 389, NOVEL AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE MAKE SELECTIVE INTERACTIONS WITH CONSERVED RESIDUES AND WATER MOLECULES IN THE ACTIVE SITE
86, 1infA, 0.9970, 0.41, 0.938, 390, 389, INFLUENZA VIRUS B/LEE/40 NEURAMINIDASE COMPLEXED WITH BANA113 INHIBITOR
87, 1ivbA, 0.9960, 0.47, 0.936, 390, 389, STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE
88, 5l17A, 0.9199, 2.00, 0.303, 388, 380, THE CRYSTAL STRUCTURE OF NEURAMINIDASE IN COMPLEX WITH ZANAMIVIR FROM A/SHANGHAI/2/2013 (H7N9) INFLUENZA VIRUS
89, 5l15A, 0.9199, 2.00, 0.303, 388, 380, THE CRYSTAL STRUCTURE OF NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR FROM A/SHANGHAI/2/2013 (H7N9) INFLUENZA VIRUS
90, 5l14A, 0.9199, 2.00, 0.303, 388, 380, THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/SHANGHAI/2/2013 (H7N9) INFLUENZA VIRUS
91, 5l18A, 0.9197, 2.01, 0.303, 388, 380, THE CRYSTAL STRUCTURE OF NEURAMINIDASE IN COMPLEX WITH SIALIC ACID FROM A/SHANGHAI/2/2013 (H7N9) INFLUENZA VIRUS
92, 4mx0A, 0.9194, 2.02, 0.303, 388, 380, SHANGHAI N9-PERAMIVIR
93, 4mwqA, 0.9194, 2.02, 0.305, 388, 380, ANHUI N9-OSELTAMIVIR CARBOXYLATE
94, 5w26A, 0.9192, 2.01, 0.305, 388, 380, INFLUENZA VIRUS NEURAMINIDASE N9 IN COMPLEX WITH 4-DEOXYGENATED 23- DIFLUORO-N-ACETYLNEURAMINIC ACID
95, 4mwyA, 0.9192, 2.02, 0.300, 388, 380, SHANGHAI N9-LANINAMIVIR
96, 4mwxA, 0.9192, 2.02, 0.300, 388, 380, SHANGHAI N9-ZANAMIVIR
97, 4mwuA, 0.9192, 2.03, 0.305, 388, 380, ANHUI N9-LANINAMIVIR
98, 4mwrA, 0.9192, 2.03, 0.305, 388, 380, ANHUI N9-ZANAMIVIR
99, 4mwjA, 0.9192, 2.02, 0.303, 388, 380, ANHUI N9
100, 5w2wA, 0.9191, 2.02, 0.305, 388, 380, INFLUENZA VIRUS NEURAMINIDASE N9 IN COMPLEX WITH 8-DEOXYGENATED 23- DIFLUORO-N-ACETYLNEURAMINIC ACID
101, 4mwwA, 0.9191, 2.03, 0.303, 388, 380, SHANGHAI N9-OSELTAMIVIR CARBOXYLATE
102, 4mwvA, 0.9191, 2.03, 0.305, 388, 380, ANHUI N9-PERAMIVIR
103, 4mwlA, 0.9191, 2.02, 0.300, 388, 380, SHANGHAI N9
104, 4dgrA, 0.9191, 2.02, 0.305, 389, 380, INFLUENZA SUBTYPE 9 NEURAMINIDASE BENZOIC ACID INHIBITOR COMPLEX
105, 2qwhA, 0.9191, 2.03, 0.305, 388, 380, THE X-RAY STRUCTURE OF A COMPLEX OF 5-N-ACETYL-5-AMINO-3-(1- ETHYLPROPOXY)-1-CYCLOHEXENE-1-CARBOXYLIC ACID (GS4071) AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE
106, 1nmbN, 0.9191, 2.01, 0.300, 388, 380, THE STRUCTURE OF A COMPLEX BETWEEN THE NC10 ANTIBODY AND INFLUENZA VIRUS NEURAMINIDASE AND COMPARISON WITH THE OVERLAPPING BINDING SITE OF THE NC41 ANTIBODY
107, 2qwfA, 0.9190, 2.02, 0.303, 388, 380, THE X-RAY STRUCTURE OF A COMPLEX OF N-ACETYL-4-GUANIDINO-6- METHYL(PROPYL)CARBOXAMIDE-45-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE
108, 2qwaA, 0.9190, 2.02, 0.303, 388, 380, THE X-RAY STRUCTURE OF A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE
109, 1l7gA, 0.9190, 2.02, 0.303, 388, 380, CRYSTAL STRUCTURE OF E119G MUTANT INFLUENZA VIRUS NEURAMINIDASE IN COMPLEX WITH BCX-1812
110, 1l7fA, 0.9190, 2.03, 0.308, 388, 380, CRYSTAL STRUCTURE OF INFLUENZA VIRUS NEURAMINIDASE IN COMPLEX WITH BCX-1812
111, 7nn9A, 0.9189, 2.02, 0.305, 388, 380, NATIVE INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN)
112, 5jyyA, 0.9189, 2.02, 0.300, 388, 380, STRUCTURE-BASED TETRAVALENT ZANAMIVIR WITH POTENT INHIBITORY ACTIVITY AGAINST DRUG-RESISTANT INFLUENZA VIRUSES
113, 3w09A, 0.9189, 2.02, 0.305, 388, 380, INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) COMPLEXED WITH 23-DIF GUANIDINO-NEU5AC2EN INHIBITOR
114, 2qwgA, 0.9189, 2.03, 0.305, 388, 380, THE X-RAY STRUCTURE OF A COMPLEX OF 5-N-ACETYL-4-AMINO-6- DIETHYLCARBOXAMIDE-45-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE
115, 1nncA, 0.9189, 2.01, 0.305, 388, 380, INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) COMPLEXED WITH 4- GUANIDINO-NEU5AC2EN INHIBITOR
116, 1l7hA, 0.9189, 2.03, 0.305, 388, 380, CRYSTAL STRUCTURE OF R292K MUTANT INFLUENZA VIRUS NEURAMINIDASE IN COMPLEX WITH BCX-1812
117, 5w2yA, 0.9188, 2.02, 0.305, 388, 380, INFLUENZA VIRUS NEURAMINIDASE N9 IN COMPLEX WITH 9-DEOXYGENATED 23- DIFLUORO-N-ACETYLNEURAMINIC ACID
118, 2qwkA, 0.9188, 2.03, 0.308, 388, 380, THE X-RAY STRUCTURE OF A COMPLEX OF 5-N-ACETYL-5-AMINO-3-(1- ETHYLPROPOXY)-1-CYCLOHEXENE-1-CARBOXYLIC ACID (GS4071) AND WILDTYPE TERN N9 INFLUENZA VIRUS NEURAMINIDASE
119, 2qwjA, 0.9188, 2.03, 0.308, 388, 380, THE X-RAY STRUCTURE OF A COMPLEX OF 5-N-ACETYL-4-AMINO-6- DIETHYLCARBOXAMIDE-45-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE
120, 2qwdA, 0.9188, 2.03, 0.305, 388, 380, THE X-RAY STRUCTURE OF A COMPLEX OF 4-AMINO-NEU5AC2EN AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE
121, 1bjiA, 0.9188, 2.02, 0.305, 388, 380, THE X-RAY STRUCTURE OF A COMPLEX OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE COMPLEXED WITH THE GLAXO 6-CARBOXAMIDE SIALIC ACID ANALOGUE GR217029
122, 2qwiA, 0.9187, 2.02, 0.305, 388, 380, THE X-RAY STRUCTURE OF A COMPLEX OF N-ACETYL-4-GUANIDINO-6- METHYL(PROPYL)CARBOXAMIDE-45-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID AND WILDTYPE TERN N9 INFLUENZA VIRUS NEURAMINIDASE
123, 2qweA, 0.9187, 2.04, 0.305, 388, 380, THE X-RAY STRUCTURE OF A COMPLEX OF 4-GUANIDINO-NEU5AC2EN AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE
124, 2qwcA, 0.9187, 2.04, 0.305, 388, 380, THE X-RAY STRUCTURE OF A COMPLEX OF NEU5AC2EN AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE
125, 2b8hA, 0.9187, 2.02, 0.303, 388, 380, A/NWS/WHALE/MAINE/1/84 (H1N9) REASSORTANT INFLUENZA VIRUS NEURAMINIDASE
126, 1f8eA, 0.9187, 2.02, 0.305, 388, 380, NATIVE INFLUENZA NEURAMINIDASE IN COMPLEX WITH 49-DIAMINO-2-DEOXY-2 3-DEHYDRO-N-ACETYL-NEURAMINIC ACID
127, 1f8cA, 0.9187, 2.03, 0.308, 388, 380, NATIVE INFLUENZA NEURAMINIDASE IN COMPLEX WITH 4-AMINO-2-DEOXY-23- DEHYDRO-N-NEURAMINIC ACID
128, 5w2uA, 0.9186, 2.02, 0.305, 388, 380, INFLUENZA VIRUS NEURAMINIDASE N9 IN COMPLEX WITH 7-DEOXYGENATED 23- DIFLUORO-N-ACETYLNEURAMINIC ACID
129, 1ncdN, 0.9186, 2.02, 0.303, 389, 380, REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX
130, 1ncbN, 0.9186, 2.01, 0.308, 389, 380, CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE
131, 1ncaN, 0.9186, 2.02, 0.305, 389, 380, REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX
132, 1f8dA, 0.9186, 2.02, 0.305, 388, 380, NATIVE INFLUENZA NEURAMINIDASE IN COMPLEX WITH 9-AMINO-2-DEOXY-23- DEHYDRO-N-NEURAMINIC ACID
133, 4wegA, 0.9185, 2.02, 0.305, 388, 380, INFLUENZA VIRUS NEURAMINIDASE N9 IN COMPLEX 23-DIFLUOROSIALIC ACID
134, 2qwbA, 0.9185, 2.04, 0.305, 388, 380, THE X-RAY STRUCTURE OF A COMPLEX OF SIALIC ACID AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE
135, 1mweA, 0.9185, 2.04, 0.308, 388, 380, THE X-RAY STRUCTURE OF A COMPLEX OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE COMPLEXED WITH SIALIC ACID AT 4 DEGREES C REVEALING A SECOND SIALIC ACID BINDING SITE
136, 2c4lA, 0.9184, 2.03, 0.305, 388, 380, STRUCTURE OF NEURAMINIDASE SUBTYPE N9 COMPLEXED WITH 30 MM SIALIC ACID (NANA NEU5AC) CRYSTAL SOAKED FOR 24 HOURS AT 291 K AND FINALLY BACKSOAKED FOR 30 MIN IN A CRYOPROTECTANT SOLUTION WHICH DID NOT CONTAIN NEU5AC
137, 2c4aA, 0.9184, 2.03, 0.305, 388, 380, STRUCTURE OF NEURAMINIDASE SUBTYPE N9 COMPLEXED WITH 30 MM SIALIC ACID (NANA NEU5AC) CRYSTAL SOAKED FOR 3 HOURS AT 291 K.
138, 1f8bA, 0.9184, 2.03, 0.305, 388, 380, NATIVE INFLUENZA VIRUS NEURAMINIDASE IN COMPLEX WITH NEU5AC2EN
139, 1nccN, 0.9183, 2.02, 0.305, 389, 380, CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE
140, 1a14N, 0.9183, 2.03, 0.303, 388, 380, COMPLEX BETWEEN NC10 ANTI-INFLUENZA VIRUS NEURAMINIDASE SINGLE CHAIN ANTIBODY WITH A 5 RESIDUE LINKER AND INFLUENZA VIRUS NEURAMINIDASE
141, 5humB, 0.9178, 2.06, 0.292, 389, 380, THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/SICHUAN/26221/2014 INFLUENZA VIRUS
142, 5humA, 0.9177, 2.06, 0.292, 389, 380, THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/SICHUAN/26221/2014 INFLUENZA VIRUS
143, 4nn9A, 0.9175, 2.04, 0.305, 388, 380, REFINED ATOMIC STRUCTURES OF N9 SUBTYPE INFLUENZA VIRUS NEURAMINIDASE AND ESCAPE MUTANTS
144, 3nn9A, 0.9174, 2.04, 0.308, 388, 380, REFINED ATOMIC STRUCTURES OF N9 SUBTYPE INFLUENZA VIRUS NEURAMINIDASE AND ESCAPE MUTANTS
145, 2cmlD, 0.9174, 2.07, 0.292, 389, 380, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM ZANAMIVIR CRYSTAL SOAKED FOR 3 HOURS AT 291 K.
146, 2cmlC, 0.9174, 2.07, 0.292, 389, 380, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM ZANAMIVIR CRYSTAL SOAKED FOR 3 HOURS AT 291 K.
147, 1v0zD, 0.9173, 2.07, 0.292, 389, 380, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6
148, 1v0zB, 0.9173, 2.07, 0.292, 389, 380, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6
149, 2cmlB, 0.9172, 2.07, 0.292, 389, 380, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM ZANAMIVIR CRYSTAL SOAKED FOR 3 HOURS AT 291 K.
150, 5humC, 0.9171, 2.07, 0.292, 389, 380, THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/SICHUAN/26221/2014 INFLUENZA VIRUS
151, 2cmlA, 0.9171, 2.07, 0.292, 389, 380, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM ZANAMIVIR CRYSTAL SOAKED FOR 3 HOURS AT 291 K.
152, 1w21D, 0.9170, 2.07, 0.292, 389, 380, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM SIALIC ACID (NANA NEU5AC) CRYSTAL SOAKED FOR 43 HOURS AT 291 K.
153, 1w21C, 0.9170, 2.08, 0.292, 389, 380, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM SIALIC ACID (NANA NEU5AC) CRYSTAL SOAKED FOR 43 HOURS AT 291 K.
154, 1w21B, 0.9170, 2.08, 0.292, 389, 380, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM SIALIC ACID (NANA NEU5AC) CRYSTAL SOAKED FOR 43 HOURS AT 291 K.
155, 1w20D, 0.9170, 2.07, 0.292, 389, 380, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM SIALIC ACID (NANA NEU5AC) CRYSTAL SOAKED FOR 3 HOURS AT 291 K
156, 1w20C, 0.9170, 2.08, 0.292, 389, 380, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM SIALIC ACID (NANA NEU5AC) CRYSTAL SOAKED FOR 3 HOURS AT 291 K
157, 1w20B, 0.9170, 2.08, 0.292, 389, 380, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM SIALIC ACID (NANA NEU5AC) CRYSTAL SOAKED FOR 3 HOURS AT 291 K
158, 1inwA, 0.9170, 2.02, 0.306, 388, 379, A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES
159, 5humD, 0.9169, 2.08, 0.292, 389, 380, THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/SICHUAN/26221/2014 INFLUENZA VIRUS
160, 2batA, 0.9169, 2.03, 0.306, 388, 379, THE STRUCTURE OF THE COMPLEX BETWEEN INFLUENZA VIRUS NEURAMINIDASE AND SIALIC ACID THE VIRAL RECEPTOR
161, 1v0zC, 0.9169, 2.08, 0.292, 389, 380, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6
162, 1nn2A, 0.9169, 2.02, 0.306, 388, 379, THREE-DIMENSIONAL STRUCTURE OF THE NEURAMINIDASE OF INFLUENZA VIRUS A(SLASH)TOKYO(SLASH)3(SLASH)67 AT 2.2 ANGSTROMS RESOLUTION
163, 4qn6A, 0.9168, 2.09, 0.295, 389, 380, CRYSTAL STRUCTURE OF NEURAMINIDASE N6 COMPLEXED WITH LANINAMIVIR
164, 4qn4B, 0.9168, 2.09, 0.295, 389, 380, CRYSTAL STRUCTURE OF NEURAMINIDASE N6
165, 1w1xC, 0.9168, 2.08, 0.292, 389, 380, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM SIALIC ACID (NANA NEU5AC) CRYSTAL SOAKED FOR 3 HOURS AT 277 K.
166, 6nn9A, 0.9167, 2.05, 0.305, 388, 380, REFINED ATOMIC STRUCTURES OF N9 SUBTYPE INFLUENZA VIRUS NEURAMINIDASE AND ESCAPE MUTANTS
167, 1w1xD, 0.9167, 2.08, 0.292, 389, 380, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM SIALIC ACID (NANA NEU5AC) CRYSTAL SOAKED FOR 3 HOURS AT 277 K.
168, 1w1xB, 0.9167, 2.08, 0.292, 389, 380, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM SIALIC ACID (NANA NEU5AC) CRYSTAL SOAKED FOR 3 HOURS AT 277 K.
169, 1v0zA, 0.9167, 2.09, 0.292, 389, 380, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6
170, 5nn9A, 0.9166, 2.05, 0.305, 388, 380, REFINED ATOMIC STRUCTURES OF N9 SUBTYPE INFLUENZA VIRUS NEURAMINIDASE AND ESCAPE MUTANTS
171, 4qn6B, 0.9166, 2.09, 0.295, 389, 380, CRYSTAL STRUCTURE OF NEURAMINIDASE N6 COMPLEXED WITH LANINAMIVIR
172, 3tibB, 0.9166, 2.02, 0.306, 388, 379, CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR OCTANOATE
173, 1w21A, 0.9166, 2.08, 0.292, 389, 380, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM SIALIC ACID (NANA NEU5AC) CRYSTAL SOAKED FOR 43 HOURS AT 291 K.
174, 1w20A, 0.9166, 2.08, 0.292, 389, 380, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM SIALIC ACID (NANA NEU5AC) CRYSTAL SOAKED FOR 3 HOURS AT 291 K
175, 4qn4A, 0.9165, 2.09, 0.295, 389, 380, CRYSTAL STRUCTURE OF NEURAMINIDASE N6
176, 3tibA, 0.9165, 2.03, 0.306, 388, 379, CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR OCTANOATE
177, 3tiaC, 0.9165, 2.03, 0.306, 388, 379, CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR
178, 3tiaA, 0.9165, 2.03, 0.306, 388, 379, CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR
179, 1inxA, 0.9165, 2.03, 0.306, 388, 379, A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES
180, 5hukB, 0.9164, 2.02, 0.303, 388, 379, THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/NORTHERN PINTAIL/WASHINGTON/40964/2014 INFLUENZA VIRUS
181, 1ivfB, 0.9164, 2.02, 0.306, 388, 379, STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE
182, 1ivfA, 0.9164, 2.02, 0.306, 388, 379, STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE
183, 3tibC, 0.9163, 2.03, 0.306, 388, 379, CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR OCTANOATE
184, 3tiaD, 0.9163, 2.03, 0.306, 388, 379, CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR
185, 1w1xA, 0.9163, 2.09, 0.292, 389, 380, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM SIALIC ACID (NANA NEU5AC) CRYSTAL SOAKED FOR 3 HOURS AT 277 K.
186, 4k1iB, 0.9162, 2.03, 0.306, 388, 379, INDUCED OPENING OF INFLUENZA VIRUS NEURAMINIDASE N2 150-LOOP SUGGESTS AN IMPORTANT ROLE IN INHIBITOR BINDING
187, 4k1iA, 0.9162, 2.03, 0.306, 388, 379, INDUCED OPENING OF INFLUENZA VIRUS NEURAMINIDASE N2 150-LOOP SUGGESTS AN IMPORTANT ROLE IN INHIBITOR BINDING
188, 3tiaB, 0.9162, 2.03, 0.306, 388, 379, CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR
189, 4k1jA, 0.9161, 2.03, 0.309, 388, 379, INDUCED OPENING OF INFLUENZA VIRUS NEURAMINIDASE N2 150-LOOP SUGGESTS AN IMPORTANT ROLE IN INHIBITOR BINDING
190, 4h53C, 0.9161, 2.05, 0.303, 388, 379, INFLUENZA N2-TYR406ASP NEURAMINIDASE IN COMPLEX WITH BETA-NEU5AC
191, 4h53A, 0.9161, 2.03, 0.303, 388, 379, INFLUENZA N2-TYR406ASP NEURAMINIDASE IN COMPLEX WITH BETA-NEU5AC
192, 3tibD, 0.9161, 2.04, 0.306, 388, 379, CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR OCTANOATE
193, 4k1hB, 0.9160, 2.04, 0.306, 388, 379, INDUCED OPENING OF INFLUENZA VIRUS NEURAMINIDASE N2 150-LOOP SUGGESTS AN IMPORTANT ROLE IN INHIBITOR BINDING
194, 3ticA, 0.9160, 2.04, 0.306, 388, 379, CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH ZANAMIVIR
195, 4k1hA, 0.9159, 2.04, 0.306, 388, 379, INDUCED OPENING OF INFLUENZA VIRUS NEURAMINIDASE N2 150-LOOP SUGGESTS AN IMPORTANT ROLE IN INHIBITOR BINDING
196, 3ticC, 0.9159, 2.04, 0.306, 388, 379, CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH ZANAMIVIR
197, 1xoeA, 0.9159, 2.04, 0.309, 387, 379, N9 TERN INFLUENZA NEURAMINIDASE COMPLEXED WITH (2R4R5R)-5-(1- ACETYLAMINO-3-METHYL-BUTYL-PYRROLIDINE-2 4-DICAROBYXYLIC ACID 4- METHYL ESTERDASE COMPLEXED WITH
198, 1nmcN, 0.9159, 2.06, 0.305, 388, 380, COMPLEX BETWEEN NC10 ANTI-INFLUENZA VIRUS NEURAMINIDASE SINGLE CHAIN ANTIBODY WITH A 15 RESIDUE LINKER AND INFLUENZA VIRUS NEURAMINIDASE
199, 1nmcA, 0.9159, 2.06, 0.305, 388, 380, COMPLEX BETWEEN NC10 ANTI-INFLUENZA VIRUS NEURAMINIDASE SINGLE CHAIN ANTIBODY WITH A 15 RESIDUE LINKER AND INFLUENZA VIRUS NEURAMINIDASE
200, 4h53B, 0.9158, 2.04, 0.303, 388, 379, INFLUENZA N2-TYR406ASP NEURAMINIDASE IN COMPLEX WITH BETA-NEU5AC
201, 1xogA, 0.9158, 2.04, 0.309, 387, 379, N9 TERN INFLUENZA NEURAMINIDASE COMPLEXED WITH A 25-DISUBSTITUTED TETRAHYDROFURAN-5-CARBOXYLIC ACID
202, 1nnaA, 0.9158, 2.06, 0.305, 387, 380, THREE-DIMENSIONAL STRUCTURE OF INFLUENZA A N9 NEURAMINIDASE AND ITS COMPLEX WITH THE INHIBITOR 2-DEOXY 23-DEHYDRO-N-ACETYL NEURAMINIC ACID
203, 1ivcB, 0.9158, 2.04, 0.306, 388, 379, STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE
204, 1ivcA, 0.9158, 2.04, 0.306, 388, 379, STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE
205, 5hukA, 0.9157, 2.04, 0.303, 388, 379, THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/NORTHERN PINTAIL/WASHINGTON/40964/2014 INFLUENZA VIRUS
206, 3ticD, 0.9157, 2.04, 0.306, 388, 379, CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH ZANAMIVIR
207, 3ticB, 0.9157, 2.04, 0.306, 388, 379, CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH ZANAMIVIR
208, 1nnbA, 0.9157, 2.07, 0.303, 387, 380, THREE-DIMENSIONAL STRUCTURE OF INFLUENZA A N9 NEURAMINIDASE AND ITS COMPLEX WITH THE INHIBITOR 2-DEOXY 23-DEHYDRO-N-ACETYL NEURAMINIC ACID
209, 2b8hC, 0.9156, 2.07, 0.303, 388, 380, A/NWS/WHALE/MAINE/1/84 (H1N9) REASSORTANT INFLUENZA VIRUS NEURAMINIDASE
210, 4k1jB, 0.9154, 2.05, 0.309, 388, 379, INDUCED OPENING OF INFLUENZA VIRUS NEURAMINIDASE N2 150-LOOP SUGGESTS AN IMPORTANT ROLE IN INHIBITOR BINDING
211, 3ti8A, 0.9154, 2.04, 0.330, 394, 379, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS NEURAMINIDASE N5 COMPLEXED WITH LANINAMIVIR
212, 4qn3B, 0.9153, 2.11, 0.295, 390, 380, CRYSTAL STRUCTURE OF NEURAMINIDASE N7
213, 4qn5B, 0.9152, 2.04, 0.330, 394, 379, NEURAMINIDASE N5 BINDS LSTA AT THE SECOND SIA BINDING SITE
214, 4qn5A, 0.9152, 2.04, 0.330, 394, 379, NEURAMINIDASE N5 BINDS LSTA AT THE SECOND SIA BINDING SITE
215, 4k1kB, 0.9152, 2.05, 0.306, 388, 379, INDUCED OPENING OF INFLUENZA VIRUS NEURAMINIDASE N2 150-LOOP SUGGESTS AN IMPORTANT ROLE IN INHIBITOR BINDING
216, 3sanA, 0.9152, 2.04, 0.330, 394, 379, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS NEURAMINIDASE N5 COMPLEXED WITH ZANAMIVIR
217, 2aepA, 0.9152, 2.05, 0.301, 388, 379, AN EPIDEMIOLOGICALLY SIGNIFICANT EPITOPE OF A 1998 INFLUENZA VIRUS NEURAMINIDASE FORMS A HIGHLY HYDRATED INTERFACE IN THE NA-ANTIBODY COMPLEX.
218, 4k1kA, 0.9151, 2.05, 0.306, 388, 379, INDUCED OPENING OF INFLUENZA VIRUS NEURAMINIDASE N2 150-LOOP SUGGESTS AN IMPORTANT ROLE IN INHIBITOR BINDING
219, 3ti8B, 0.9151, 2.04, 0.330, 394, 379, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS NEURAMINIDASE N5 COMPLEXED WITH LANINAMIVIR
220, 1ingB, 0.9151, 2.05, 0.303, 388, 379, INFLUENZA A SUBTYPE N2 NEURAMINIDASE COMPLEXED WITH AROMATIC BANA109 INHIBITOR
221, 1ingA, 0.9151, 2.05, 0.303, 388, 379, INFLUENZA A SUBTYPE N2 NEURAMINIDASE COMPLEXED WITH AROMATIC BANA109 INHIBITOR
222, 3sanB, 0.9150, 2.04, 0.330, 394, 379, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS NEURAMINIDASE N5 COMPLEXED WITH ZANAMIVIR
223, 1inyA, 0.9150, 2.08, 0.305, 388, 380, A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES
224, 4h52A, 0.9149, 2.05, 0.306, 388, 379, WILD-TYPE INFLUENZA N2 NEURAMINIDASE COVALENT COMPLEX WITH 3-FLUORO- NEU5AC
225, 2aeqA, 0.9149, 2.05, 0.298, 388, 379, AN EPIDEMIOLOGICALLY SIGNIFICANT EPITOPE OF A 1998 INFLUENZA VIRUS NEURAMINIDASE FORMS A HIGHLY HYDRATED INTERFACE IN THE NA-ANTIBODY COMPLEX.
226, 1ivdB, 0.9149, 2.05, 0.306, 388, 379, STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE
227, 1ivdA, 0.9149, 2.05, 0.306, 388, 379, STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE
228, 1inhB, 0.9149, 2.05, 0.306, 388, 379, INFLUENZA A SUBTYPE N2 NEURAMINIDASE COMPLEXED WITH AROMATIC BANA111 INHIBITOR
229, 1inhA, 0.9149, 2.05, 0.306, 388, 379, INFLUENZA A SUBTYPE N2 NEURAMINIDASE COMPLEXED WITH AROMATIC BANA111 INHIBITOR
230, 5hukC, 0.9148, 2.05, 0.303, 388, 379, THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/NORTHERN PINTAIL/WASHINGTON/40964/2014 INFLUENZA VIRUS
231, 4qn3A, 0.9146, 2.12, 0.295, 390, 380, CRYSTAL STRUCTURE OF NEURAMINIDASE N7
232, 4h52B, 0.9146, 2.06, 0.306, 388, 379, WILD-TYPE INFLUENZA N2 NEURAMINIDASE COVALENT COMPLEX WITH 3-FLUORO- NEU5AC
233, 4gzxA, 0.9146, 2.07, 0.290, 388, 379, N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HUMAN SIALIC ACID RECEPTOR
234, 4gztC, 0.9146, 2.07, 0.290, 388, 379, N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE
235, 4gzoA, 0.9146, 2.06, 0.293, 388, 379, N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HEPES
236, 4gzsD, 0.9145, 2.07, 0.290, 388, 379, N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HEPES
237, 1ivgB, 0.9145, 2.06, 0.306, 388, 379, STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE
238, 1ivgA, 0.9145, 2.06, 0.306, 388, 379, STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE
239, 5hukD, 0.9144, 2.06, 0.303, 388, 379, THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/NORTHERN PINTAIL/WASHINGTON/40964/2014 INFLUENZA VIRUS
240, 4qn7B, 0.9144, 2.12, 0.295, 390, 380, CRYSTAL STRUCTURE OF NEURAMNIDASE N7 COMPLEXED WITH OSELTAMIVIR
241, 4gzpA, 0.9144, 2.07, 0.293, 388, 379, N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE
242, 4gzxB, 0.9143, 2.07, 0.290, 388, 379, N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HUMAN SIALIC ACID RECEPTOR
243, 4gzsC, 0.9143, 2.07, 0.290, 388, 379, N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HEPES
244, 4gzsB, 0.9143, 2.07, 0.290, 388, 379, N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HEPES
245, 1iveB, 0.9143, 2.06, 0.306, 388, 379, STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE
246, 1iveA, 0.9143, 2.06, 0.306, 388, 379, STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE
247, 4qn7A, 0.9142, 2.14, 0.297, 390, 380, CRYSTAL STRUCTURE OF NEURAMNIDASE N7 COMPLEXED WITH OSELTAMIVIR
248, 4gzxD, 0.9142, 2.07, 0.290, 388, 379, N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HUMAN SIALIC ACID RECEPTOR
249, 4gzqA, 0.9141, 2.07, 0.293, 388, 379, N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH SIALIC ACID
250, 4gzxC, 0.9140, 2.07, 0.290, 388, 379, N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HUMAN SIALIC ACID RECEPTOR
251, 4gzwA, 0.9140, 2.08, 0.290, 388, 379, N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH AVIAN SIALIC ACID RECEPTOR
252, 4gzsA, 0.9140, 2.07, 0.290, 388, 379, N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HEPES
253, 4gztB, 0.9139, 2.08, 0.290, 388, 379, N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE
254, 4gztD, 0.9138, 2.08, 0.290, 388, 379, N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE
255, 4gzwD, 0.9136, 2.08, 0.293, 388, 379, N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH AVIAN SIALIC ACID RECEPTOR
256, 4gzwC, 0.9135, 2.08, 0.290, 388, 379, N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH AVIAN SIALIC ACID RECEPTOR
257, 4gzwB, 0.9135, 2.09, 0.290, 388, 379, N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH AVIAN SIALIC ACID RECEPTOR
258, 4gztA, 0.9134, 2.09, 0.290, 388, 379, N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE
259, 2b8hB, 0.9130, 2.12, 0.303, 388, 380, A/NWS/WHALE/MAINE/1/84 (H1N9) REASSORTANT INFLUENZA VIRUS NEURAMINIDASE
260, 2b8hD, 0.9128, 2.13, 0.303, 388, 380, A/NWS/WHALE/MAINE/1/84 (H1N9) REASSORTANT INFLUENZA VIRUS NEURAMINIDASE
261, 3salB, 0.9118, 2.12, 0.330, 394, 379, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS NEURAMINIDASE N5
262, 4ks3A, 0.9115, 2.09, 0.335, 388, 379, INFLUENZA NEURAMINIDASE IN COMPLEX WITH ANTIVIRAL COMPOUND (3S4R5R)- 4-(ACETYLAMINO)-3-[4-(3-HYDROXYPROPYL)-1H-123-TRIAZOL-1-YL]-5- (PENTAN-3-YLOXY)CYCLOHEX-1-ENE-1-CARBOXYLIC ACID
263, 4h53D, 0.9114, 2.12, 0.303, 388, 379, INFLUENZA N2-TYR406ASP NEURAMINIDASE IN COMPLEX WITH BETA-NEU5AC
264, 3salA, 0.9113, 2.12, 0.330, 394, 379, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS NEURAMINIDASE N5
265, 4ks1A, 0.9112, 2.10, 0.335, 389, 379, INFLUENZA NEURAMINIDASE IN COMPLEX WITH ANTIVIRAL COMPOUND (3S4R5R)- 4-(ACETYLAMINO)-3-AMINO-5-(PENTAN-3-YLOXY)CYCLOHEX-1-ENE-1-CARBOXYLIC ACID
266, 4d8sA, 0.9112, 2.10, 0.335, 388, 379, INFLUENZA NA IN COMPLEX WITH ANTIVIRAL COMPOUND
267, 2htrA, 0.9112, 2.10, 0.330, 387, 379, N8 NEURAMINIDASE IN COMPLEX WITH DANA
268, 6br5A, 0.9111, 2.12, 0.290, 387, 379, N2 NEURAMINIDASE IN COMPLEX WITH A NOVEL ANTIVIRAL COMPOUND
269, 6br6A, 0.9110, 2.12, 0.290, 387, 379, N2 NEURAMINIDASE IN COMPLEX WITH A NOVEL ANTIVIRAL COMPOUND
270, 4ks2A, 0.9109, 2.11, 0.335, 389, 379, INFLUENZA NEURAMINIDASE IN COMPLEX WITH ANTIVIRAL COMPOUND (3S4R5R)- 4-(ACETYLAMINO)-3-CARBAMIMIDAMIDO-5-(PENTAN-3-YLOXY)CYCLOHEX-1-ENE-1- CARBOXYLIC ACID
271, 2htuA, 0.9109, 2.11, 0.330, 387, 379, N8 NEURAMINIDASE IN COMPLEX WITH PERAMIVIR
272, 4m3mA, 0.9101, 2.13, 0.338, 390, 379, INFLUENZA NEURAMINIDASE IN COMPLEX WITH A STEREOMUTATED ANALOGUE OF OSELTAMIVIR CARBOXYLATE
273, 2ht8A, 0.9101, 2.12, 0.330, 387, 379, N8 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR
274, 5hunA, 0.9097, 2.14, 0.325, 389, 379, THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/GYRFALCON/WASHINGTON/41088-6/2014 INFLUENZA VIRUS
275, 2htqA, 0.9096, 2.13, 0.332, 387, 379, N8 NEURAMINIDASE IN COMPLEX WITH ZANAMIVIR
276, 3nssB, 0.9093, 2.02, 0.335, 387, 376, THE 2009 PANDEMIC H1N1 NEURAMINIDASE N1 LACKS THE 150-CAVITY IN ITS ACTIVE SITES
277, 4wa5A, 0.9092, 2.16, 0.330, 388, 379, THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A H3N8 INFLUENZA VIRUS ISOLATED FROM NEW ENGLAND HARBOR SEALS IN COMPLEX WITH ZANAMIVIR
278, 4wa3A, 0.9091, 2.16, 0.332, 388, 379, THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A H3N8 INFLUENZA VIRUS ISOLATED FROM NEW ENGLAND HARBOR SEALS
279, 3ti5B, 0.9090, 2.02, 0.335, 387, 376, CRYSTAL STRUCTURE OF 2009 PANDEMIC H1N1 NEURAMINIDASE COMPLEXED WITH ZANAMIVIR
280, 3ti6B, 0.9089, 2.02, 0.335, 387, 376, CRYSTAL STRUCTURE OF 2009 PANDEMIC H1N1 NEURAMINIDASE COMPLEXED WITH OSELTAMIVIR
281, 3o9jA, 0.9088, 2.15, 0.335, 387, 379, INFLUENZA NA IN COMPLEX WITH COMPOUND 5
282, 3ti5A, 0.9087, 2.03, 0.335, 387, 376, CRYSTAL STRUCTURE OF 2009 PANDEMIC H1N1 NEURAMINIDASE COMPLEXED WITH ZANAMIVIR
283, 3ti4B, 0.9086, 2.03, 0.335, 387, 376, CRYSTAL STRUCTURE OF 2009 PANDEMIC H1N1 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR OCTANOATE
284, 3ti3B, 0.9086, 2.03, 0.335, 387, 376, CRYSTAL STRUCTURE OF 2009 PANDEMIC H1N1 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR
285, 3ti3A, 0.9086, 2.03, 0.335, 387, 376, CRYSTAL STRUCTURE OF 2009 PANDEMIC H1N1 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR
286, 3nssA, 0.9086, 2.03, 0.335, 387, 376, THE 2009 PANDEMIC H1N1 NEURAMINIDASE N1 LACKS THE 150-CAVITY IN ITS ACTIVE SITES
287, 4gb1A, 0.9085, 2.15, 0.335, 387, 379, SYNTHESIS AND EVALUATION OF NOVEL 3-C-ALKYLATED-NEU5AC2EN DERIVATIVES AS PROBES OF INFLUENZA VIRUS SIALIDASE 150-LOOP FLEXIBILITY
288, 5nzeA, 0.9084, 2.03, 0.335, 387, 376, COMPLEX OF S247N MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR 
289, 3ti6A, 0.9084, 2.03, 0.335, 387, 376, CRYSTAL STRUCTURE OF 2009 PANDEMIC H1N1 NEURAMINIDASE COMPLEXED WITH OSELTAMIVIR
290, 3ti4A, 0.9084, 2.04, 0.335, 387, 376, CRYSTAL STRUCTURE OF 2009 PANDEMIC H1N1 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR OCTANOATE
291, 4ks5A, 0.9083, 2.17, 0.335, 388, 379, INFLUENZA NEURAMINIDASE IN COMPLEX WITH ANTIVIRAL COMPOUND (3S4R5R)- 4-(ACETYLAMINO)-3-[4-(2-HYDROXYPROPAN-2-YL)-1H-123-TRIAZOL-1-YL]-5- (PENTAN-3-YLOXY)CYCLOHEX-1-ENE-1-CARBOXYLIC ACID
292, 5nznC, 0.9082, 2.04, 0.332, 387, 376, COMPLEX OF H275Y/S247N MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR 
293, 5nzeB, 0.9082, 2.04, 0.335, 387, 376, COMPLEX OF S247N MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR 
294, 5nweA, 0.9082, 2.04, 0.332, 388, 376, COMPLEX OF H275Y MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR 
295, 2ht5A, 0.9082, 2.16, 0.332, 387, 379, N8 NEURAMINIDASE
296, 5nzfC, 0.9081, 2.04, 0.330, 387, 376, COMPLEX OF H275Y/I223V MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR 
297, 5nz4A, 0.9081, 2.09, 0.326, 387, 377, COMPLEX OF I223V MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR 
298, 3ckzA, 0.9081, 2.02, 0.324, 385, 376, N1 NEURAMINIDASE H274Y + ZANAMIVIR
299, 2ht7A, 0.9081, 2.16, 0.332, 387, 379, N8 NEURAMINIDASE IN OPEN COMPLEX WITH OSELTAMIVIR
300, 5nznA, 0.9080, 2.04, 0.332, 387, 376, COMPLEX OF H275Y/S247N MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR 
301, 5nz4B, 0.9080, 2.04, 0.332, 387, 376, COMPLEX OF I223V MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR 
302, 5nweC, 0.9080, 2.04, 0.332, 388, 376, COMPLEX OF H275Y MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR 
303, 3o9kA, 0.9080, 2.16, 0.335, 387, 379, INFLUENZA NA IN COMPLEX WITH COMPOUND 6
304, 3cl0A, 0.9080, 2.02, 0.324, 385, 376, N1 NEURAMINIDASE H274Y + OSELTAMIVIR
305, 5nznD, 0.9079, 2.04, 0.332, 387, 376, COMPLEX OF H275Y/S247N MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR 
306, 5nznB, 0.9079, 2.04, 0.332, 387, 376, COMPLEX OF H275Y/S247N MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR 
307, 5nweB, 0.9079, 2.04, 0.332, 388, 376, COMPLEX OF H275Y MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR 
308, 4mjuA, 0.9079, 2.17, 0.332, 389, 379, INFLUENZA NEURAMINIDASE IN COMPLEX WITH A NOVEL ANTIVIRAL COMPOUND
309, 5nzfD, 0.9078, 2.04, 0.330, 387, 376, COMPLEX OF H275Y/I223V MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR 
310, 5nzfB, 0.9078, 2.04, 0.330, 387, 376, COMPLEX OF H275Y/I223V MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR 
311, 5nzfA, 0.9078, 2.05, 0.330, 387, 376, COMPLEX OF H275Y/I223V MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR 
312, 5nweD, 0.9078, 2.04, 0.332, 388, 376, COMPLEX OF H275Y MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR 
313, 4b7qD, 0.9078, 2.04, 0.335, 387, 376, H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS
314, 3b7eB, 0.9078, 2.07, 0.329, 385, 377, NEURAMINIDASE OF A/BREVIG MISSION/1/1918 H1N1 STRAIN IN COMPLEX WITH ZANAMIVIR
315, 4ks4A, 0.9077, 2.18, 0.335, 389, 379, INFLUENZA NEURAMINIDASE IN COMPLEX WITH ANTIVIRAL COMPOUND (3S4R5R)- 4-(ACETYLAMINO)-3-{4-[(1R)-1-HYDROXYPROPYL]-1H-123-TRIAZOL-1-YL}-5- (PENTAN-3-YLOXY)CYCLOHEX-1-ENE-1-CARBOXYLIC ACID
316, 4mjvA, 0.9074, 2.18, 0.332, 390, 379, INFLUENZA NEURAMINIDASE IN COMPLEX WITH A NOVEL ANTIVIRAL COMPOUND
317, 4b7rD, 0.9074, 2.05, 0.335, 387, 376, H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS
318, 3b7eA, 0.9074, 2.03, 0.335, 385, 376, NEURAMINIDASE OF A/BREVIG MISSION/1/1918 H1N1 STRAIN IN COMPLEX WITH ZANAMIVIR
319, 3cl2A, 0.9072, 2.03, 0.322, 385, 376, N1 NEURAMINIDASE N294S + OSELTAMIVIR
320, 3cl2F, 0.9071, 2.03, 0.322, 385, 376, N1 NEURAMINIDASE N294S + OSELTAMIVIR
321, 3cl2B, 0.9071, 2.03, 0.322, 385, 376, N1 NEURAMINIDASE N294S + OSELTAMIVIR
322, 2hu4F, 0.9071, 2.03, 0.327, 385, 376, N1 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR 2
323, 3cl2E, 0.9070, 2.04, 0.322, 385, 376, N1 NEURAMINIDASE N294S + OSELTAMIVIR
324, 3cl2D, 0.9070, 2.04, 0.322, 385, 376, N1 NEURAMINIDASE N294S + OSELTAMIVIR
325, 3cl2C, 0.9070, 2.04, 0.322, 385, 376, N1 NEURAMINIDASE N294S + OSELTAMIVIR
326, 2hu4G, 0.9070, 2.03, 0.324, 385, 376, N1 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR 2
327, 3cl2H, 0.9069, 2.04, 0.322, 385, 376, N1 NEURAMINIDASE N294S + OSELTAMIVIR
328, 3cl2G, 0.9069, 2.04, 0.322, 385, 376, N1 NEURAMINIDASE N294S + OSELTAMIVIR
329, 2hu4H, 0.9069, 2.04, 0.324, 385, 376, N1 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR 2
330, 4hzwA, 0.9068, 2.18, 0.310, 388, 378, CRYSTAL STRUCTURE OF INFLUENZA A NEURAMINIDASE N3 COMPLEXED WITH LANINAMIVIR
331, 4hzxA, 0.9066, 2.18, 0.310, 388, 378, CRYSTAL STRUCTURE OF INFLUENZA A NEURAMINIDASE N3 COMPLEXED WITH OSELTAMIVIR
332, 2hu4C, 0.9066, 2.04, 0.324, 385, 376, N1 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR 2
333, 2htwA, 0.9066, 2.12, 0.318, 388, 377, N4 NEURAMINIDASE IN COMPLEX WITH DANA
334, 4b7rA, 0.9065, 2.06, 0.335, 387, 376, H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS
335, 2hu4A, 0.9065, 2.04, 0.324, 385, 376, N1 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR 2
336, 4b7nA, 0.9064, 2.06, 0.332, 386, 376, H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS
337, 4i00A, 0.9062, 2.19, 0.307, 388, 378, CRYSTAL STRUCTURE OF INFLUENZA A NEURAMINIDASE N3-H274Y COMPLEXED WITH ZANAMIVIR
338, 2hu4E, 0.9062, 2.05, 0.324, 385, 376, N1 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR 2
339, 2hu4D, 0.9062, 2.05, 0.324, 385, 376, N1 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR 2
340, 2hu4B, 0.9062, 2.05, 0.324, 385, 376, N1 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR 2
341, 4b7qA, 0.9061, 2.07, 0.335, 387, 376, H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS
342, 4b7rB, 0.9060, 2.07, 0.335, 387, 376, H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS
343, 4qnpA, 0.9057, 2.09, 0.335, 386, 376, CRYSTAL STRUCTURE OF THE 2009 PANDEMIC H1N1 INFLUENZA VIRUS NEURAMINIDASE WITH A NEUTRALIZING ANTIBODY
344, 4b7rC, 0.9057, 2.08, 0.335, 387, 376, H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS
345, 4hzvA, 0.9056, 2.20, 0.307, 388, 378, THE CRYSTAL STRUCTURE OF INFLUENZA A NEURAMINIDASE N3
346, 4b7jA, 0.9055, 2.08, 0.332, 387, 376, H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS
347, 4qnpB, 0.9054, 2.09, 0.335, 386, 376, CRYSTAL STRUCTURE OF THE 2009 PANDEMIC H1N1 INFLUENZA VIRUS NEURAMINIDASE WITH A NEUTRALIZING ANTIBODY
348, 4hzyA, 0.9054, 2.20, 0.307, 388, 378, CRYSTAL STRUCTURE OF INFLUENZA A NEURAMINIDASE N3-H274Y
349, 4b7qC, 0.9054, 2.08, 0.338, 387, 376, H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS
350, 4b7qB, 0.9054, 2.09, 0.335, 387, 376, H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS
351, 5hugA, 0.9053, 2.15, 0.318, 388, 377, THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/AMERICAN GREEN-WINGED TEAL/WASHINGTON/195750/2014 INFLUENZA VIRUS
352, 2htyG, 0.9046, 2.09, 0.324, 385, 376, N1 NEURAMINIDASE
353, 2hu0G, 0.9045, 2.09, 0.324, 385, 376, N1 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR 1
354, 2htvB, 0.9045, 2.17, 0.316, 388, 377, N4 NEURAMINIDASE
355, 2hu0H, 0.9044, 2.09, 0.324, 385, 376, N1 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR 1
356, 3beqA, 0.9042, 2.15, 0.329, 385, 377, NEURAMINIDASE OF A/BREVIG MISSION/1/1918 H1N1 STRAIN
357, 2htyH, 0.9042, 2.10, 0.324, 385, 376, N1 NEURAMINIDASE
358, 3cyeA, 0.9041, 2.15, 0.329, 385, 377, CYRSTAL STRUCTURE OF THE NATIVE 1918 H1N1 NEURAMINIDASE FROM A CRYSTAL WITH LATTICE-TRANSLOCATION DEFECTS
359, 2hu0B, 0.9040, 2.10, 0.324, 385, 376, N1 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR 1
360, 2htvA, 0.9040, 2.18, 0.316, 388, 377, N4 NEURAMINIDASE
361, 3cyeB, 0.9039, 2.15, 0.329, 385, 377, CYRSTAL STRUCTURE OF THE NATIVE 1918 H1N1 NEURAMINIDASE FROM A CRYSTAL WITH LATTICE-TRANSLOCATION DEFECTS
362, 3beqB, 0.9039, 2.15, 0.329, 385, 377, NEURAMINIDASE OF A/BREVIG MISSION/1/1918 H1N1 STRAIN
363, 2hu0F, 0.9039, 2.10, 0.324, 385, 376, N1 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR 1
364, 2htyF, 0.9038, 2.10, 0.324, 385, 376, N1 NEURAMINIDASE
365, 2htyE, 0.9037, 2.10, 0.324, 385, 376, N1 NEURAMINIDASE
366, 2htyC, 0.9037, 2.10, 0.324, 385, 376, N1 NEURAMINIDASE
367, 2htyB, 0.9037, 2.10, 0.324, 385, 376, N1 NEURAMINIDASE
368, 4hzzA, 0.9036, 2.22, 0.307, 387, 378, CRYSTAL STRUCTURE OF INFLUENZA NEURAMINIDASE N3-H274Y COMPLEXED WITH OSELTAMIVIR
369, 2hu0A, 0.9036, 2.10, 0.324, 385, 376, N1 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR 1
370, 2hu0E, 0.9034, 2.11, 0.324, 385, 376, N1 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR 1
371, 2htyA, 0.9034, 2.10, 0.324, 385, 376, N1 NEURAMINIDASE
372, 2hu0C, 0.9033, 2.11, 0.324, 385, 376, N1 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR 1
373, 2htyD, 0.9033, 2.11, 0.324, 385, 376, N1 NEURAMINIDASE
374, 2hu0D, 0.9030, 2.11, 0.324, 385, 376, N1 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR 1
375, 4b7mA, 0.9025, 2.15, 0.332, 386, 376, H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS
376, 4b7mB, 0.9020, 2.20, 0.326, 386, 377, H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS
377, 4wa4A, 0.9016, 2.10, 0.328, 384, 375, THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A H3N8 INFLUENZA VIRUS ISOLATED FROM NEW ENGLAND HARBOR SEALS IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE
378, 1nmaN, 0.8982, 2.03, 0.304, 378, 372, N9 NEURAMINIDASE COMPLEXES WITH ANTIBODIES NC41 AND NC10: EMPIRICAL FREE-ENERGY CALCULATIONS CAPTURE SPECIFICITY TRENDS OBSERVED WITH MUTANT BINDING DATA
379, 4gezB, 0.8432, 2.62, 0.224, 365, 361, STRUCTURE OF A NEURAMINIDASE-LIKE PROTEIN FROM A/BAT/GUATEMALA/164/2009
380, 4mc7C, 0.8429, 2.48, 0.237, 363, 358, CRYSTAL STRUCTURE OF A SUBTYPE N11 NEURAMINIDASE-LIKE PROTEIN OF A/FLAT-FACED BAT/PERU/033/2010 (H18N11)
381, 4mc7B, 0.8428, 2.48, 0.237, 363, 358, CRYSTAL STRUCTURE OF A SUBTYPE N11 NEURAMINIDASE-LIKE PROTEIN OF A/FLAT-FACED BAT/PERU/033/2010 (H18N11)
382, 4gdiF, 0.8428, 2.67, 0.224, 367, 362, A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/164/2009
383, 4fvkB, 0.8428, 2.67, 0.224, 367, 362, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF NEURAMINIDASE-LIKE MOLECULE N10 DERIVED FROM BAT INFLUENZA A VIRUS
384, 4mc7D, 0.8426, 2.48, 0.237, 363, 358, CRYSTAL STRUCTURE OF A SUBTYPE N11 NEURAMINIDASE-LIKE PROTEIN OF A/FLAT-FACED BAT/PERU/033/2010 (H18N11)
385, 4gezH, 0.8426, 2.63, 0.224, 365, 361, STRUCTURE OF A NEURAMINIDASE-LIKE PROTEIN FROM A/BAT/GUATEMALA/164/2009
386, 4fvkA, 0.8425, 2.67, 0.224, 367, 362, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF NEURAMINIDASE-LIKE MOLECULE N10 DERIVED FROM BAT INFLUENZA A VIRUS
387, 4mc7A, 0.8424, 2.48, 0.237, 363, 358, CRYSTAL STRUCTURE OF A SUBTYPE N11 NEURAMINIDASE-LIKE PROTEIN OF A/FLAT-FACED BAT/PERU/033/2010 (H18N11)
388, 4gdiE, 0.8424, 2.67, 0.224, 367, 362, A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/164/2009
389, 4gezL, 0.8422, 2.65, 0.227, 365, 362, STRUCTURE OF A NEURAMINIDASE-LIKE PROTEIN FROM A/BAT/GUATEMALA/164/2009
390, 4gezF, 0.8422, 2.66, 0.227, 365, 362, STRUCTURE OF A NEURAMINIDASE-LIKE PROTEIN FROM A/BAT/GUATEMALA/164/2009
391, 4gezD, 0.8420, 2.66, 0.227, 365, 362, STRUCTURE OF A NEURAMINIDASE-LIKE PROTEIN FROM A/BAT/GUATEMALA/164/2009
392, 4gezC, 0.8419, 2.67, 0.227, 365, 362, STRUCTURE OF A NEURAMINIDASE-LIKE PROTEIN FROM A/BAT/GUATEMALA/164/2009
393, 4gezE, 0.8418, 2.65, 0.224, 365, 361, STRUCTURE OF A NEURAMINIDASE-LIKE PROTEIN FROM A/BAT/GUATEMALA/164/2009
394, 4gezG, 0.8417, 2.67, 0.227, 365, 362, STRUCTURE OF A NEURAMINIDASE-LIKE PROTEIN FROM A/BAT/GUATEMALA/164/2009
395, 4gdiA, 0.8415, 2.70, 0.224, 367, 362, A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/164/2009
396, 4gezI, 0.8412, 2.65, 0.224, 365, 361, STRUCTURE OF A NEURAMINIDASE-LIKE PROTEIN FROM A/BAT/GUATEMALA/164/2009
397, 4gezA, 0.8409, 2.69, 0.227, 365, 362, STRUCTURE OF A NEURAMINIDASE-LIKE PROTEIN FROM A/BAT/GUATEMALA/164/2009
398, 4gdiB, 0.8408, 2.71, 0.218, 367, 362, A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/164/2009
399, 4gdiC, 0.8403, 2.71, 0.224, 367, 362, A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/164/2009
400, 4gdiD, 0.8389, 2.73, 0.218, 367, 362, A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/164/2009
401, 4gezJ, 0.8380, 2.66, 0.225, 363, 360, STRUCTURE OF A NEURAMINIDASE-LIKE PROTEIN FROM A/BAT/GUATEMALA/164/2009
402, 4gezK, 0.8367, 2.71, 0.227, 364, 361, STRUCTURE OF A NEURAMINIDASE-LIKE PROTEIN FROM A/BAT/GUATEMALA/164/2009
403, 4k3yB, 0.8237, 2.37, 0.247, 354, 348, CRYSTAL STRUCTURE OF A SUBTYPE N11 NEURAMINIDASE-LIKE PROTEIN OF A/FLAT-FACED BAT/PERU/033/2010 (H18N11)
404, 4k3yA, 0.8235, 2.56, 0.246, 354, 350, CRYSTAL STRUCTURE OF A SUBTYPE N11 NEURAMINIDASE-LIKE PROTEIN OF A/FLAT-FACED BAT/PERU/033/2010 (H18N11)
405, 4k3yD, 0.8225, 2.48, 0.246, 354, 349, CRYSTAL STRUCTURE OF A SUBTYPE N11 NEURAMINIDASE-LIKE PROTEIN OF A/FLAT-FACED BAT/PERU/033/2010 (H18N11)
406, 4k3yC, 0.8225, 2.46, 0.249, 355, 349, CRYSTAL STRUCTURE OF A SUBTYPE N11 NEURAMINIDASE-LIKE PROTEIN OF A/FLAT-FACED BAT/PERU/033/2010 (H18N11)
407, 4gdjB, 0.7538, 2.36, 0.245, 321, 318, A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/060/2010
408, 4gdjA, 0.7512, 2.37, 0.246, 317, 317, A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/060/2010
409, 4gdjD, 0.7461, 2.32, 0.248, 314, 314, A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/060/2010
410, 4gdjC, 0.7434, 2.38, 0.248, 314, 314, A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/060/2010
411, 4fzhC, 0.7223, 4.23, 0.082, 486, 352, STRUCTURE OF THE ULSTER STRAIN NEWCASTLE DISEASE VIRUS HEMAGGLUTININ- NEURAMINIDASE REVEALS AUTO-INHIBITORY INTERACTIONS ASSOCIATED WITH LOW VIRULENCE
412, 4fzhA, 0.7215, 4.21, 0.091, 486, 351, STRUCTURE OF THE ULSTER STRAIN NEWCASTLE DISEASE VIRUS HEMAGGLUTININ- NEURAMINIDASE REVEALS AUTO-INHIBITORY INTERACTIONS ASSOCIATED WITH LOW VIRULENCE
413, 4fzhB, 0.7190, 4.35, 0.082, 486, 353, STRUCTURE OF THE ULSTER STRAIN NEWCASTLE DISEASE VIRUS HEMAGGLUTININ- NEURAMINIDASE REVEALS AUTO-INHIBITORY INTERACTIONS ASSOCIATED WITH LOW VIRULENCE
414, 4fzhD, 0.7182, 4.25, 0.085, 486, 351, STRUCTURE OF THE ULSTER STRAIN NEWCASTLE DISEASE VIRUS HEMAGGLUTININ- NEURAMINIDASE REVEALS AUTO-INHIBITORY INTERACTIONS ASSOCIATED WITH LOW VIRULENCE
415, 1usxA, 0.7115, 4.04, 0.100, 446, 340, CRYSTAL STRUCTURE OF THE NEWCASTLE DISEASE VIRUS HEMAGGLUTININ-NEURAMINIDASE COMPLEXED WITH THIOSIALOSIDE
416, 1usrB, 0.7107, 4.03, 0.097, 446, 339, NEWCASTLE DISEASE VIRUS HEMAGGLUTININ-NEURAMINIDASE: EVIDENCE FOR A SECOND SIALIC ACID BINDING SITE AND IMPLICATIONS FOR FUSION
417, 1usxB, 0.7105, 4.04, 0.100, 446, 339, CRYSTAL STRUCTURE OF THE NEWCASTLE DISEASE VIRUS HEMAGGLUTININ-NEURAMINIDASE COMPLEXED WITH THIOSIALOSIDE
418, 1usrA, 0.7104, 4.03, 0.097, 447, 339, NEWCASTLE DISEASE VIRUS HEMAGGLUTININ-NEURAMINIDASE: EVIDENCE FOR A SECOND SIALIC ACID BINDING SITE AND IMPLICATIONS FOR FUSION
419, 1e8vB, 0.7100, 4.05, 0.097, 446, 339, STRUCTURE OF THE MULTIFUNCTIONAL PARAMYXOVIRUS HEMAGGLUTININ-NEURAMINIDASE
420, 1e8vA, 0.7100, 4.05, 0.097, 447, 339, STRUCTURE OF THE MULTIFUNCTIONAL PARAMYXOVIRUS HEMAGGLUTININ-NEURAMINIDASE
421, 1usxC, 0.7097, 4.01, 0.101, 446, 338, CRYSTAL STRUCTURE OF THE NEWCASTLE DISEASE VIRUS HEMAGGLUTININ-NEURAMINIDASE COMPLEXED WITH THIOSIALOSIDE
422, 1e8tA, 0.7072, 4.19, 0.096, 446, 342, STRUCTURE OF THE MULTIFUNCTIONAL PARAMYXOVIRUS HEMAGGLUTININ-NEURAMINIDASE
423, 1e8uA, 0.7064, 4.06, 0.103, 446, 339, STRUCTURE OF THE MULTIFUNCTIONAL PARAMYXOVIRUS HEMAGGLUTININ-NEURAMINIDASE
424, 1e8tB, 0.7059, 4.11, 0.100, 449, 339, STRUCTURE OF THE MULTIFUNCTIONAL PARAMYXOVIRUS HEMAGGLUTININ-NEURAMINIDASE
425, 1e8uB, 0.7058, 4.08, 0.101, 449, 338, STRUCTURE OF THE MULTIFUNCTIONAL PARAMYXOVIRUS HEMAGGLUTININ-NEURAMINIDASE
426, 4jf7C, 0.7018, 4.06, 0.092, 493, 338, STRUCTURE OF THE PARAINFLUENZA VIRUS 5 (PIV5) HEMAGGLUTININ- NEURAMINIDASE (HN) ECTODOMAIN
427, 4jf7B, 0.7012, 4.18, 0.088, 501, 339, STRUCTURE OF THE PARAINFLUENZA VIRUS 5 (PIV5) HEMAGGLUTININ- NEURAMINIDASE (HN) ECTODOMAIN
428, 3t1eB, 0.7005, 4.15, 0.092, 445, 337, THE STRUCTURE OF THE NEWCASTLE DISEASE VIRUS HEMAGGLUTININ- NEURAMINIDASE (HN) ECTODOMAIN REVEALS A 4-HELIX BUNDLE STALK
429, 3d11A, 0.6997, 3.99, 0.086, 427, 337, CRYSTAL STRUCTURES OF THE NIPAH G ATTACHMENT GLYCOPROTEIN
430, 1z50A, 0.6994, 4.14, 0.092, 448, 338, PARAINFLUENZA VIRUS 5 (SV5) HEMAGGLUTININ-NEURAMINIDASE (HN) WITH LIGAND DANA (SOAKED WITH SIALIC ACID PH 8.0)
431, 1z4wA, 0.6994, 4.17, 0.095, 448, 338, PARAINFLUENZA VIRUS 5 (SV5) HEMAGGLUTININ-NEURAMINIDASE (HN) WITH LIGAND DANA (SOAKED WITH DANA PH8.0)
432, 1z4zA, 0.6993, 4.15, 0.095, 448, 338, PARAINFLUENZA VIRUS 5 (SV5) HEMAGGLUTININ-NEURAMINIDASE (HN) WITH LIGAND DANA(SOAKED WITH SIALIC ACID PH7.0))
433, 1z4xA, 0.6993, 4.14, 0.095, 448, 338, PARAINFLUENZA VIRUS 5 (SV5) HEMAGGLUTININ-NEURAMINIDASE (HN) WITH LIGAND SIALYLLACTOSE (SOAKED WITH SIALYLLACTOSE PH8.0)
434, 4jf7A, 0.6985, 4.16, 0.089, 501, 338, STRUCTURE OF THE PARAINFLUENZA VIRUS 5 (PIV5) HEMAGGLUTININ- NEURAMINIDASE (HN) ECTODOMAIN
435, 3t1eA, 0.6984, 4.15, 0.098, 447, 337, THE STRUCTURE OF THE NEWCASTLE DISEASE VIRUS HEMAGGLUTININ- NEURAMINIDASE (HN) ECTODOMAIN REVEALS A 4-HELIX BUNDLE STALK
436, 4jf7D, 0.6979, 4.18, 0.094, 492, 339, STRUCTURE OF THE PARAINFLUENZA VIRUS 5 (PIV5) HEMAGGLUTININ- NEURAMINIDASE (HN) ECTODOMAIN
437, 6cmgA, 0.6967, 4.11, 0.086, 428, 337, CRYSTAL STRUCTURE OF THE HENDRA VIRUS ATTACHMENT G GLYCOPROTEIN BOUND TO A POTENT CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODY M102.3 
438, 5b2dA, 0.6966, 4.22, 0.077, 450, 338, CRYSTAL STRUCTURE OF MUMPS VIRUS HEMAGGLUTININ-NEURAMINIDASE BOUND TO 3-SIALYLLACTOSE
439, 5b2dB, 0.6964, 4.24, 0.077, 450, 338, CRYSTAL STRUCTURE OF MUMPS VIRUS HEMAGGLUTININ-NEURAMINIDASE BOUND TO 3-SIALYLLACTOSE
440, 6cmiB, 0.6963, 4.18, 0.080, 428, 338, CRYSTAL STRUCTURE OF THE HENDRA VIRUS ATTACHMENT G GLYCOPROTEIN BOUND TO A POTENT CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODY M102.3 
441, 5b2cB, 0.6961, 4.30, 0.077, 450, 339, CRYSTAL STRUCTURE OF MUMPS VIRUS HEMAGGLUTININ-NEURAMINIDASE
442, 5b2cA, 0.6959, 4.24, 0.077, 450, 338, CRYSTAL STRUCTURE OF MUMPS VIRUS HEMAGGLUTININ-NEURAMINIDASE
443, 1v3bA, 0.6953, 4.14, 0.083, 431, 336, STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III
444, 4wefA, 0.6943, 4.17, 0.089, 431, 336, STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III: COMPLEX WITH DIFLUOROSIALIC ACID
445, 1v3eA, 0.6939, 4.16, 0.086, 431, 336, STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III: COMPLEX WITH ZANAMAVIR
446, 4mzeB, 0.6937, 4.18, 0.080, 432, 336, CRYSTAL STRUCTURE OF HPIV3 HEMAGGLUTININ-NEURAMINIDASE H552Q/Q559R MUTANT
447, 1v3cA, 0.6934, 4.16, 0.086, 431, 336, STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III: COMPLEX WITH NEU5AC
448, 3d12A, 0.6933, 4.19, 0.086, 428, 338, CRYSTAL STRUCTURES OF NIPAH VIRUS G ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH ITS RECEPTOR EPHRIN-B3
449, 3d12D, 0.6932, 4.19, 0.086, 428, 338, CRYSTAL STRUCTURES OF NIPAH VIRUS G ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH ITS RECEPTOR EPHRIN-B3
450, 1v2iB, 0.6932, 4.18, 0.092, 431, 337, STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III
451, 1v3dA, 0.6927, 4.17, 0.086, 431, 336, STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III: COMPLEX WITH NEU5AC2EN
452, 1v3bB, 0.6927, 4.19, 0.089, 431, 336, STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III
453, 5kv8A, 0.6926, 4.11, 0.081, 430, 335, CRYSTAL STRUCTURE OF A HPIV HAEMAGGLUTININ-NEURAMINIDASE-INHIBITOR COMPLEX
454, 4wefB, 0.6924, 4.15, 0.093, 431, 335, STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III: COMPLEX WITH DIFLUOROSIALIC ACID
455, 4mzaB, 0.6924, 4.18, 0.083, 437, 336, CRYSTAL STRUCTURE OF HPIV3 HEMAGGLUTININ-NEURAMINIDASE
456, 6c0mB, 0.6923, 4.17, 0.083, 428, 336, THE SYNTHESIS; BIOLOGICAL EVALUATION AND STRUCTURAL INSIGHTS OF UNSATURATED 3-N-SUBSTITUTED SIALIC ACIDS AS PROBES OF HUMAN PARAINFLUENZA VIRUS-3 HAEMAGGLUTININ-NEURAMINIDASE 
457, 1v3cB, 0.6921, 4.19, 0.089, 431, 336, STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III: COMPLEX WITH NEU5AC
458, 1v3eB, 0.6919, 4.15, 0.090, 431, 335, STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III: COMPLEX WITH ZANAMAVIR
459, 4mzeA, 0.6917, 4.21, 0.077, 432, 336, CRYSTAL STRUCTURE OF HPIV3 HEMAGGLUTININ-NEURAMINIDASE H552Q/Q559R MUTANT
460, 6c0mA, 0.6914, 4.22, 0.086, 431, 337, THE SYNTHESIS; BIOLOGICAL EVALUATION AND STRUCTURAL INSIGHTS OF UNSATURATED 3-N-SUBSTITUTED SIALIC ACIDS AS PROBES OF HUMAN PARAINFLUENZA VIRUS-3 HAEMAGGLUTININ-NEURAMINIDASE 
461, 4xjrA, 0.6914, 4.13, 0.081, 429, 335, THE CATALYTIC MECHANISM OF HUMAN PARAINFLUENZA VIRUS TYPE 3 HAEMAGGLUTININ-NEURAMINIDASE REVEALED
462, 4xjqB, 0.6914, 4.20, 0.083, 434, 336, THE CATALYTIC MECHANISM OF HUMAN PARAINFLUENZA VIRUS TYPE 3 HAEMAGGLUTININ-NEURAMINIDASE REVEALED
463, 5kv8B, 0.6913, 4.18, 0.087, 424, 335, CRYSTAL STRUCTURE OF A HPIV HAEMAGGLUTININ-NEURAMINIDASE-INHIBITOR COMPLEX
464, 4uf7A, 0.6911, 4.02, 0.078, 417, 334, GHANAIAN HENIPAVIRUS (GH-M74A) ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN EPHRINB2
465, 1v3dB, 0.6910, 4.21, 0.095, 431, 336, STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III: COMPLEX WITH NEU5AC2EN
466, 5nopA, 0.6907, 4.28, 0.071, 423, 338, STRUCTURE OF MOJIANG VIRUS ATTACHMENT GLYCOPROTEIN
467, 4mzaA, 0.6906, 4.23, 0.077, 432, 336, CRYSTAL STRUCTURE OF HPIV3 HEMAGGLUTININ-NEURAMINIDASE
468, 5kv9B, 0.6905, 4.16, 0.087, 430, 335, CRYSTAL STRUCTURE OF A HPIV HAEMAGGLUTININ-NEURAMINIDASE-INHIBITOR COMPLEX
469, 1v2iA, 0.6904, 4.30, 0.086, 431, 338, STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III
470, 3h72B, 0.6900, 3.76, 0.131, 477, 320, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE D39 NEURAMINIDASE A PRECURSOR (NANA) IN COMPLEX WITH NANA
471, 4xjqA, 0.6898, 4.28, 0.083, 432, 337, THE CATALYTIC MECHANISM OF HUMAN PARAINFLUENZA VIRUS TYPE 3 HAEMAGGLUTININ-NEURAMINIDASE REVEALED
472, 1z4vA, 0.6896, 4.13, 0.096, 444, 334, PARAINFLUENZA VIRUS 5 (SV5) HEMAGGLUTININ-NEURAMINIDASE (HN) WITH LIGAND DANA (SOAKED WITH DANA PH 7.0)
473, 3h73B, 0.6891, 3.84, 0.127, 477, 322, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE D39 NEURAMINIDASE A PRECURSOR (NANA) IN COMPLEX WITH DANA
474, 4uf7B, 0.6890, 4.02, 0.078, 412, 333, GHANAIAN HENIPAVIRUS (GH-M74A) ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN EPHRINB2
475, 3h72A, 0.6890, 3.64, 0.129, 474, 318, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE D39 NEURAMINIDASE A PRECURSOR (NANA) IN COMPLEX WITH NANA
476, 4xjrB, 0.6888, 4.27, 0.083, 426, 337, THE CATALYTIC MECHANISM OF HUMAN PARAINFLUENZA VIRUS TYPE 3 HAEMAGGLUTININ-NEURAMINIDASE REVEALED
477, 5nopB, 0.6885, 4.26, 0.071, 434, 337, STRUCTURE OF MOJIANG VIRUS ATTACHMENT GLYCOPROTEIN
478, 3h73A, 0.6883, 3.65, 0.129, 474, 318, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE D39 NEURAMINIDASE A PRECURSOR (NANA) IN COMPLEX WITH DANA
479, 1z4yA, 0.6883, 4.18, 0.087, 443, 333, PARAINFLUENZA VIRUS 5 (SV5) HEMAGGLUTININ-NEURAMINIDASE (HN) (PH 8.0)
480, 2ya7C, 0.6880, 3.58, 0.127, 470, 316, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANA (TIGR4) IN COMPLEX WITH ZANAMIVIR
481, 2ya5A, 0.6865, 3.62, 0.127, 471, 316, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANA (TIGR4) IN COMPLEX WITH SIALIC ACID
482, 2ya7A, 0.6864, 3.59, 0.130, 469, 315, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANA (TIGR4) IN COMPLEX WITH ZANAMIVIR
483, 5kkyA, 0.6860, 3.75, 0.123, 471, 318, STRUCTURE OF STREPTOCOCCUS PNEUMONIA NANA BOUND WITH INHIBITOR 9N3NEU5AC2EN
484, 2ya6A, 0.6859, 3.72, 0.126, 470, 318, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANA (TIGR4) IN COMPLEX WITH DANA
485, 4xyxA, 0.6858, 3.79, 0.138, 660, 318, NANB PLUS OPTACTAMIDE
486, 2f29A, 0.6858, 3.35, 0.100, 370, 310, CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 Q116E MUTANT IN COMPLEX WITH DANA INHIBITOR
487, 5kkyB, 0.6856, 3.72, 0.123, 470, 317, STRUCTURE OF STREPTOCOCCUS PNEUMONIA NANA BOUND WITH INHIBITOR 9N3NEU5AC2EN
488, 2ya8A, 0.6856, 3.70, 0.123, 470, 317, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANA (TIGR4) IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE
489, 2ya4A, 0.6856, 3.57, 0.127, 470, 315, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANA (TIGR4)
490, 2ya7D, 0.6854, 3.56, 0.127, 470, 315, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANA (TIGR4) IN COMPLEX WITH ZANAMIVIR
491, 2vvzB, 0.6854, 3.65, 0.130, 470, 316, STRUCTURE OF THE CATALYTIC DOMAIN OF STREPTOCOCCUS PNEUMONIAE SIALIDASE NANA
492, 2vvzA, 0.6853, 3.58, 0.127, 470, 315, STRUCTURE OF THE CATALYTIC DOMAIN OF STREPTOCOCCUS PNEUMONIAE SIALIDASE NANA
493, 2f27B, 0.6851, 3.37, 0.103, 373, 310, CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 E111Q-Q112E DOUBLE MUTANT IN COMPLEX WITH DANA INHIBITOR
494, 1vcuA, 0.6851, 3.37, 0.103, 370, 310, STRUCTURE OF THE HUMAN CYTOSOLIC SIALIDASE NEU2 IN COMPLEX WITH THE INHIBITOR DANA
495, 2w20B, 0.6848, 3.63, 0.127, 469, 315, STRUCTURE OF THE CATALYTIC DOMAIN OF THE NATIVE NANA SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE
496, 1vcuB, 0.6846, 3.36, 0.103, 373, 310, STRUCTURE OF THE HUMAN CYTOSOLIC SIALIDASE NEU2 IN COMPLEX WITH THE INHIBITOR DANA
497, 2w20A, 0.6845, 3.61, 0.127, 470, 315, STRUCTURE OF THE CATALYTIC DOMAIN OF THE NATIVE NANA SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE
498, 4xjzA, 0.6844, 3.71, 0.142, 658, 316, CRYSTAL STRUCTURE OF APO NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE AT PH 7.4 IN PBS WITH DMSO
499, 2ya7B, 0.6844, 3.65, 0.127, 468, 315, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANA (TIGR4) IN COMPLEX WITH ZANAMIVIR
500, 4xjwA, 0.6842, 3.71, 0.136, 658, 316, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH OPTACTIN AT PH 7.4 IN PBS WITH DMSO AS THE CRYOPROTECTANT
501, 2f29B, 0.6841, 3.39, 0.106, 370, 310, CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 Q116E MUTANT IN COMPLEX WITH DANA INHIBITOR
502, 2f25B, 0.6839, 3.38, 0.106, 370, 310, CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 E111Q MUTANT IN COMPLEX WITH DANA INHIBITOR
503, 4xjuA, 0.6836, 3.74, 0.142, 658, 316, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 4-ACETAMIDO-2-FLUORO-3-HYDROXY-6-[12- DIHYDROXYETHYL]-78-DIOXABICYCLO[3.2.1]OCTANE-1-CARBOXYLIC ACID
504, 2ya6B, 0.6836, 3.62, 0.127, 470, 315, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANA (TIGR4) IN COMPLEX WITH DANA
505, 4xj9A, 0.6835, 3.72, 0.136, 658, 316, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH OPTACTIN AT PH 5.0 IN 50MM SODIUM ACETATE WITH DMSO AS THE CRYOPROTECTANT
506, 2vwdA, 0.6835, 3.93, 0.085, 413, 328, NIPAH VIRUS ATTACHMENT GLYCOPROTEIN
507, 2f27A, 0.6835, 3.39, 0.103, 370, 310, CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 E111Q-Q112E DOUBLE MUTANT IN COMPLEX WITH DANA INHIBITOR
508, 4xogA, 0.6833, 3.74, 0.136, 660, 316, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH OPTACTIN AND DANA
509, 4fpkA, 0.6832, 3.74, 0.133, 658, 316, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(3-METHYLBENZYL)AMMONIO]ETHANESULFONATE
510, 2f25A, 0.6832, 3.37, 0.106, 373, 310, CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 E111Q MUTANT IN COMPLEX WITH DANA INHIBITOR
511, 4xikA, 0.6831, 3.73, 0.142, 658, 316, CRYSTAL STRUCTURE OF NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH DMSO
512, 4fovA, 0.6830, 3.73, 0.136, 658, 316, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 3-CYCLOHEXYL-1-PROPYLSULFONIC ACID
513, 4foqA, 0.6830, 3.73, 0.136, 658, 316, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-AMINOETHANESULFONIC ACID
514, 4xjaA, 0.6829, 3.75, 0.142, 658, 316, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 5-ACETAMIDO-23-DIFLUORO-3-HYDROXY-6-[123- TRIHYDROXYPROPYL]OXANE-2-CARBOXYLIC ACID
515, 4xj8A, 0.6829, 3.74, 0.142, 658, 316, CRYSTAL STRUCTURE OF APO NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE AT PH 5.0 IN 50MM SODIUM ACETATE WITH DMSO
516, 4xe9A, 0.6829, 3.74, 0.142, 658, 316, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH OPTACTIN
517, 4fphA, 0.6829, 3.73, 0.136, 658, 316, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(3-FLUOROBENZYL)AMMONIO]ETHANESULFONATE
518, 4foyA, 0.6829, 3.74, 0.136, 658, 316, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-(BENZYLAMMONIO)ETHANESULFONATE
519, 4fq4A, 0.6828, 3.69, 0.137, 658, 315, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(4-FLUORO-3-METHYLBENZYL)AMMONIO]ETHANESULFONATE
520, 2ya5B, 0.6828, 3.69, 0.127, 470, 316, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANA (TIGR4) IN COMPLEX WITH SIALIC ACID
521, 4fpyA, 0.6827, 3.74, 0.142, 658, 316, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(3-BROMOBENZYL)AMMONIO]ETHANESULFONATE
522, 4fplA, 0.6827, 3.74, 0.136, 658, 316, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(34-DICHLOROBENZYL)AMMONIO]ETHANESULFONATE
523, 2ya8B, 0.6827, 3.63, 0.127, 470, 315, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANA (TIGR4) IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE
524, 2ya4B, 0.6827, 3.61, 0.127, 471, 315, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANA (TIGR4)
525, 4fpgA, 0.6826, 3.75, 0.136, 658, 316, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(3-HYDROXYBENZYL)AMMONIO]ETHANESULFONATE
526, 4fpjA, 0.6825, 3.74, 0.136, 658, 316, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(3-METHOXYBENZYL)AMMONIO]ETHANESULFONATE
527, 4fpeA, 0.6824, 3.74, 0.142, 658, 316, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(4-METHOXYBENZYL)AMMONIO]ETHANESULFONATE
528, 4xhxA, 0.6823, 3.76, 0.142, 658, 316, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH OPTACTIN AND 2-[(3-CHLOROBENZYL) AMMONIO]ETHANESULFONATE
529, 4fpfA, 0.6823, 3.70, 0.137, 658, 315, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(3-CHLOROBENZYL)AMMONIO]ETHANESULFONATE
530, 2x9mA, 0.6823, 4.18, 0.075, 419, 333, HENDRA VIRUS ATTACHMENT GLYCOPROTEIN
531, 4fowA, 0.6822, 3.75, 0.139, 658, 316, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 3-AMMONIOPROPANE-1-SULFONATE
532, 4xmaA, 0.6821, 3.76, 0.136, 658, 316, CRYSTAL STRUCTURE OF THE K499G MUTANT OF NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH OPTACTIN
533, 4xioA, 0.6819, 3.76, 0.136, 658, 316, CRYSTAL STRUCTURE OF APO NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE AT PH 8.0 WITH MPD AS THE CRYOPROTECTANT
534, 2sliA, 0.6819, 3.79, 0.107, 679, 319, LEECH INTRAMOLECULAR TRANS-SIALIDASE COMPLEXED WITH 27- ANHYDRO-NEU5AC THE REACTION PRODUCT
535, 2jkbA, 0.6819, 3.74, 0.130, 661, 316, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANB IN COMPLEX WITH 27-ANHYDRO-NEU5AC
536, 4xilA, 0.6815, 3.71, 0.133, 658, 315, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH OPTACTIN AT PH 7.4 IN PBS WITH MPD AS THE CRYOPROTECTANT
537, 4xhbA, 0.6813, 3.77, 0.136, 658, 316, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH PENTANEDIOL AND CHES
538, 4fp2A, 0.6813, 3.77, 0.136, 658, 316, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2[(CYCLOHEXYLMETHYL)AMMONIO]SULFONATE
539, 4fpoB, 0.6812, 3.77, 0.142, 658, 316, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(3-CHLORO-4-METHOXYBENZYL)AMMONIO]ETHANESULFONATE
540, 4xmiA, 0.6811, 3.73, 0.143, 657, 315, CRYSTAL STRUCTURE OF THE K499G MUTANT OF NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE
541, 1sllA, 0.6810, 3.81, 0.110, 679, 319, SIALIDASE L FROM LEECH MACROBDELLA DECORA
542, 4fp3A, 0.6807, 3.77, 0.136, 658, 316, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(FURAN-2-YLMETHYL)AMMONIO]SULFONATE
543, 4sliA, 0.6806, 3.83, 0.110, 679, 319, LEECH INTRAMOLECULAR TRANS-SIALIDASE COMPLEXED WITH 2- PROPENYL-NEU5AC AN INACTIVE SUBSTRATE ANALOGUE
544, 4fpcA, 0.6805, 3.79, 0.136, 658, 316, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(4-CHLOROBENZYL)AMMONIO]ETHANESULFONATE
545, 3sliA, 0.6805, 3.84, 0.110, 679, 319, LEECH INTRAMOLECULAR TRANS-SIALIDASE COMPLEXED WITH 27- ANHYDRO-NEU5AC PREPARED BY SOAKING WITH 3 -SIALYLLACTOSE
546, 1sliA, 0.6805, 3.84, 0.110, 679, 319, LEECH INTRAMOLECULAR TRANS-SIALIDASE COMPLEXED WITH DANA
547, 2vw2A, 0.6803, 3.74, 0.133, 658, 315, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE
548, 4x49A, 0.6802, 3.97, 0.106, 489, 320, CRYSTAL STRUCTURE OF THE INTRAMOLECULAR TRANS-SIALIDASE FROM RUMINOCOCCUS GNAVUS IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE
549, 2x9mB, 0.6802, 4.21, 0.084, 418, 332, HENDRA VIRUS ATTACHMENT GLYCOPROTEIN
550, 2vw1A, 0.6802, 3.74, 0.133, 658, 315, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE
551, 4x47A, 0.6797, 3.97, 0.106, 489, 320, CRYSTAL STRUCTURE OF THE INTRAMOLECULAR TRANS-SIALIDASE FROM RUMINOCOCCUS GNAVUS IN COMPLEX WITH NEU5AC2EN
552, 4m4vB, 0.6797, 3.66, 0.104, 384, 316, STRUCTURAL EVALUATION R171L MUTANT OF THE ASPERGILLUS FUMIGATUS KDNASE (SIALIDASE)
553, 2xzjB, 0.6797, 3.63, 0.111, 384, 315, THE ASPERGILLUS FUMIGATUS SIALIDASE IS A KDNASE: STRUCTURAL AND MECHANISTIC INSIGHTS
554, 2xziB, 0.6796, 3.64, 0.111, 384, 315, THE ASPERGILLUS FUMIGATUS SIALIDASE IS A KDNASE: STRUCTURAL AND MECHANISTIC INSIGHTS
555, 2vw0A, 0.6795, 3.76, 0.130, 657, 315, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE
556, 2vsmA, 0.6794, 4.10, 0.085, 413, 329, NIPAH VIRUS ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN CELL SURFACE RECEPTOR EPHRINB2
557, 4m4uB, 0.6792, 3.67, 0.101, 384, 316, STRUCTURAL EVALUATION D84A MUTANT OF THE ASPERGILLUS FUMIGATUS KDNASE (SIALIDASE)
558, 2xzkA, 0.6791, 3.70, 0.114, 385, 316, THE ASPERGILLUS FUMIGATUS SIALIDASE IS A KDNASE: STRUCTURAL AND MECHANISTIC INSIGHTS
559, 4m4vA, 0.6790, 3.60, 0.108, 385, 314, STRUCTURAL EVALUATION R171L MUTANT OF THE ASPERGILLUS FUMIGATUS KDNASE (SIALIDASE)
560, 4x6kA, 0.6789, 3.93, 0.110, 485, 319, CRYSTAL STRUCTURE OF THE INTRAMOLECULAR TRANS-SIALIDASE FROM RUMINOCOCCUS GNAVUS IN COMPLEX WITH SIASTATIN B
561, 4m4uA, 0.6789, 3.60, 0.105, 384, 314, STRUCTURAL EVALUATION D84A MUTANT OF THE ASPERGILLUS FUMIGATUS KDNASE (SIALIDASE)
562, 2xzkB, 0.6787, 3.58, 0.108, 384, 314, THE ASPERGILLUS FUMIGATUS SIALIDASE IS A KDNASE: STRUCTURAL AND MECHANISTIC INSIGHTS
563, 2xzjA, 0.6784, 3.52, 0.109, 386, 313, THE ASPERGILLUS FUMIGATUS SIALIDASE IS A KDNASE: STRUCTURAL AND MECHANISTIC INSIGHTS
564, 4m4nA, 0.6783, 3.53, 0.105, 386, 313, STRUCTURAL EVALUATION THE Y358H MUTANT OF THE ASPERGILLUS FUMIGATUS KDNASE (SIALIDASE)
565, 4m4nB, 0.6781, 3.59, 0.105, 384, 314, STRUCTURAL EVALUATION THE Y358H MUTANT OF THE ASPERGILLUS FUMIGATUS KDNASE (SIALIDASE)
566, 2xziA, 0.6768, 3.79, 0.101, 385, 318, THE ASPERGILLUS FUMIGATUS SIALIDASE IS A KDNASE: STRUCTURAL AND MECHANISTIC INSIGHTS
567, 2x9mD, 0.6766, 4.28, 0.078, 417, 332, HENDRA VIRUS ATTACHMENT GLYCOPROTEIN
568, 2x9mC, 0.6766, 4.29, 0.078, 417, 332, HENDRA VIRUS ATTACHMENT GLYCOPROTEIN
569, 4x4aA, 0.6757, 3.79, 0.105, 485, 315, CRYSTAL STRUCTURE OF THE INTRAMOLECULAR TRANS-SIALIDASE FROM RUMINOCOCCUS GNAVUS IN COMPLEX WITH 27-ANHYDRO-NEU5AC
570, 2vwdB, 0.6757, 4.01, 0.095, 410, 325, NIPAH VIRUS ATTACHMENT GLYCOPROTEIN
571, 2vk5A, 0.6743, 3.74, 0.092, 448, 315, THE STRUCTURE OF CLOSTRIDIUM PERFRINGENS NANI SIALIDASE AND ITS CATALYTIC INTERMEDIATES
572, 2vk7B, 0.6742, 3.87, 0.095, 448, 317, THE STRUCTURE OF CLOSTRIDIUM PERFRINGENS NANI SIALIDASE AND ITS CATALYTIC INTERMEDIATES
573, 2bf6A, 0.6742, 3.74, 0.092, 448, 315, ATOMIC RESOLUTION STRUCTURE OF THE BACTERIAL SIALIDASE NANI FROM CLOSTRIDIUM PERFRINGENS IN COMPLEX WITH ALPHA-SIALIC ACID (NEU5AC).
574, 5tspB, 0.6739, 3.75, 0.095, 448, 315, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF CLOSTRIDIUM PERFRINGENS NEURAMINIDASE (NANI) IN COMPLEX WITH A CHES
575, 2vk7A, 0.6732, 3.76, 0.092, 448, 315, THE STRUCTURE OF CLOSTRIDIUM PERFRINGENS NANI SIALIDASE AND ITS CATALYTIC INTERMEDIATES
576, 1eutA, 0.6727, 3.40, 0.105, 601, 306, SIALIDASE LARGE 68KD FORM COMPLEXED WITH GALACTOSE
577, 5tspA, 0.6725, 3.76, 0.095, 448, 315, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF CLOSTRIDIUM PERFRINGENS NEURAMINIDASE (NANI) IN COMPLEX WITH A CHES
578, 2vk6A, 0.6725, 3.77, 0.095, 448, 315, THE STRUCTURE OF CLOSTRIDIUM PERFRINGENS NANI SIALIDASE AND ITS CATALYTIC INTERMEDIATES
579, 1euuA, 0.6725, 3.41, 0.105, 601, 306, SIALIDASE OR NEURAMINIDASE LARGE 68KD FORM
580, 2berA, 0.6720, 3.42, 0.101, 601, 306, Y370G ACTIVE SITE MUTANT OF THE SIALIDASE FROM MICROMONOSPORA VIRIDIFACIENS IN COMPLEX WITH BETA-NEU5AC (SIALIC ACID).
581, 2vskA, 0.6718, 4.05, 0.083, 400, 324, HENDRA VIRUS ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN CELL SURFACE RECEPTOR EPHRINB2
582, 3h71B, 0.6714, 3.81, 0.124, 465, 314, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE D39 NEURAMINIDASE A PRECURSOR (NANA)
583, 1w8nA, 0.6713, 3.42, 0.101, 601, 306, CONTRIBUTION OF THE ACTIVE SITE ASPARTIC ACID TO CATALYSIS IN THE BACTERIAL NEURAMINIDASE FROM MICROMONOSPORA VIRIDIFACIENS.
584, 2agsA, 0.6712, 3.80, 0.099, 634, 314, TRYPANOSOMA RANGELI SIALIDASE IN COMPLEX WITH 2-KETO-3- DEOXY-D-GLYCERO-D-GALACTO-23-DIFLUORO-NONONIC ACID (23- DIFLUORO-KDN)
585, 1eurA, 0.6712, 3.43, 0.105, 361, 306, SIALIDASE
586, 1wcqA, 0.6710, 3.44, 0.101, 601, 306, MUTAGENESIS OF THE NUCLEOPHILIC TYROSINE IN A BACTERIAL SIALIDASE TO PHENYLALANINE.
587, 2a75A, 0.6708, 3.81, 0.099, 632, 314, TRYPANOSOMA RANGELI SIALIDASE IN COMPLEX WITH 23- DIFLUOROSIALIC ACID (COVALENT INTERMEDIATE)
588, 1n1tA, 0.6708, 3.81, 0.099, 628, 314, TRYPANOSOMA RANGELI SIALIDASE IN COMPLEX WITH DANA AT 1.6 A
589, 1eusA, 0.6708, 3.35, 0.105, 358, 305, SIALIDASE COMPLEXED WITH 2-DEOXY-23-DEHYDRO-N- ACETYLNEURAMINIC ACID
590, 2vskC, 0.6706, 4.08, 0.077, 399, 324, HENDRA VIRUS ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN CELL SURFACE RECEPTOR EPHRINB2
591, 2fhrA, 0.6705, 3.80, 0.099, 625, 314, TRYPANOSOMA RANGELI SIALIDASE IN COMPLEX WITH 23- DIFLUOROSIALIC ACID (COVALENT INTERMEDIATE)
592, 1wcqB, 0.6704, 3.44, 0.101, 601, 306, MUTAGENESIS OF THE NUCLEOPHILIC TYROSINE IN A BACTERIAL SIALIDASE TO PHENYLALANINE.
593, 4ncsA, 0.6703, 3.39, 0.099, 350, 304, HUMAN SIALIDASE 2 IN COMPLEX WITH 23-DIFLUOROSIALIC ACID (COVALENT INTERMEDIATE)
594, 1ms3A, 0.6703, 3.81, 0.105, 623, 314, MONOCLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE
595, 2f12A, 0.6702, 3.40, 0.105, 359, 304, CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 IN COMPLEX WITH 3- HYDROXYPROPYL ETHER MIMETIC INHIBITOR
596, 1w8oA, 0.6702, 3.46, 0.101, 601, 306, CONTRIBUTION OF THE ACTIVE SITE ASPARTIC ACID TO CATALYSIS IN THE BACTERIAL NEURAMINIDASE FROM MICROMONOSPORA VIRIDIFACIENS
597, 1s0iA, 0.6702, 3.87, 0.098, 623, 315, TRYPANOSOMA CRUZI TRANS-SIALIDASE IN COMPLEX WITH SIALYL- LACTOSE (MICHAELIS COMPLEX)
598, 1ms3B, 0.6702, 3.81, 0.105, 623, 314, MONOCLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE
599, 1n1vA, 0.6701, 3.82, 0.099, 628, 314, TRYPANOSOMA RANGELI SIALIDASE IN COMPLEX WITH DANA
600, 5f9tA, 0.6700, 3.99, 0.119, 659, 318, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC COVALENT COMPLEX WITH A FLUORINATED NEU5AC DERIVATIVE
601, 3pjqA, 0.6699, 3.87, 0.102, 626, 315, TRYPANOSOMA CRUZI TRANS-SIALIDASE-LIKE INACTIVE ISOFORM (INCLUDING THE NATURAL MUTATION TYR342HIS) IN COMPLEX WITH LACTOSE
602, 2bzdC, 0.6699, 3.41, 0.098, 600, 305, GALACTOSE RECOGNITION BY THE CARBOHYDRATE-BINDING MODULE OF A BACTERIAL SIALIDASE.
603, 1n1sA, 0.6699, 3.81, 0.099, 628, 314, TRYPANOSOMA RANGELI SIALIDASE
604, 1wcqC, 0.6698, 3.35, 0.099, 599, 304, MUTAGENESIS OF THE NUCLEOPHILIC TYROSINE IN A BACTERIAL SIALIDASE TO PHENYLALANINE.
605, 4nc5A, 0.6697, 3.40, 0.099, 354, 304, HUMAN SIALIDASE 2 IN COMPLEX WITH 23-DIFLUOROSIALIC ACID (COVALENT INTERMEDIATE)
606, 2bzdB, 0.6697, 3.46, 0.101, 601, 306, GALACTOSE RECOGNITION BY THE CARBOHYDRATE-BINDING MODULE OF A BACTERIAL SIALIDASE.
607, 2bzdA, 0.6697, 3.47, 0.101, 601, 306, GALACTOSE RECOGNITION BY THE CARBOHYDRATE-BINDING MODULE OF A BACTERIAL SIALIDASE.
608, 1mz6A, 0.6697, 3.81, 0.099, 620, 314, TRYPANOSOMA RANGELI SIALIDASE IN COMPLEX WITH THE INHIBITOR DANA
609, 1mz5A, 0.6697, 3.82, 0.099, 622, 314, TRYPANOSOMA RANGELI SIALIDASE
610, 4yw2A, 0.6696, 4.00, 0.119, 659, 318, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC COMPLEX 6 SL
611, 2xcyA, 0.6696, 3.64, 0.110, 381, 310, CRYSTAL STRUCTURE OF ASPERGILLUS FUMIGATUS SIALIDASE
612, 4yw5A, 0.6694, 4.00, 0.119, 659, 318, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC COMPLEX WITH OSELTAMIVIR CARBOXYLATE
613, 3h71A, 0.6694, 3.72, 0.128, 462, 313, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE D39 NEURAMINIDASE A PRECURSOR (NANA)
614, 2f13A, 0.6694, 3.41, 0.102, 351, 304, CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 IN COMPLEX WITH 2 3 - DIHYDROXYPROPYL ETHER MIMETIC INHIBITOR
615, 5f9tB, 0.6692, 4.01, 0.119, 659, 318, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC COVALENT COMPLEX WITH A FLUORINATED NEU5AC DERIVATIVE
616, 4yw4A, 0.6692, 4.02, 0.119, 659, 318, STREPTOCOCCUS PNEUMONIAE SIALIDASE NANC
617, 4yw3A, 0.6692, 4.01, 0.119, 659, 318, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC COMPLEX WITH NEU5AC AND NEU5AC2EN FOLLOWING SOAKING WITH NEU5AC2EN
618, 4yw1A, 0.6691, 4.02, 0.119, 659, 318, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC COMPLEX WITH NEU5AC AND NEU5AC2EN FOLLOWING SOAKING WITH 3 SL
619, 2ah2A, 0.6691, 3.83, 0.096, 624, 314, TRYPANOSOMA CRUZI TRANS-SIALIDASE IN COMPLEX WITH 23-DIFLUOROSIALIC ACID (COVALENT INTERMEDIATE)
620, 1s0jA, 0.6691, 3.76, 0.102, 623, 313, TRYPANOSOMA CRUZI TRANS-SIALIDASE IN COMPLEX WITH MUNANA (MICHAELIS COMPLEX)
621, 4yz1A, 0.6690, 4.01, 0.119, 656, 318, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC APO STRUCTURE.
622, 2xcyB, 0.6688, 3.66, 0.103, 379, 311, CRYSTAL STRUCTURE OF ASPERGILLUS FUMIGATUS SIALIDASE
623, 3b69A, 0.6687, 3.76, 0.105, 626, 313, T CRUZI TRANS-SIALIDASE COMPLEX WITH BENZOYLATED NANA DERIVATIVE
624, 2f10A, 0.6687, 3.42, 0.109, 349, 304, CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 IN COMPLEX WITH PERAMIVIR INHIBITOR
625, 1wcsA, 0.6687, 3.76, 0.099, 628, 313, A MUTANT OF TRYPANOSOMA RANGELI SIALIDASE DISPLAYING TRANS- SIALIDASE ACTIVITY
626, 4yw3B, 0.6686, 4.03, 0.119, 659, 318, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC COMPLEX WITH NEU5AC AND NEU5AC2EN FOLLOWING SOAKING WITH NEU5AC2EN
627, 4yw2B, 0.6686, 4.03, 0.119, 659, 318, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC COMPLEX 6 SL
628, 3opzC, 0.6686, 3.79, 0.105, 625, 313, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
629, 1ms1B, 0.6685, 3.79, 0.096, 622, 313, MONOCLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE IN COMPLEX WITH 3-DEOXY-23-DEHYDRO-N-ACETYLNEURAMINIC ACID (DANA)
630, 1ms1A, 0.6685, 3.77, 0.105, 622, 313, MONOCLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE IN COMPLEX WITH 3-DEOXY-23-DEHYDRO-N-ACETYLNEURAMINIC ACID (DANA)
631, 4yz1B, 0.6684, 3.95, 0.120, 656, 317, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC APO STRUCTURE.
632, 4yw5B, 0.6684, 4.03, 0.119, 659, 318, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC COMPLEX WITH OSELTAMIVIR CARBOXYLATE
633, 3opzB, 0.6684, 3.79, 0.105, 625, 313, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
634, 3opzA, 0.6684, 3.79, 0.105, 625, 313, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
635, 4yw4B, 0.6683, 4.04, 0.119, 659, 318, STREPTOCOCCUS PNEUMONIAE SIALIDASE NANC
636, 1ms4A, 0.6681, 3.79, 0.105, 623, 313, TRICLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE
637, 4yw1B, 0.6680, 4.03, 0.113, 659, 318, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC COMPLEX WITH NEU5AC AND NEU5AC2EN FOLLOWING SOAKING WITH 3 SL
638, 1ms5A, 0.6680, 3.87, 0.096, 623, 314, TRICLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE SOAKED WITH N-ACETYLNEURAMINYL-A-23-THIO-GALACTOSIDE (NA-S-GAL)
639, 2f0zA, 0.6678, 3.42, 0.106, 356, 303, CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 IN COMPLEX WITH ZANAMIVIR INHIBITOR
640, 1ms9A, 0.6678, 3.80, 0.105, 622, 313, TRICLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE IN COMPLEX WITH LACTOSE
641, 1ms4B, 0.6678, 3.80, 0.105, 623, 313, TRICLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE
642, 2f11A, 0.6677, 3.42, 0.106, 347, 303, CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 IN COMPLEX WITH ISOBUTYL ETHER MIMETIC INHIBITOR
643, 1ms5B, 0.6677, 3.87, 0.105, 621, 314, TRICLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE SOAKED WITH N-ACETYLNEURAMINYL-A-23-THIO-GALACTOSIDE (NA-S-GAL)
644, 1ms9B, 0.6676, 3.80, 0.105, 623, 313, TRICLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE IN COMPLEX WITH LACTOSE
645, 4yz2B, 0.6673, 3.98, 0.120, 656, 317, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC IN COMPLEX WITH 2- DEOXY-23-DIDEHYDRO-N-ACETYLNEURAMINIC ACID.
646, 4yz4B, 0.6671, 3.99, 0.120, 656, 317, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC IN COMPLEX WITH N- ACETYLNEURAMINIC ACID.
647, 1mr5A, 0.6670, 3.76, 0.106, 621, 312, ORTHORHOMBIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE
648, 4yz4A, 0.6669, 3.99, 0.120, 655, 317, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC IN COMPLEX WITH N- ACETYLNEURAMINIC ACID.
649, 4yz3B, 0.6669, 4.00, 0.113, 656, 318, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC IN COMPLEX WITH OSELTAMIVIR.
650, 4yz2A, 0.6669, 3.99, 0.120, 655, 317, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC IN COMPLEX WITH 2- DEOXY-23-DIDEHYDRO-N-ACETYLNEURAMINIC ACID.
651, 4yz5A, 0.6668, 3.99, 0.120, 656, 317, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC IN COMPLEX WITH 3- SIALYLLACTOSE
652, 1ms8A, 0.6668, 3.82, 0.105, 624, 313, TRICLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE IN COMPLEX WITH 3-DEOXY-23-DEHYDRO-N-ACETYLNEURAMINIC ACID (DANA)
653, 4yz3A, 0.6665, 4.01, 0.110, 654, 318, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC IN COMPLEX WITH OSELTAMIVIR.
654, 4yz5B, 0.6664, 4.01, 0.113, 654, 318, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC IN COMPLEX WITH 3- SIALYLLACTOSE
655, 1ms8B, 0.6664, 3.89, 0.105, 623, 314, TRICLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE IN COMPLEX WITH 3-DEOXY-23-DEHYDRO-N-ACETYLNEURAMINIC ACID (DANA)
656, 1ms0B, 0.6661, 3.94, 0.102, 623, 315, MONOCLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE IN COMPLEX WITH 3-DEOXY-23-DEHYDRO-N-ACETYLNEURAMINIC ACID (DANA)AND LACTOSE
657, 1ms0A, 0.6661, 3.90, 0.102, 623, 314, MONOCLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE IN COMPLEX WITH 3-DEOXY-23-DEHYDRO-N-ACETYLNEURAMINIC ACID (DANA)AND LACTOSE
658, 4j9tA, 0.6659, 3.26, 0.086, 355, 302, CRYSTAL STRUCTURE OF A PUTATIVE DE NOVO DESIGNED UNNATURAL AMINO ACID DEPENDENT METALLOPROTEIN NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET OR61
659, 1sntA, 0.6656, 3.47, 0.102, 352, 303, STRUCTURE OF THE HUMAN CYTOSOLIC SIALIDASE NEU2
660, 1so7A, 0.6653, 3.47, 0.102, 361, 303, MALTOSE-INDUCED STRUCTURE OF THE HUMAN CYTOLSOLIC SIALIDASE NEU2
661, 1n1yA, 0.6652, 3.94, 0.092, 628, 315, TRYPANOSOMA RANGELI SIALIDASE IN COMPLEX WITH SIALIC ACID
662, 6ekuA, 0.6650, 3.63, 0.107, 755, 308, VIBRIO CHOLERAE NEURAMINIDASE COMPLEXED WITH ZANAMIVIR
663, 1w0pA, 0.6648, 3.71, 0.110, 753, 309, VIBRIO CHOLERAE SIALIDASE WITH ALPHA-26-SIALYLLACTOSE
664, 1w0oA, 0.6646, 3.70, 0.110, 753, 309, VIBRIO CHOLERAE SIALIDASE
665, 2simA, 0.6637, 3.77, 0.109, 381, 311, THE STRUCTURES OF SALMONELLA TYPHIMURIUM LT2 NEURAMINIDASE AND ITS COMPLEX WITH A TRANSITION STATE ANALOGUE AT 1.6 ANGSTROMS RESOLUTION
666, 2f24A, 0.6637, 3.57, 0.092, 359, 305, CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 E111Q MUTANT
667, 3h6jA, 0.6635, 3.62, 0.071, 438, 308, CRYSTAL STRUCTURE OF A PUTATIVE NEURAMINIDASE FROM PSEUDOMONAS AERUGINOSA
668, 1dilA, 0.6634, 3.78, 0.106, 381, 311, SIALIDASE FROM SALMONELLA TYPHIMURIUM COMPLEXED WITH APANA AND EPANA INHIBITORS
669, 1dimA, 0.6633, 3.78, 0.106, 381, 311, SIALIDASE FROM SALMONELLA TYPHIMURIUM COMPLEXED WITH EPANA INHIBITOR
670, 2silA, 0.6632, 3.78, 0.106, 381, 311, THE STRUCTURES OF SALMONELLA TYPHIMURIUM LT2 NEURAMINIDASE AND ITS COMPLEX WITH A TRANSITION STATE ANALOGUE AT 1.6 ANGSTROMS RESOLUTION
671, 2w38A, 0.6630, 3.57, 0.072, 432, 307, CRYSTAL STRUCTURE OF THE PSEUDAMINIDASE FROM PSEUDOMONAS AERUGINOSA
672, 2f26A, 0.6627, 3.48, 0.103, 362, 302, CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 E111Q-Q112E DOUBLE MUTANT
673, 1kitA, 0.6622, 3.71, 0.104, 757, 308, VIBRIO CHOLERAE NEURAMINIDASE
674, 2f28A, 0.6612, 3.45, 0.103, 358, 301, CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 Q116E MUTANT
675, 3silA, 0.6591, 3.71, 0.097, 378, 308, SIALIDASE FROM SALMONELLA TYPHIMURIUM
676, 4hizC, 0.6589, 3.62, 0.088, 655, 308, PHAGE PHI92 ENDOSIALIDASE
677, 4hizB, 0.6587, 3.46, 0.079, 652, 305, PHAGE PHI92 ENDOSIALIDASE
678, 1v0eD, 0.6537, 3.45, 0.079, 666, 302, ENDOSIALIDASE OF BACTERIOPHAGE K1F
679, 1v0eF, 0.6533, 3.48, 0.083, 666, 303, ENDOSIALIDASE OF BACTERIOPHAGE K1F
680, 1v0fD, 0.6532, 3.49, 0.079, 666, 303, ENDOSIALIDASE OF BACTERIOPHAGE K1F IN COMPLEX WITH OLIGOMERIC ALPHA-28-SIALIC ACID
681, 3ju4A, 0.6531, 3.49, 0.079, 670, 303, CRYSTAL STRUCTURE ANALYSIS OF ENDOSIALIDASENF AT 0.98 A RESOLUTION
682, 1v0fF, 0.6531, 3.46, 0.079, 666, 302, ENDOSIALIDASE OF BACTERIOPHAGE K1F IN COMPLEX WITH OLIGOMERIC ALPHA-28-SIALIC ACID
683, 3gvlA, 0.6530, 3.49, 0.079, 670, 303, CRYSTAL STRUCTURE OF ENDO-NEURAMINIDASENF
684, 3gvkB, 0.6529, 3.50, 0.079, 666, 303, CRYSTAL STRUCTURE OF ENDO-NEURAMINIDASE NF MUTANT
685, 1v0fE, 0.6529, 3.49, 0.079, 666, 303, ENDOSIALIDASE OF BACTERIOPHAGE K1F IN COMPLEX WITH OLIGOMERIC ALPHA-28-SIALIC ACID
686, 1v0fC, 0.6529, 3.50, 0.079, 666, 303, ENDOSIALIDASE OF BACTERIOPHAGE K1F IN COMPLEX WITH OLIGOMERIC ALPHA-28-SIALIC ACID
687, 1v0fA, 0.6529, 3.50, 0.079, 666, 303, ENDOSIALIDASE OF BACTERIOPHAGE K1F IN COMPLEX WITH OLIGOMERIC ALPHA-28-SIALIC ACID
688, 1v0fB, 0.6527, 3.50, 0.079, 666, 303, ENDOSIALIDASE OF BACTERIOPHAGE K1F IN COMPLEX WITH OLIGOMERIC ALPHA-28-SIALIC ACID
689, 3gvjA, 0.6526, 3.49, 0.076, 670, 303, CRYSTAL STRUCTURE OF AN ENDO-NEURAMINIDASENF MUTANT
690, 1v0eA, 0.6524, 3.53, 0.072, 666, 304, ENDOSIALIDASE OF BACTERIOPHAGE K1F
691, 1v0eC, 0.6520, 3.51, 0.079, 666, 303, ENDOSIALIDASE OF BACTERIOPHAGE K1F
692, 1v0eB, 0.6520, 3.51, 0.079, 666, 303, ENDOSIALIDASE OF BACTERIOPHAGE K1F
693, 3gvkC, 0.6518, 3.52, 0.079, 666, 303, CRYSTAL STRUCTURE OF ENDO-NEURAMINIDASE NF MUTANT
694, 1v0eE, 0.6518, 3.51, 0.076, 666, 303, ENDOSIALIDASE OF BACTERIOPHAGE K1F
695, 3gvkA, 0.6515, 3.52, 0.079, 644, 303, CRYSTAL STRUCTURE OF ENDO-NEURAMINIDASE NF MUTANT
696, 5hx0B, 0.6482, 3.85, 0.077, 359, 311, CRYSTAL STRUCTURE OF UNKNOWN FUNCTION PROTEIN DFER_1899 FROMDYADOBACTER FERMENTANS DSM 18053
697, 5hx0A, 0.6480, 3.85, 0.077, 360, 311, CRYSTAL STRUCTURE OF UNKNOWN FUNCTION PROTEIN DFER_1899 FROMDYADOBACTER FERMENTANS DSM 18053
698, 4q6kA, 0.6480, 3.57, 0.130, 507, 300, CRYSTAL STRUCTURE OF A PUTATIVE NEURAMINIDASE (BACCAC_01090) FROM BACTEROIDES CACCAE ATCC 43185 AT 1.90 A RESOLUTION (PSI COMMUNITY TARGET)
699, 4q6kD, 0.6476, 3.58, 0.130, 506, 300, CRYSTAL STRUCTURE OF A PUTATIVE NEURAMINIDASE (BACCAC_01090) FROM BACTEROIDES CACCAE ATCC 43185 AT 1.90 A RESOLUTION (PSI COMMUNITY TARGET)
700, 4q6kC, 0.6474, 3.58, 0.130, 506, 300, CRYSTAL STRUCTURE OF A PUTATIVE NEURAMINIDASE (BACCAC_01090) FROM BACTEROIDES CACCAE ATCC 43185 AT 1.90 A RESOLUTION (PSI COMMUNITY TARGET)
701, 4q6kB, 0.6461, 3.60, 0.130, 507, 300, CRYSTAL STRUCTURE OF A PUTATIVE NEURAMINIDASE (BACCAC_01090) FROM BACTEROIDES CACCAE ATCC 43185 AT 1.90 A RESOLUTION (PSI COMMUNITY TARGET)
702, 4fj6A, 0.6460, 3.57, 0.110, 502, 300, CRYSTAL STRUCTURE OF A GLYCOSIDE HYDROLASE FAMILY 33 CANDIDATE SIALIDASE (BDI_2946) FROM PARABACTEROIDES DISTASONIS ATCC 8503 AT 1.90 A RESOLUTION
703, 4fj6B, 0.6459, 3.62, 0.110, 503, 301, CRYSTAL STRUCTURE OF A GLYCOSIDE HYDROLASE FAMILY 33 CANDIDATE SIALIDASE (BDI_2946) FROM PARABACTEROIDES DISTASONIS ATCC 8503 AT 1.90 A RESOLUTION
704, 4fj6D, 0.6452, 3.67, 0.116, 504, 301, CRYSTAL STRUCTURE OF A GLYCOSIDE HYDROLASE FAMILY 33 CANDIDATE SIALIDASE (BDI_2946) FROM PARABACTEROIDES DISTASONIS ATCC 8503 AT 1.90 A RESOLUTION
705, 4fj6C, 0.6441, 3.56, 0.120, 502, 299, CRYSTAL STRUCTURE OF A GLYCOSIDE HYDROLASE FAMILY 33 CANDIDATE SIALIDASE (BDI_2946) FROM PARABACTEROIDES DISTASONIS ATCC 8503 AT 1.90 A RESOLUTION
706, 4bbwA, 0.6429, 3.59, 0.121, 502, 298, THE CRYSTAL STRUCTURE OF SIALIDASE VPI 5482 (BTSA) FROM BACTEROIDES THETAIOTAOMICRON
707, 5m1zA, 0.6325, 4.10, 0.062, 359, 304, STRUCTURE OF THE ALPHA-L-ARABINOFURANOSIDASE ARB93A FROM FUSARIUM GRAMINEARUM IN COMPLEX WITH AN HYDROXIMOLACTONE INHIBITOR
708, 2ydpA, 0.6324, 4.11, 0.069, 361, 305, STRUCTURE OF THE E242A MUTANT OF THE ALPHA-L-ARABINOFURANOSIDASE ARB93A FROM FUSARIUM GRAMINEARUM IN COMPLEX WITH AN IMINOSUGAR INHIBITOR
709, 2ydtA, 0.6317, 4.05, 0.063, 359, 303, STRUCTURE OF THE ALPHA-L-ARABINOFURANOSIDASE ARB93A FROM FUSARIUM GRAMINEARUM IN COMPLEXE WITH AN IMINOSUGAR INHIBITOR
710, 2ydpB, 0.6315, 4.04, 0.063, 359, 303, STRUCTURE OF THE E242A MUTANT OF THE ALPHA-L-ARABINOFURANOSIDASE ARB93A FROM FUSARIUM GRAMINEARUM IN COMPLEX WITH AN IMINOSUGAR INHIBITOR
711, 2ydpC, 0.6308, 4.05, 0.063, 359, 303, STRUCTURE OF THE E242A MUTANT OF THE ALPHA-L-ARABINOFURANOSIDASE ARB93A FROM FUSARIUM GRAMINEARUM IN COMPLEX WITH AN IMINOSUGAR INHIBITOR
712, 4a9vA, 0.6307, 4.86, 0.076, 581, 328, PSEUDOMONAS FLUORESCENS PHOX
713, 2w5nA, 0.6300, 4.11, 0.069, 365, 304, NATIVE STRUCTURE OF THE GH93 ALPHA-L-ARABINOFURANOSIDASE OF FUSARIUM GRAMINEARUM
714, 4amfA, 0.6299, 4.87, 0.076, 581, 328, PSEUDOMONAS FLUORESCENS PHOX IN COMPLEX WITH THE SUBSTRATE ANALOGUE APPCP
715, 3a71A, 0.6293, 4.01, 0.060, 353, 301, HIGH RESOLUTION STRUCTURE OF PENICILLIUM CHRYSOGENUM ALPHA-L- ARABINANASE
716, 3a72A, 0.6292, 4.03, 0.060, 353, 301, HIGH RESOLUTION STRUCTURE OF PENICILLIUM CHRYSOGENUM ALPHA-L- ARABINANASE COMPLEXED WITH ARABINOBIOSE
717, 3zwuB, 0.6289, 4.88, 0.082, 580, 328, PSEUDOMONAS FLUORESCENS PHOX IN COMPLEX WITH VANADATE A TRANSITION STATE ANALOGUE
718, 3zwuA, 0.6286, 4.87, 0.079, 580, 329, PSEUDOMONAS FLUORESCENS PHOX IN COMPLEX WITH VANADATE A TRANSITION STATE ANALOGUE
719, 4a9xA, 0.6284, 4.86, 0.076, 581, 327, PSEUDOMONAS FLUORESCENS PHOX IN COMPLEX WITH THE SUBSTRATE ANALOGUE APPCP
720, 4amfB, 0.6283, 4.83, 0.080, 581, 327, PSEUDOMONAS FLUORESCENS PHOX IN COMPLEX WITH THE SUBSTRATE ANALOGUE APPCP
721, 4alfA, 0.6283, 4.83, 0.079, 581, 328, PSEUDOMONAS FLUORESCENS PHOX IN COMPLEX WITH PHOSPHATE
722, 4alfB, 0.6279, 4.88, 0.079, 581, 328, PSEUDOMONAS FLUORESCENS PHOX IN COMPLEX WITH PHOSPHATE
723, 2w5oA, 0.6210, 4.08, 0.070, 354, 299, COMPLEX STRUCTURE OF THE GH93 ALPHA-L-ARABINOFURANOSIDASE OF FUSARIUM GRAMINEARUM WITH ARABINOBIOSE
724, 2zb6A, 0.6118, 4.83, 0.050, 427, 318, CRYSTAL STRUCTURE OF THE MEASLES VIRUS HEMAGGLUTININ (OLIGO-SUGAR TYPE)
725, 5neuA, 0.6101, 4.66, 0.077, 590, 312, LOCALISED RECONSTRUCTION OF INTEGRIN ALPHA V BETA 6 BOUND TO FOOT AND MOUTH DISEASE VIRUS O1 MANISA - POSE B.
726, 6djpA, 0.6100, 4.74, 0.077, 593, 313, INTEGRIN ALPHA-V BETA-8 IN COMPLEX WITH THE FABS 8B8 AND 68 
727, 4wk0A, 0.6089, 4.77, 0.051, 449, 314, METAL ION AND LIGAND BINDING OF INTEGRIN
728, 4wjkA, 0.6086, 4.81, 0.054, 452, 315, METAL ION AND LIGAND BINDING OF INTEGRIN
729, 3vi3C, 0.6083, 4.74, 0.058, 589, 313, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)
730, 4wk2A, 0.6080, 4.76, 0.051, 448, 314, METAL ION AND LIGAND BINDING OF INTEGRIN
731, 6avrA, 0.6079, 4.79, 0.073, 924, 314, HUMAN ALPHA-V BETA-3 INTEGRIN (INTERMEDIATE CONFORMATION) IN COMPLEX WITH THE THERAPEUTIC ANTIBODY LM609
732, 5ffoE, 0.6075, 4.74, 0.080, 587, 313, INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA
733, 3vi4C, 0.6073, 4.75, 0.058, 589, 313, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE
734, 3alxC, 0.6073, 5.06, 0.050, 514, 319, CRYSTAL STRUCTURE OF THE MEASLES VIRUS HEMAGGLUTININ BOUND TO ITS CELLULAR RECEPTOR SLAM (MV-H(L482R)-SLAM(N102H/R108Y) FUSION)
735, 3vi3A, 0.6072, 4.75, 0.058, 601, 313, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)
736, 5ffoA, 0.6071, 4.75, 0.080, 589, 313, INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA
737, 6avqA, 0.6070, 4.82, 0.073, 927, 314, THE THERAPEUTIC ANTIBODY LM609 SELECTIVELY INHIBITS LIGAND BINDING TO HUMAN ALPHA-V BETA-3 INTEGRIN VIA STERIC HINDRANCE
738, 3vi4A, 0.6068, 4.80, 0.057, 601, 314, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE
739, 5ffgA, 0.6066, 4.85, 0.076, 591, 314, CRYSTAL STRUCTURE OF INTEGRIN ALPHA V BETA 6 HEAD
740, 4um9C, 0.6065, 4.78, 0.077, 589, 313, CRYSTAL STRUCTURE OF ALPHA V BETA 6 WITH PEPTIDE
741, 6avuA, 0.6063, 4.72, 0.077, 923, 312, HUMAN ALPHA-V BETA-3 INTEGRIN (OPEN CONFORMATION) IN COMPLEX WITH THE THERAPEUTIC ANTIBODY LM609
742, 2zb5A, 0.6063, 4.87, 0.060, 424, 315, CRYSTAL STRUCTURE OF THE MEASLES VIRUS HEMAGGLUTININ (COMPLEX-SUGAR- TYPE)
743, 4wk4A, 0.6062, 4.79, 0.054, 450, 313, METAL ION AND LIGAND BINDING OF INTEGRIN
744, 4um9A, 0.6062, 4.73, 0.080, 594, 312, CRYSTAL STRUCTURE OF ALPHA V BETA 6 WITH PEPTIDE
745, 1jv2A, 0.6060, 4.77, 0.080, 927, 313, CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN ALPHAVBETA3
746, 4um8C, 0.6058, 4.78, 0.080, 588, 313, CRYSTAL STRUCTURE OF ALPHA V BETA 6
747, 4mmyA, 0.6056, 4.73, 0.080, 924, 312, INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO THE TENTH DOMAIN OF FIBRONECTIN WITH THE IAKGDWND MOTIF
748, 4g1mA, 0.6054, 4.79, 0.077, 929, 313, RE-REFINEMENT OF ALPHA V BETA 3 STRUCTURE
749, 5a11A, 0.6053, 4.28, 0.040, 345, 300, THE CRYSTAL STRUCTURE OF TA-TFP A THIOCYANATE-FORMING PROTEIN INVOLVED IN GLUCOSINOLATE BREAKDOWN (SPACE GROUP P21)
750, 3ijeA, 0.6050, 4.81, 0.077, 938, 313, CRYSTAL STRUCTURE OF THE COMPLETE INTEGRIN ALHAVBETA3 ECTODOMAIN PLUS AN ALPHA/BETA TRANSMEMBRANE FRAGMENT
751, 5netA, 0.6048, 4.84, 0.077, 589, 313, LOCALISED RECONSTRUCTION OF INTEGRIN ALPHA V BETA 6 BOUND TO FOOT AND MOUTH DISEASE VIRUS O1 MANISA - POSE A.
752, 5nerA, 0.6048, 4.84, 0.077, 589, 313, LOCALISED RECONSTRUCTION OF ALPHA V BETA 6 BOUND TO FOOT AND MOUTH DISEASE VIRUS O PANASIA - POSE A PRIME.
753, 5nemA, 0.6048, 4.84, 0.077, 589, 313, LOCALISED RECONSTRUCTION OF ALPHA V BETA 6 BOUND TO FOOT AND MOUTH DISEASE VIRUS O PANASIA - POSE A.
754, 4mmzA, 0.6048, 4.81, 0.080, 920, 313, INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO AN ANTAGONISTIC TENTH DOMAIN OF FIBRONECTIN
755, 1u8cA, 0.6048, 4.79, 0.080, 927, 313, A NOVEL ADAPTATION OF THE INTEGRIN PSI DOMAIN REVEALED FROM ITS CRYSTAL STRUCTURE
756, 4o02A, 0.6044, 4.76, 0.074, 915, 312, ALPHAVBETA3 INTEGRIN IN COMPLEX WITH MONOCLONAL ANTIBODY FAB FRAGMENT.
757, 4um8A, 0.6043, 4.77, 0.083, 591, 312, CRYSTAL STRUCTURE OF ALPHA V BETA 6
758, 1m1xA, 0.6042, 4.81, 0.080, 927, 313, CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN ALPHA VBETA3 BOUND TO MN2+
759, 5a11B, 0.6039, 4.37, 0.043, 345, 302, THE CRYSTAL STRUCTURE OF TA-TFP A THIOCYANATE-FORMING PROTEIN INVOLVED IN GLUCOSINOLATE BREAKDOWN (SPACE GROUP P21)
760, 4gjtA, 0.6036, 4.78, 0.061, 411, 311, COMPLEX STRUCTURE OF NECTIN-4 BOUND TO MV-H
761, 4mmxA, 0.6032, 4.77, 0.077, 924, 312, INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO THE TENTH DOMAIN OF FIBRONECTIN
762, 5a10A, 0.6031, 4.39, 0.040, 352, 301, THE CRYSTAL STRUCTURE OF TA-TFP A THIOCYANATE-FORMING PROTEIN INVOLVED IN GLUCOSINOLATE BREAKDOWN (SPACE GROUP C2)
763, 4cakA, 0.6031, 4.80, 0.051, 912, 313, THREE-DIMENSIONAL RECONSTRUCTION OF INTACT HUMAN INTEGRIN ALPHAIIBBETA3 IN A PHOSPHOLIPID BILAYER NANODISC
764, 3nidC, 0.6031, 4.97, 0.032, 453, 316, THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
765, 3fcuA, 0.6031, 4.82, 0.054, 457, 315, STRUCTURE OF HEADPIECE OF INTEGRIN AIIBB3 IN OPEN CONFORMATION
766, 4z7nA, 0.6030, 4.77, 0.051, 455, 313, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
767, 4z7qC, 0.6029, 4.98, 0.032, 453, 316, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV-NH2 PEPTIDE
768, 4z7oA, 0.6029, 4.77, 0.051, 455, 313, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
769, 3ze2A, 0.6029, 4.77, 0.051, 454, 313, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
770, 3ze0A, 0.6028, 4.81, 0.054, 455, 314, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
771, 3nigA, 0.6028, 4.98, 0.032, 457, 316, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
772, 3nifC, 0.6028, 4.97, 0.032, 453, 316, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
773, 2vdqA, 0.6028, 4.97, 0.032, 452, 316, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE HHLGGAKQRGDV
774, 4z7qA, 0.6027, 4.82, 0.054, 454, 314, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV-NH2 PEPTIDE
775, 3ze1A, 0.6027, 4.85, 0.057, 455, 315, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
776, 2vdrA, 0.6027, 4.98, 0.032, 452, 316, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE LGGAKQRGDV
777, 2vdkA, 0.6027, 4.98, 0.032, 452, 316, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE
778, 3zdzA, 0.6025, 4.77, 0.051, 455, 313, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
779, 4z7oC, 0.6024, 4.78, 0.054, 453, 313, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
780, 3alxB, 0.6024, 5.15, 0.044, 526, 319, CRYSTAL STRUCTURE OF THE MEASLES VIRUS HEMAGGLUTININ BOUND TO ITS CELLULAR RECEPTOR SLAM (MV-H(L482R)-SLAM(N102H/R108Y) FUSION)
781, 1tyeA, 0.6024, 4.73, 0.051, 452, 312, STRUCTURAL BASIS FOR ALLOSTERY IN INTEGRINS AND BINDING OF LIGAND- MIMETIC THERAPEUTICS TO THE PLATELET RECEPTOR FOR FIBRINOGEN
782, 3t3pA, 0.6023, 4.99, 0.032, 454, 316, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
783, 3nifA, 0.6023, 4.78, 0.051, 454, 313, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
784, 3nidA, 0.6023, 4.82, 0.054, 454, 314, THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
785, 1tyeC, 0.6023, 4.75, 0.058, 452, 313, STRUCTURAL BASIS FOR ALLOSTERY IN INTEGRINS AND BINDING OF LIGAND- MIMETIC THERAPEUTICS TO THE PLATELET RECEPTOR FOR FIBRINOGEN
786, 3fcsC, 0.6022, 4.85, 0.054, 903, 315, STRUCTURE OF COMPLETE ECTODOMAIN OF INTEGRIN AIIBB3
787, 1l5gA, 0.6022, 4.83, 0.077, 927, 313, CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN AVB3 IN COMPLEX WITH AN ARG-GLY-ASP LIGAND
788, 3zdxA, 0.6021, 5.00, 0.032, 457, 316, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
789, 3fcsA, 0.6021, 4.85, 0.054, 913, 315, STRUCTURE OF COMPLETE ECTODOMAIN OF INTEGRIN AIIBB3
790, 4g1eA, 0.6020, 4.74, 0.080, 964, 311, CRYSTAL STRUCTURE OF INTEGRIN ALPHA V BETA 3 WITH COIL-COILED TAG.
791, 3zdxC, 0.6020, 5.00, 0.035, 453, 316, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
792, 3fcuC, 0.6020, 4.94, 0.035, 451, 315, STRUCTURE OF HEADPIECE OF INTEGRIN AIIBB3 IN OPEN CONFORMATION
793, 2vdnA, 0.6020, 5.00, 0.032, 452, 316, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST EPTIFIBATIDE
794, 5hdbA, 0.6019, 4.86, 0.057, 454, 315, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH RO-435054
795, 3t3mA, 0.6019, 5.01, 0.032, 454, 316, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
796, 4z7nC, 0.6018, 5.01, 0.032, 453, 316, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
797, 3ze0C, 0.6017, 4.79, 0.054, 453, 313, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
798, 2vc2A, 0.6017, 4.78, 0.058, 452, 313, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST L-739758
799, 3ze1C, 0.6016, 4.79, 0.054, 453, 313, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
800, 3zdzC, 0.6015, 4.79, 0.054, 453, 313, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
801, 5hdbC, 0.6014, 4.82, 0.054, 453, 313, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH RO-435054
802, 1tyeE, 0.6014, 4.77, 0.054, 452, 312, STRUCTURAL BASIS FOR ALLOSTERY IN INTEGRINS AND BINDING OF LIGAND- MIMETIC THERAPEUTICS TO THE PLATELET RECEPTOR FOR FIBRINOGEN
803, 3ze2C, 0.6013, 4.79, 0.054, 453, 313, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
804, 2vdlA, 0.6013, 4.79, 0.058, 452, 313, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE
805, 5gq0A, 0.6009, 4.35, 0.057, 338, 299, CRYSTAL STRUCTURE OF THE EPITHIOSPECIFIER PROTEIN ESP FROM ARABIDOPSIS THALIANA
806, 3zdyA, 0.6009, 4.81, 0.051, 454, 313, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
807, 3t3pC, 0.6008, 4.80, 0.054, 453, 313, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
808, 3alwA, 0.6008, 4.86, 0.055, 510, 311, CRYSTAL STRUCTURE OF THE MEASLES VIRUS HEMAGGLUTININ BOUND TO ITS CELLULAR RECEPTOR SLAM (FORM I MV-H-SLAM(N102H/R108Y) FUSION)
809, 2vdoA, 0.6008, 4.79, 0.058, 452, 313, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDE HHLGGAKQAGDV
810, 3nigC, 0.6007, 4.80, 0.054, 453, 313, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
811, 3t3mC, 0.6006, 4.81, 0.054, 453, 313, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
812, 2vdpA, 0.6006, 4.76, 0.054, 452, 312, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDELGGAKQAGDV
813, 3alxD, 0.6005, 5.01, 0.054, 504, 313, CRYSTAL STRUCTURE OF THE MEASLES VIRUS HEMAGGLUTININ BOUND TO ITS CELLULAR RECEPTOR SLAM (MV-H(L482R)-SLAM(N102H/R108Y) FUSION)
814, 2vdmA, 0.6005, 4.76, 0.054, 452, 312, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST TIROFIBAN
815, 3fcuE, 0.5996, 4.77, 0.058, 452, 312, STRUCTURE OF HEADPIECE OF INTEGRIN AIIBB3 IN OPEN CONFORMATION
816, 3alxA, 0.5995, 4.89, 0.042, 515, 311, CRYSTAL STRUCTURE OF THE MEASLES VIRUS HEMAGGLUTININ BOUND TO ITS CELLULAR RECEPTOR SLAM (MV-H(L482R)-SLAM(N102H/R108Y) FUSION)
817, 3zdyC, 0.5991, 4.78, 0.054, 453, 312, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
818, 3alzA, 0.5989, 5.10, 0.048, 417, 315, CRYSTAL STRUCTURE OF THE MEASLES VIRUS HEMAGGLUTININ BOUND TO ITS CELLULAR RECEPTOR SLAM (FORM I)
819, 5gq0B, 0.5984, 4.37, 0.057, 330, 298, CRYSTAL STRUCTURE OF THE EPITHIOSPECIFIER PROTEIN ESP FROM ARABIDOPSIS THALIANA
820, 2rkcA, 0.5971, 4.75, 0.062, 399, 307, CRYSTAL STRUCTURE OF THE MEASLES VIRUS HEMAGGLUTININ
821, 5h47L, 0.5967, 3.76, 0.064, 310, 281, CRYSTAL STRUCTURE OF AOL COMPLEXED WITH 2-MESE-FUC
822, 1iucA, 0.5965, 3.44, 0.040, 312, 275, FUCOSE-SPECIFIC LECTIN FROM ALEURIA AURANTIA WITH THREE LIGANDS
823, 4c1yB, 0.5964, 3.91, 0.067, 314, 284, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH B-METHYLFUCOSIDE
824, 3inbB, 0.5964, 4.73, 0.052, 403, 306, STRUCTURE OF THE MEASLES VIRUS HEMAGGLUTININ BOUND TO THE CD46 RECEPTOR
825, 5mxcA, 0.5961, 3.53, 0.043, 313, 276, ALEURIA AURANTIA LECTIN (AAL) N224Q MUTANT IN COMPLEX WITH ALPHA- METHYL-L-FUCOSIDE
826, 1iubA, 0.5960, 3.45, 0.040, 312, 275, FUCOSE-SPECIFIC LECTIN FROM ALEURIA AURANTIA (HG-DERIVATIVE FORM)
827, 4ahaB, 0.5954, 3.94, 0.067, 314, 284, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH FUCOSYLATED MONOSACCHARIDES (FUC1-2GAL FUC1-3GLCNAC FUC1-4GLCNAC AND FUC1-6GLCNAC)
828, 1ofzA, 0.5952, 3.46, 0.040, 312, 275, CRYSTAL STRUCTURE OF FUNGAL LECTIN: SIX-BLADED BETA-PROPELLER FOLD AND NOVEL FUCOSE RECOGNITION MODE FOR ALEURIA AURANTIA LECTIN
829, 1ofzB, 0.5951, 3.46, 0.044, 312, 275, CRYSTAL STRUCTURE OF FUNGAL LECTIN: SIX-BLADED BETA-PROPELLER FOLD AND NOVEL FUCOSE RECOGNITION MODE FOR ALEURIA AURANTIA LECTIN
830, 4c1yD, 0.5950, 3.94, 0.067, 314, 284, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH B-METHYLFUCOSIDE
831, 5h47B, 0.5949, 3.78, 0.064, 310, 281, CRYSTAL STRUCTURE OF AOL COMPLEXED WITH 2-MESE-FUC
832, 5h47K, 0.5948, 3.79, 0.064, 310, 281, CRYSTAL STRUCTURE OF AOL COMPLEXED WITH 2-MESE-FUC
833, 4ahaA, 0.5948, 3.96, 0.067, 314, 284, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH FUCOSYLATED MONOSACCHARIDES (FUC1-2GAL FUC1-3GLCNAC FUC1-4GLCNAC AND FUC1-6GLCNAC)
834, 5h47F, 0.5947, 3.75, 0.061, 310, 280, CRYSTAL STRUCTURE OF AOL COMPLEXED WITH 2-MESE-FUC
835, 5h47A, 0.5947, 3.79, 0.064, 310, 281, CRYSTAL STRUCTURE OF AOL COMPLEXED WITH 2-MESE-FUC
836, 5h47H, 0.5943, 3.79, 0.064, 310, 281, CRYSTAL STRUCTURE OF AOL COMPLEXED WITH 2-MESE-FUC
837, 5eo7A, 0.5943, 3.74, 0.068, 310, 280, CRYSTAL STRUCTURE OF AOL
838, 5eo7C, 0.5941, 3.79, 0.068, 310, 281, CRYSTAL STRUCTURE OF AOL
839, 5h47I, 0.5940, 3.73, 0.064, 310, 280, CRYSTAL STRUCTURE OF AOL COMPLEXED WITH 2-MESE-FUC
840, 4d4uB, 0.5940, 3.89, 0.067, 313, 283, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH LEWISY TETRASACCHARIDE.
841, 4d4uA, 0.5939, 3.93, 0.067, 313, 284, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH LEWISY TETRASACCHARIDE.
842, 4d52D, 0.5931, 3.93, 0.067, 313, 283, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH L-GALACTOPYRANOSE.
843, 5h47J, 0.5930, 3.78, 0.061, 310, 280, CRYSTAL STRUCTURE OF AOL COMPLEXED WITH 2-MESE-FUC
844, 2pooA, 0.5921, 4.05, 0.077, 353, 286, THERMOSTABLE PHYTASE IN FULLY CALCIUM LOADED STATE
845, 1pooA, 0.5920, 4.05, 0.080, 353, 286, THERMOSTABLE PHYTASE FROM BACILLUS SP
846, 1cvmA, 0.5919, 4.05, 0.077, 353, 286, CADMIUM INHIBITED CRYSTAL STRUCTURE OF PHYTASE FROM BACILLUS AMYLOLIQUEFACIENS
847, 1qlgA, 0.5917, 4.05, 0.077, 353, 286, CRYSTAL STRUCTURE OF PHYTASE WITH MAGNESIUM FROM BACILLUS AMYLOLIQUEFACIENS
848, 4uouB, 0.5915, 3.99, 0.066, 313, 286, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) - APO-FORM
849, 3amrA, 0.5915, 4.05, 0.077, 352, 286, CRYSTAL STRUCTURES OF BACILLUS SUBTILIS ALKALINE PHYTASE IN COMPLEX WITH CA2+ CO2+ NI2+ MG2+ AND MYO-INOSITOL HEXASULFATE
850, 1h6lA, 0.5915, 4.09, 0.080, 353, 287, BETA-PROPELLER PHYTASE IN COMPLEX WITH PHOSPHATE AND CALCIUM IONS
851, 4uouA, 0.5911, 4.06, 0.066, 313, 288, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) - APO-FORM
852, 4d52B, 0.5909, 3.91, 0.074, 313, 284, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH L-GALACTOPYRANOSE.
853, 5eo8A, 0.5908, 3.88, 0.060, 311, 284, CRYSTAL STRUCTURE OF AOL(868)
854, 4uouC, 0.5908, 4.07, 0.066, 313, 288, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) - APO-FORM
855, 4d52C, 0.5907, 3.91, 0.067, 310, 284, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH L-GALACTOPYRANOSE.
856, 3amsA, 0.5904, 4.09, 0.087, 352, 287, CRYSTAL STRUCTURES OF BACILLUS SUBTILIS ALKALINE PHYTASE IN COMPLEX WITH CA2+ CD2+ CO2+ NI2+ MG2+ AND MYO-INOSITOL HEXASULFATE
857, 5h47C, 0.5903, 3.86, 0.064, 310, 283, CRYSTAL STRUCTURE OF AOL COMPLEXED WITH 2-MESE-FUC
858, 5h47G, 0.5899, 3.87, 0.064, 310, 283, CRYSTAL STRUCTURE OF AOL COMPLEXED WITH 2-MESE-FUC
859, 5tihA, 0.5898, 4.14, 0.074, 326, 285, STRUCTURAL BASIS FOR INHIBITION OF ERYTHROCYTE INVASION BY ANTIBODIES TO PLASMODIUM FALCIPARUM PROTEIN CYRPA
860, 5h47E, 0.5898, 3.87, 0.064, 310, 283, CRYSTAL STRUCTURE OF AOL COMPLEXED WITH 2-MESE-FUC
861, 5eo7B, 0.5898, 3.86, 0.064, 310, 283, CRYSTAL STRUCTURE OF AOL
862, 5tikB, 0.5896, 3.89, 0.071, 324, 281, STRUCTURAL BASIS FOR INHIBITION OF ERYTHROCYTE INVASION BY ANTIBODIES TO PLASMODIUM FALCIPARUM PROTEIN CYRPA
863, 4agiC, 0.5886, 4.07, 0.063, 312, 287, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH SELENO FUCOSIDE.
864, 4agiB, 0.5885, 4.06, 0.063, 312, 287, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH SELENO FUCOSIDE.
865, 4uouD, 0.5882, 4.22, 0.065, 313, 292, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) - APO-FORM
866, 4c1yC, 0.5878, 4.14, 0.062, 314, 290, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH B-METHYLFUCOSIDE
867, 4d52A, 0.5874, 4.19, 0.065, 314, 291, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH L-GALACTOPYRANOSE.
868, 5tikC, 0.5873, 3.98, 0.074, 321, 282, STRUCTURAL BASIS FOR INHIBITION OF ERYTHROCYTE INVASION BY ANTIBODIES TO PLASMODIUM FALCIPARUM PROTEIN CYRPA
869, 4agtB, 0.5873, 4.26, 0.068, 314, 293, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH FUC1-6GLCNAC.
870, 4agtA, 0.5869, 4.21, 0.065, 314, 291, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH FUC1-6GLCNAC.
871, 4ah4B, 0.5867, 4.18, 0.065, 313, 291, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH BGA OLIGOSACCHARIDE.
872, 4c1yA, 0.5864, 4.17, 0.069, 313, 291, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH B-METHYLFUCOSIDE
873, 4ah4A, 0.5863, 4.19, 0.065, 313, 291, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH BGA OLIGOSACCHARIDE.
874, 4agiD, 0.5856, 4.23, 0.069, 312, 291, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH SELENO FUCOSIDE.
875, 4agiA, 0.5856, 4.19, 0.069, 312, 290, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH SELENO FUCOSIDE.
876, 5h47D, 0.5848, 4.06, 0.066, 310, 288, CRYSTAL STRUCTURE OF AOL COMPLEXED WITH 2-MESE-FUC
877, 3inbA, 0.5848, 4.72, 0.060, 389, 299, STRUCTURE OF THE MEASLES VIRUS HEMAGGLUTININ BOUND TO THE CD46 RECEPTOR
878, 3fw0A, 0.5842, 4.00, 0.049, 329, 284, STRUCTURE OF PEPTIDYL-ALPHA-HYDROXYGLYCINE ALPHA-AMIDATING LYASE (PAL) BOUND TO ALPHA-HYDROXYHIPPURIC ACID (NON- PEPTIDIC SUBSTRATE)
879, 3fvzA, 0.5842, 3.98, 0.042, 329, 284, STRUCTURE OF PEPTIDYL-ALPHA-HYDROXYGLYCINE ALPHA-AMIDATING LYASE (PAL)
880, 2dsoD, 0.5820, 3.82, 0.057, 321, 280, CRYSTAL STRUCTURE OF D138N MUTANT OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
881, 5ezoA, 0.5812, 4.04, 0.067, 321, 282, CRYSTAL STRUCTURE OF PFCYRPA IN COMPLEX WITH AN INVASION-INHIBITORY ANTIBODY FAB.
882, 2uvkB, 0.5811, 3.74, 0.076, 346, 277, STRUCTURE OF YJHT
883, 2dsoF, 0.5811, 3.84, 0.057, 320, 280, CRYSTAL STRUCTURE OF D138N MUTANT OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
884, 2dg1F, 0.5811, 3.77, 0.054, 321, 278, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS COMPLEXED WITH CA2+
885, 2dsoE, 0.5810, 3.84, 0.057, 321, 280, CRYSTAL STRUCTURE OF D138N MUTANT OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
886, 2dsoB, 0.5810, 3.82, 0.061, 321, 279, CRYSTAL STRUCTURE OF D138N MUTANT OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
887, 2dsoA, 0.5810, 3.85, 0.057, 322, 280, CRYSTAL STRUCTURE OF D138N MUTANT OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
888, 2dsoC, 0.5809, 3.84, 0.057, 323, 280, CRYSTAL STRUCTURE OF D138N MUTANT OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
889, 2dg1C, 0.5809, 3.84, 0.057, 320, 280, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS COMPLEXED WITH CA2+
890, 2dg1B, 0.5808, 3.78, 0.054, 322, 278, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS COMPLEXED WITH CA2+
891, 5tikD, 0.5807, 3.96, 0.076, 318, 278, STRUCTURAL BASIS FOR INHIBITION OF ERYTHROCYTE INVASION BY ANTIBODIES TO PLASMODIUM FALCIPARUM PROTEIN CYRPA
892, 2dg1E, 0.5806, 3.81, 0.050, 321, 279, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS COMPLEXED WITH CA2+
893, 2dg1D, 0.5806, 3.77, 0.057, 322, 279, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS COMPLEXED WITH CA2+
894, 2dg1A, 0.5803, 3.85, 0.057, 321, 280, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS COMPLEXED WITH CA2+
895, 5tikA, 0.5757, 3.97, 0.076, 310, 275, STRUCTURAL BASIS FOR INHIBITION OF ERYTHROCYTE INVASION BY ANTIBODIES TO PLASMODIUM FALCIPARUM PROTEIN CYRPA
896, 2dg0J, 0.5743, 3.81, 0.062, 316, 276, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
897, 2dg0F, 0.5743, 3.81, 0.062, 316, 276, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
898, 2dg0C, 0.5743, 3.81, 0.062, 315, 276, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
899, 4o5tA, 0.5742, 3.90, 0.073, 319, 275, CRYSTAL STRUCTURE OF DIELS-ALDERASE CE20 IN COMPLEX WITH A PRODUCT ANALOG
900, 2dg0E, 0.5742, 3.82, 0.062, 316, 276, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
901, 2dg0L, 0.5741, 3.82, 0.062, 316, 276, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
902, 2dg0I, 0.5740, 3.82, 0.062, 314, 276, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
903, 2dg0K, 0.5739, 3.82, 0.062, 316, 276, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
904, 2dg0H, 0.5739, 3.82, 0.062, 316, 276, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
905, 2dg0D, 0.5739, 3.82, 0.062, 315, 276, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
906, 2dg0A, 0.5738, 3.83, 0.062, 317, 276, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
907, 4o5sA, 0.5735, 3.93, 0.076, 323, 275, CRYSTAL STRUCTURE OF DIELS-ALDERASE CE11
908, 2dg0G, 0.5735, 3.83, 0.062, 315, 276, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
909, 2dg0B, 0.5734, 3.84, 0.062, 315, 276, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
910, 3u0sB, 0.5730, 3.78, 0.066, 327, 272, CRYSTAL STRUCTURE OF AN ENZYME REDESIGNED THROUGH MULTIPLAYER ONLINE GAMING: CE6
911, 3u0sA, 0.5730, 3.78, 0.066, 327, 272, CRYSTAL STRUCTURE OF AN ENZYME REDESIGNED THROUGH MULTIPLAYER ONLINE GAMING: CE6
912, 3a9hA, 0.5727, 4.49, 0.070, 338, 287, CRYSTAL STRUCTURE OF PQQ-DEPENDENT SUGAR DEHYDROGENASE HOLO-FORM
913, 3a9gA, 0.5719, 4.47, 0.066, 338, 286, CRYSTAL STRUCTURE OF PQQ-DEPENDENT SUGAR DEHYDROGENASE APO-FORM
914, 6eksA, 0.5718, 4.54, 0.039, 749, 284, VIBRIO CHOLERAE NEURAMINIDASE COMPLEXED WITH OSELTAMIVIR CARBOXYLATE
915, 4o5tB, 0.5714, 3.97, 0.073, 326, 275, CRYSTAL STRUCTURE OF DIELS-ALDERASE CE20 IN COMPLEX WITH A PRODUCT ANALOG
916, 3li5A, 0.5706, 3.62, 0.074, 312, 269, DIISOPROPYL FLUOROPHOSPHATASE (DFPASE) E21QN120DN175DD229N MUTANT
917, 2iaoA, 0.5705, 3.62, 0.078, 312, 269, CRYSTAL STRUCTURE OF SQUID GANGLION DFPASE E37Q MUTANT
918, 2uvkA, 0.5704, 3.70, 0.074, 339, 271, STRUCTURE OF YJHT
919, 2iaxA, 0.5704, 3.62, 0.078, 312, 269, CRYSTAL STRUCTURE OF SQUID GANGLION DFPASE D232S MUTANT
920, 2iavA, 0.5704, 3.63, 0.078, 312, 269, CRYSTAL STRUCTURE OF SQUID GANGLION DFPASE H287A MUTANT
921, 3hliD, 0.5703, 3.62, 0.078, 312, 269, DIISOPROPYL FLUOROPHOSPHATASE (DFPASE) ACTIVE SITE MUTANTS
922, 2iawA, 0.5703, 3.67, 0.081, 312, 270, CRYSTAL STRUCTURE OF SQUID GANGLION DFPASE N175D MUTANT
923, 2iaqA, 0.5703, 3.62, 0.074, 312, 269, CRYSTAL STRUCTURE OF SQUID GANGLION DFPASE S271A MUTANT
924, 2iatA, 0.5702, 3.63, 0.078, 312, 269, CRYSTAL STRUCTURE OF SQUID GANGLION DFPASE W244L MUTANT
925, 3o4pA, 0.5701, 3.63, 0.078, 314, 269, DFPASE AT 0.85 ANGSTROM RESOLUTION (H ATOMS INCLUDED)
926, 1pjxA, 0.5701, 3.63, 0.078, 314, 269, 0.85 ANGSTROM STRUCTURE OF SQUID GANGLION DFPASE
927, 2iapA, 0.5700, 3.67, 0.081, 312, 270, CRYSTAL STRUCTURE OF SQUID GANGLION DFPASE E21Q MUTANT
928, 1e1aA, 0.5700, 3.63, 0.078, 312, 269, CRYSTAL STRUCTURE OF DFPASE FROM LOLIGO VULGARIS
929, 3hlhD, 0.5699, 3.70, 0.081, 312, 271, DIISOPROPYL FLUOROPHOSPHATASE (DFPASE) ACTIVE SITE MUTANTS
930, 2iauA, 0.5699, 3.63, 0.078, 312, 269, CRYSTAL STRUCTURE OF SQUID GANGLION DFPASE W244Y MUTANT
931, 2iarA, 0.5698, 3.63, 0.078, 312, 269, CRYSTAL STRUCTURE OF SQUID GANGLION DFPASE W244H MUTANT
932, 3li3A, 0.5697, 3.64, 0.078, 313, 269, DIISOPROPYL FLUOROPHOSPHATASE (DFPASE) D121E MUTANT
933, 2iasA, 0.5697, 3.64, 0.078, 312, 269, CRYSTAL STRUCTURE OF SQUID GANGLION DFPASE W244F MUTANT
934, 3li4A, 0.5696, 3.64, 0.078, 312, 269, DIISOPROPYL FLUOROPHOSPHATASE (DFPASE) N120DN175DD229N MUTANT
935, 3kggA, 0.5696, 3.64, 0.078, 313, 269, X-RAY STRUCTURE OF PERDEUTERATED DIISOPROPYL FLUOROPHOSPHATASE (DFPASE): PERDEUTERATION OF PROTEINS FOR NEUTRON DIFFRACTION
936, 3hliA, 0.5696, 3.67, 0.081, 313, 270, DIISOPROPYL FLUOROPHOSPHATASE (DFPASE) ACTIVE SITE MUTANTS
937, 2gvuA, 0.5696, 3.64, 0.078, 312, 269, CRYSTAL STRUCTURE OF DIISOPROPYL FLUOROPHOSPHATASE (DFPASE) MUTANT D229N / N120D
938, 3hlhA, 0.5694, 3.70, 0.081, 312, 271, DIISOPROPYL FLUOROPHOSPHATASE (DFPASE) ACTIVE SITE MUTANTS
939, 2gvxA, 0.5693, 3.68, 0.081, 312, 270, STRUCTURE OF DIISOPROPYL FLUOROPHOSPHATASE (DFPASE) MUTANT D229N / N175D
940, 2gvwA, 0.5692, 3.69, 0.081, 312, 270, STRUCTURE OF DIISOPROPYL FLUOROPHOSPHATASE (DFPASE) HOLOENZYME (RT)
941, 2gvvA, 0.5692, 3.69, 0.081, 309, 270, STRUCTURE OF DIISOPROPYL FLUOROPHOSPHATASE (DFPASE) IN COMPLEX WITH DICYCLOPENTYLPHOSPHOROAMIDATE (DCPPA)
942, 3hliC, 0.5691, 3.69, 0.081, 312, 270, DIISOPROPYL FLUOROPHOSPHATASE (DFPASE) ACTIVE SITE MUTANTS
943, 3hlhC, 0.5691, 3.69, 0.081, 312, 270, DIISOPROPYL FLUOROPHOSPHATASE (DFPASE) ACTIVE SITE MUTANTS
944, 3hliB, 0.5690, 3.65, 0.078, 312, 269, DIISOPROPYL FLUOROPHOSPHATASE (DFPASE) ACTIVE SITE MUTANTS
945, 3bycA, 0.5689, 3.72, 0.077, 312, 271, JOINT NEUTRON AND X-RAY STRUCTURE OF DIISOPROPYL FLUOROPHOSPHATASE. DEUTERIUM OCCUPANCIES ARE 1-Q WHERE Q IS OCCUPANCY OF H
946, 4o5sB, 0.5688, 3.85, 0.074, 312, 272, CRYSTAL STRUCTURE OF DIELS-ALDERASE CE11
947, 3hlhB, 0.5687, 3.76, 0.078, 312, 270, DIISOPROPYL FLUOROPHOSPHATASE (DFPASE) ACTIVE SITE MUTANTS
948, 6fptA, 0.5683, 4.00, 0.073, 391, 273, CRYSTAL STRUCTURE OF DANIO RERIO LIN41 FILAMIN-NHL DOMAINS 
949, 4gn8A, 0.5681, 3.84, 0.062, 297, 272, MOUSE SMP30/GNL-15-AG COMPLEX
950, 4gn7A, 0.5680, 3.77, 0.063, 297, 271, MOUSE SMP30/GNL
951, 3i1cA, 0.5679, 3.71, 0.081, 314, 270, CRYSTAL STRUCTURE OF A NOVEL ENGINEERED DIELS-ALDERASE: DA_20_00_A74I
952, 4gn9A, 0.5678, 3.83, 0.066, 297, 272, MOUSE SMP30/GNL-GLUCOSE COMPLEX
953, 6fq3A, 0.5677, 3.88, 0.070, 390, 271, CRYSTAL STRUCTURE OF DANIO RERIO LIN41 FILAMIN-NHL DOMAINS IN COMPLEX WITH LIN-29A 5 UTR 13MER RNA 
954, 4gnaA, 0.5676, 3.83, 0.066, 297, 271, MOUSE SMP30/GNL-XYLITOL COMPLEX
955, 5d9cA, 0.5672, 4.03, 0.051, 307, 274, LUCIFERIN-REGENERATING ENZYME SOLVED BY SIRAS USING XFEL (REFINED AGAINST HG DERIVATIVE DATA)
956, 2qe8A, 0.5668, 3.76, 0.055, 333, 271, CRYSTAL STRUCTURE OF A PUTATIVE HYDROLASE (AVA_4197) FROM ANABAENA VARIABILIS ATCC 29413 AT 1.35 A RESOLUTION
957, 6fqlA, 0.5667, 3.94, 0.074, 390, 272, CRYSTAL STRUCTURE OF DANIO RERIO LIN41 FILAMIN-NHL DOMAINS IN COMPLEX WITH MAB-10 3 UTR 13MER RNA 
958, 4gncA, 0.5667, 3.90, 0.066, 298, 272, HUMAN SMP30/GNL-15-AG COMPLEX
959, 5xfeA, 0.5666, 3.90, 0.051, 306, 272, LUCIFERIN-REGENERATING ENZYME SOLVED BY SAD USING XFEL (REFINED AGAINST 11000 PATTERNS)
960, 5gx2A, 0.5664, 3.95, 0.055, 307, 273, LUCIFERIN-REGENERATING ENZYME COLLECTED WITH SERIAL SYNCHROTRON ROTATIONAL CRYSTALLOGRAPHY WITH ACCUMULATED DOSE OF 3.4 MGY (3RD MEASUREMENT)
961, 5gx1A, 0.5664, 3.95, 0.055, 307, 273, LUCIFERIN-REGENERATING ENZYME COLLECTED WITH SERIAL SYNCHROTRON ROTATIONAL CRYSTALLOGRAPHY WITH ACCUMULATED DOSE OF 1.1 MGY (1ST MEASUREMENT)
962, 5d9bA, 0.5664, 4.05, 0.051, 307, 274, LUCIFERIN-REGENERATING ENZYME SOLVED BY SIRAS USING XFEL (REFINED AGAINST NATIVE DATA)
963, 5gx3A, 0.5663, 3.95, 0.051, 307, 273, LUCIFERIN-REGENERATING ENZYME COLLECTED WITH SERIAL SYNCHROTRON ROTATIONAL CRYSTALLOGRAPHY WITH ACCUMULATED DOSE OF 6.9 MGY (6TH MEASUREMENT)
964, 5gx4A, 0.5662, 3.96, 0.051, 307, 273, LUCIFERIN-REGENERATING ENZYME COLLECTED WITH SERIAL SYNCHROTRON ROTATIONAL CRYSTALLOGRAPHY WITH ACCUMULATED DOSE OF 14 MGY (12TH MEASUREMENT)
965, 5gtqA, 0.5662, 3.96, 0.055, 307, 273, LUCIFERIN-REGENERATING ENZYME AT CRYOGENIC TEMPERATURE
966, 4gn9B, 0.5662, 3.81, 0.063, 297, 271, MOUSE SMP30/GNL-GLUCOSE COMPLEX
967, 5gx5A, 0.5660, 3.96, 0.051, 307, 273, LUCIFERIN-REGENERATING ENZYME COLLECTED WITH SERIAL SYNCHROTRON ROTATIONAL CRYSTALLOGRAPHY WITH ACCUMULATED DOSE OF 26 MGY (23RD MEASUREMENT)
968, 4gnaB, 0.5660, 3.82, 0.063, 297, 271, MOUSE SMP30/GNL-XYLITOL COMPLEX
969, 4gn7B, 0.5660, 3.82, 0.063, 297, 271, MOUSE SMP30/GNL
970, 4gnbA, 0.5658, 3.81, 0.070, 297, 271, HUMAN SMP30/GNL
971, 4gn8B, 0.5657, 3.83, 0.063, 297, 271, MOUSE SMP30/GNL-15-AG COMPLEX
972, 2qe8B, 0.5655, 3.72, 0.052, 332, 270, CRYSTAL STRUCTURE OF A PUTATIVE HYDROLASE (AVA_4197) FROM ANABAENA VARIABILIS ATCC 29413 AT 1.35 A RESOLUTION
973, 6fptB, 0.5653, 4.06, 0.077, 388, 273, CRYSTAL STRUCTURE OF DANIO RERIO LIN41 FILAMIN-NHL DOMAINS 
974, 3g4hB, 0.5653, 3.83, 0.074, 297, 271, CRYSTAL STRUCTURE OF HUMAN SENESCENCE MARKER PROTEIN-30 (ZINC BOUND)
975, 3g4eA, 0.5653, 3.82, 0.066, 297, 271, CRYSTAL STRUCTURE OF HUMAN SENESCENCE MARKER PROTEIN-30(SMP30)(CALCIUM BOUND)
976, 4qqsB, 0.5652, 4.57, 0.045, 313, 286, CRYSTAL STRUCTURE OF A THERMOSTABLE FAMILY-43 GLYCOSIDE HYDROLASE
977, 5d9dA, 0.5649, 4.03, 0.051, 306, 273, LUCIFERIN-REGENERATING ENZYME SOLVED BY SAD USING SYNCHROTRON RADIATION AT ROOM TEMPERATURE
978, 3g4eB, 0.5635, 3.85, 0.070, 297, 270, CRYSTAL STRUCTURE OF HUMAN SENESCENCE MARKER PROTEIN-30(SMP30)(CALCIUM BOUND)
979, 4gncB, 0.5634, 3.94, 0.070, 297, 271, HUMAN SMP30/GNL-15-AG COMPLEX
980, 3g4hA, 0.5634, 3.77, 0.067, 297, 269, CRYSTAL STRUCTURE OF HUMAN SENESCENCE MARKER PROTEIN-30 (ZINC BOUND)
981, 4qqsA, 0.5632, 4.63, 0.049, 312, 286, CRYSTAL STRUCTURE OF A THERMOSTABLE FAMILY-43 GLYCOSIDE HYDROLASE
982, 4gnbB, 0.5631, 3.79, 0.071, 297, 269, HUMAN SMP30/GNL
983, 5flwA, 0.5612, 4.63, 0.076, 302, 289, CRYSTAL STRUCTURE OF PUTATIVE EXO-BETA-13-GALACTANASE FROM BIFIDOBACTERIUM BIFIDUM S17
984, 2p9wA, 0.5611, 4.47, 0.053, 333, 284, CRYSTAL STRUCTURE OF THE MAJOR MALASSEZIA SYMPODIALIS ALLERGEN MALA S 2 1
985, 2g8sB, 0.5603, 4.17, 0.055, 341, 273, CRYSTAL STRUCTURE OF THE SOLUBLE ALDOSE SUGAR DEHYDROGENASE (ASD) FROM ESCHERICHIA COLI IN THE APO-FORM
986, 5flwB, 0.5602, 4.64, 0.080, 302, 289, CRYSTAL STRUCTURE OF PUTATIVE EXO-BETA-13-GALACTANASE FROM BIFIDOBACTERIUM BIFIDUM S17
987, 5a9qY, 0.5596, 4.35, 0.079, 322, 279, HUMAN NUCLEAR PORE COMPLEX
988, 5a9qP, 0.5596, 4.35, 0.079, 322, 279, HUMAN NUCLEAR PORE COMPLEX
989, 5a9qG, 0.5596, 4.35, 0.079, 322, 279, HUMAN NUCLEAR PORE COMPLEX
990, 5a9q7, 0.5596, 4.35, 0.079, 322, 279, HUMAN NUCLEAR PORE COMPLEX
991, 3vh0D, 0.5594, 4.18, 0.079, 322, 277, CRYSTAL STRUCTURE OF E. COLI YNCE COMPLEXED WITH DNA
992, 3vh0A, 0.5594, 4.18, 0.079, 322, 277, CRYSTAL STRUCTURE OF E. COLI YNCE COMPLEXED WITH DNA
993, 2g8sA, 0.5592, 4.19, 0.048, 342, 273, CRYSTAL STRUCTURE OF THE SOLUBLE ALDOSE SUGAR DEHYDROGENASE (ASD) FROM ESCHERICHIA COLI IN THE APO-FORM
994, 6cvzA, 0.5586, 4.26, 0.047, 337, 276, CRYSTAL STRUCTURE OF THE WD40-REPEAT OF RFWD3 
995, 3vh0C, 0.5574, 4.17, 0.076, 321, 277, CRYSTAL STRUCTURE OF E. COLI YNCE COMPLEXED WITH DNA
996, 3vh0B, 0.5573, 4.17, 0.076, 321, 277, CRYSTAL STRUCTURE OF E. COLI YNCE COMPLEXED WITH DNA
997, 3f3pA, 0.5566, 4.30, 0.054, 300, 276, CRYSTAL STRUCTURE OF THE NUCLEOPORIN PAIR NUP85-SEH1 SPACE GROUP P21212
998, 1q7fB, 0.5566, 3.59, 0.069, 282, 261, BRAIN TUMOR NHL DOMAIN
999, 3f3pJ, 0.5565, 4.29, 0.054, 305, 276, CRYSTAL STRUCTURE OF THE NUCLEOPORIN PAIR NUP85-SEH1 SPACE GROUP P21212
1000, 3f3gF, 0.5561, 4.32, 0.058, 300, 276, CRYSTAL STRUCTURE OF THE NUCLEOPORIN PAIR NUP85-SEH1 SPACE GROUP P212121
1001, 3f3gE, 0.5561, 4.31, 0.058, 300, 276, CRYSTAL STRUCTURE OF THE NUCLEOPORIN PAIR NUP85-SEH1 SPACE GROUP P212121
1002, 3f3gB, 0.5561, 4.32, 0.058, 300, 276, CRYSTAL STRUCTURE OF THE NUCLEOPORIN PAIR NUP85-SEH1 SPACE GROUP P212121
1003, 3f3gA, 0.5559, 4.32, 0.058, 300, 276, CRYSTAL STRUCTURE OF THE NUCLEOPORIN PAIR NUP85-SEH1 SPACE GROUP P212121
1004, 3f3pF, 0.5558, 4.34, 0.054, 305, 276, CRYSTAL STRUCTURE OF THE NUCLEOPORIN PAIR NUP85-SEH1 SPACE GROUP P21212
1005, 3f3pE, 0.5557, 4.33, 0.054, 300, 276, CRYSTAL STRUCTURE OF THE NUCLEOPORIN PAIR NUP85-SEH1 SPACE GROUP P21212
1006, 3f3fF, 0.5557, 4.34, 0.054, 306, 276, CRYSTAL STRUCTURE OF THE NUCLEOPORIN PAIR NUP85-SEH1 SPACE GROUP P21
1007, 3f3fA, 0.5552, 4.44, 0.054, 308, 278, CRYSTAL STRUCTURE OF THE NUCLEOPORIN PAIR NUP85-SEH1 SPACE GROUP P21
1008, 3f3pB, 0.5551, 4.33, 0.054, 300, 276, CRYSTAL STRUCTURE OF THE NUCLEOPORIN PAIR NUP85-SEH1 SPACE GROUP P21212
1009, 2vpjA, 0.5544, 3.69, 0.073, 289, 260, CRYSTAL STRUCTURE OF THE KELCH DOMAIN OF HUMAN KLHL12
1010, 3f3pI, 0.5540, 4.32, 0.055, 304, 275, CRYSTAL STRUCTURE OF THE NUCLEOPORIN PAIR NUP85-SEH1 SPACE GROUP P21212
1011, 4xmmC, 0.5539, 4.34, 0.054, 307, 276, STRUCTURE OF THE YEAST COAT NUCLEOPORIN COMPLEX SPACE GROUP C2
1012, 3f3fB, 0.5539, 4.44, 0.061, 307, 277, CRYSTAL STRUCTURE OF THE NUCLEOPORIN PAIR NUP85-SEH1 SPACE GROUP P21
1013, 4csdB, 0.5537, 3.56, 0.065, 267, 260, STRUCTURE OF MONOMERIC RALSTONIA SOLANACEARUM LECTIN
1014, 4hizA, 0.5535, 4.96, 0.084, 658, 286, PHAGE PHI92 ENDOSIALIDASE
1015, 4zlrB, 0.5533, 3.61, 0.081, 278, 260, STRUCTURE OF THE BRAT-NHL DOMAIN BOUND TO CONSENSUS RNA MOTIF
1016, 5gvaA, 0.5530, 3.80, 0.041, 305, 266, WD40 DOMAIN OF HUMAN AND-1
1017, 5fznA, 0.5529, 3.86, 0.046, 290, 262, STRUCTURE OF THE KEAP1 KELCH DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR.
1018, 3vgzB, 0.5528, 4.18, 0.077, 318, 274, CRYSTAL STRUCTURE OF E. COLI YNCE
1019, 4zlrA, 0.5526, 3.62, 0.081, 278, 260, STRUCTURE OF THE BRAT-NHL DOMAIN BOUND TO CONSENSUS RNA MOTIF
1020, 3vgzC, 0.5526, 4.25, 0.073, 320, 275, CRYSTAL STRUCTURE OF E. COLI YNCE
1021, 5fnqA, 0.5522, 3.82, 0.046, 290, 261, STRUCTURE OF THE KEAP1 KELCH DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR.
1022, 6cvzC, 0.5520, 4.40, 0.051, 334, 276, CRYSTAL STRUCTURE OF THE WD40-REPEAT OF RFWD3 
1023, 3vgzD, 0.5512, 4.22, 0.073, 318, 274, CRYSTAL STRUCTURE OF E. COLI YNCE
1024, 5fnsA, 0.5511, 3.87, 0.046, 289, 261, STRUCTURE OF THE KEAP1 KELCH DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR.
1025, 4l7bA, 0.5511, 3.97, 0.060, 291, 265, STRUCTURE OF KEAP1 KELCH DOMAIN WITH (1S2R)-2-{[(1S)-1-[(13-DIOXO-1 3-DIHYDRO-2H-ISOINDOL-2-YL)METHYL]-34-DIHYDROISOQUINOLIN-2(1H)- YL]CARBONYL}CYCLOHEXANECARBOXYLIC ACID
1026, 1x2jA, 0.5511, 3.66, 0.042, 290, 259, STRUCTURAL BASIS FOR THE DEFECTS OF HUMAN LUNG CANCER SOMATIC MUTATIONS IN THE REPRESSION ACTIVITY OF KEAP1 ON NRF2
1027, 5fzjA, 0.5510, 3.81, 0.046, 289, 260, STRUCTURE OF THE KEAP1 KELCH DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR.
1028, 2z32A, 0.5510, 3.89, 0.053, 290, 264, CRYSTAL STRUCTURE OF KEAP1 COMPLEXED WITH PROTHYMOSIN ALPHA
1029, 1q7fA, 0.5510, 3.67, 0.073, 279, 260, BRAIN TUMOR NHL DOMAIN
1030, 4l7dA, 0.5508, 3.77, 0.046, 286, 259, STRUCTURE OF KEAP1 KELCH DOMAIN WITH (1S2R)-2-{[(1S)-5-METHYL-1-[(1- OXO-13-DIHYDRO-2H-ISOINDOL-2-YL)METHYL]-34-DIHYDROISOQUINOLIN- 2(1H)-YL]CARBONYL}CYCLOHEXANECARBOXYLIC ACID
1031, 4l7bB, 0.5508, 3.88, 0.072, 292, 263, STRUCTURE OF KEAP1 KELCH DOMAIN WITH (1S2R)-2-{[(1S)-1-[(13-DIOXO-1 3-DIHYDRO-2H-ISOINDOL-2-YL)METHYL]-34-DIHYDROISOQUINOLIN-2(1H)- YL]CARBONYL}CYCLOHEXANECARBOXYLIC ACID
1032, 6fmqB, 0.5507, 3.88, 0.046, 285, 261, KEAP1 - PEPTIDE COMPLEX 
1033, 5fntA, 0.5507, 3.87, 0.046, 289, 261, STRUCTURE OF THE KEAP1 KELCH DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR.
1034, 3vgzA, 0.5507, 4.19, 0.073, 318, 274, CRYSTAL STRUCTURE OF E. COLI YNCE
1035, 5cgjA, 0.5506, 3.76, 0.050, 290, 260, CRYSTAL STRUCTURE OF MURINE KEAP1 IN COMPLEX WITH RA839 A NON- COVALENT SMALL-MOLECULE BINDER TO KEAP1 AND SELECTIVE ACTIVATOR OF NRF2 SIGNALLING.
1036, 2dyhA, 0.5504, 3.87, 0.057, 296, 264, CRYSTAL STRUCTURE OF THE KEAP1 PROTEIN IN COMPLEXED WITH THE N-TERMINAL REGION OF THE NRF2 TRANSCRIPTION FACTOR
1037, 5fnrA, 0.5502, 3.86, 0.046, 289, 261, STRUCTURE OF THE KEAP1 KELCH DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR.
1038, 6fmqA, 0.5501, 3.81, 0.057, 285, 261, KEAP1 - PEPTIDE COMPLEX 
1039, 4xmbA, 0.5501, 3.67, 0.046, 286, 259, CRYSTAL STRUCTURE OF 22 -(NAPHTHALENE-14-DIYLBIS(((4-METHOXYPHENYL) SULFONYL)AZANEDIYL))DIACETAMIDE BOUND TO HUMAN KEAP1 KELCH DOMAIN
1040, 4ifnX, 0.5500, 3.84, 0.046, 285, 260, CRYSTAL STRUCTURES OF APO KEAP1 KEAP1-PEPTIDE AND KEAP1-COMPOUND COMPLEXES
1041, 5ex7A, 0.5497, 3.53, 0.078, 274, 257, CRYSTAL STRUCTURE OF BRAT NHL DOMAIN IN COMPLEX WITH AN 8-NT HUNCHBACK MRNA
1042, 4csdA, 0.5496, 3.52, 0.062, 266, 257, STRUCTURE OF MONOMERIC RALSTONIA SOLANACEARUM LECTIN
1043, 3srgA, 0.5495, 4.16, 0.059, 337, 272, SERUM PARAOXONASE-1 BY DIRECTED EVOLUTION AT PH 6.5 IN COMPLEX WITH 2- HYDROXYQUINOLINE
1044, 3ii7A, 0.5494, 3.66, 0.074, 288, 258, CRYSTAL STRUCTURE OF THE KELCH DOMAIN OF HUMAN KLHL7
1045, 3fm0A, 0.5494, 4.45, 0.069, 328, 276, CRYSTAL STRUCTURE OF WD40 PROTEIN CIAO1
1046, 4n1bC, 0.5491, 3.77, 0.046, 287, 259, STRUCTURE OF KEAP1 KELCH DOMAIN WITH(1S2R)-2-[(1S)-1-[(1-OXO-23- DIHYDRO-1H-ISOINDOL-2-YL)METHYL]-1234-TETRAHYDROISOQUINOLINE-2- CARBONYL]CYCLOHEXANE-1-CARBOXYLIC ACID
1047, 3wdzA, 0.5490, 3.81, 0.069, 285, 262, CRYSTAL STRUCTURE OF KEAP1 IN COMPLEX WITH PHOSPHORYLATED P62
1048, 1x2rA, 0.5490, 3.91, 0.057, 290, 264, STRUCTURAL BASIS FOR THE DEFECTS OF HUMAN LUNG CANCER SOMATIC MUTATIONS IN THE REPRESSION ACTIVITY OF KEAP1 ON NRF2
1049, 2hesX, 0.5489, 4.20, 0.092, 308, 271, CYTOSOLIC IRON-SULPHUR ASSEMBLY PROTEIN- 1
1050, 1u6dX, 0.5488, 3.92, 0.053, 288, 263, CRYSTAL STRUCTURE OF THE KELCH DOMAIN OF HUMAN KEAP1
1051, 6fmpB, 0.5486, 3.90, 0.057, 285, 262, KEAP1 - PEPTIDE COMPLEX 
1052, 4ifjA, 0.5486, 3.99, 0.057, 288, 265, CRYSTAL STRUCTURES OF APO KEAP1 KEAP1-PEPTIDE AND KEAP1-COMPOUND COMPLEXES
1053, 6cvzB, 0.5485, 4.37, 0.047, 330, 274, CRYSTAL STRUCTURE OF THE WD40-REPEAT OF RFWD3 
1054, 4in4B, 0.5483, 3.81, 0.046, 284, 259, CRYSTAL STRUCTURE OF CPD 15 BOUND TO KEAP1 KELCH DOMAIN
1055, 3wn7A, 0.5482, 3.94, 0.057, 286, 263, CRYSTAL STRUCTURE OF KEAP1 IN COMPLEX WITH THE N-TERMINAL REGION OF THE NRF2 TRANSCRIPTION FACTOR
1056, 4n1bA, 0.5481, 3.83, 0.050, 286, 261, STRUCTURE OF KEAP1 KELCH DOMAIN WITH(1S2R)-2-[(1S)-1-[(1-OXO-23- DIHYDRO-1H-ISOINDOL-2-YL)METHYL]-1234-TETRAHYDROISOQUINOLINE-2- CARBONYL]CYCLOHEXANE-1-CARBOXYLIC ACID
1057, 4l7dC, 0.5481, 3.86, 0.050, 287, 262, STRUCTURE OF KEAP1 KELCH DOMAIN WITH (1S2R)-2-{[(1S)-5-METHYL-1-[(1- OXO-13-DIHYDRO-2H-ISOINDOL-2-YL)METHYL]-34-DIHYDROISOQUINOLIN- 2(1H)-YL]CARBONYL}CYCLOHEXANECARBOXYLIC ACID
1058, 4in4A, 0.5481, 3.97, 0.057, 288, 263, CRYSTAL STRUCTURE OF CPD 15 BOUND TO KEAP1 KELCH DOMAIN
1059, 3wn7L, 0.5481, 3.95, 0.057, 286, 264, CRYSTAL STRUCTURE OF KEAP1 IN COMPLEX WITH THE N-TERMINAL REGION OF THE NRF2 TRANSCRIPTION FACTOR
1060, 5x54B, 0.5480, 3.83, 0.069, 285, 262, CRYSTAL STRUCTURE OF THE KEAP1 KELCH DOMAIN IN COMPLEX WITH A TETRAPEPTIDE
1061, 3zgdA, 0.5480, 3.82, 0.046, 285, 260, CRYSTAL STRUCTURE OF A KEAP1 MUTANT
1062, 4novA, 0.5479, 4.56, 0.094, 298, 277, XSA43E A GH43 FAMILY ENZYME FROM BUTYRIVIBRIO PROTEOCLASTICUS
1063, 5f72K, 0.5478, 3.90, 0.057, 285, 263, DE NOVO DESIGN AND CRYSTALLOGRAPHIC VALIDATION OF ANTIBODIES TARGETING A PRE-SELECTED EPITOPE
1064, 4zy3B, 0.5478, 3.87, 0.057, 285, 262, CRYSTAL STRUCTURE OF KEAP1 IN COMPLEX WITH A SMALL CHEMICAL COMPOUND K67
1065, 4l7cA, 0.5478, 3.69, 0.047, 286, 257, STRUCTURE OF KEAP1 KELCH DOMAIN WITH 2-{[(1S)-2-{[(1R2S)-2-(1H- TETRAZOL-5-YL)CYCLOHEXYL]CARBONYL}-1234-TETRAHYDROISOQUINOLIN-1- YL]METHYL}-1H-ISOINDOLE-13(2H)-DIONE
1066, 3vnhA, 0.5478, 3.90, 0.061, 288, 263, CRYSTAL STRUCTURE OF KEAP1 SOAKED WITH SYNTHETIC SMALL MOLECULAR
1067, 5fnuA, 0.5477, 3.86, 0.046, 288, 260, STRUCTURE OF THE KEAP1 KELCH DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR.
1068, 4l7cB, 0.5477, 3.85, 0.050, 286, 259, STRUCTURE OF KEAP1 KELCH DOMAIN WITH 2-{[(1S)-2-{[(1R2S)-2-(1H- TETRAZOL-5-YL)CYCLOHEXYL]CARBONYL}-1234-TETRAHYDROISOQUINOLIN-1- YL]METHYL}-1H-ISOINDOLE-13(2H)-DIONE
1069, 3zgcA, 0.5477, 3.82, 0.046, 285, 260, CRYSTAL STRUCTURE OF THE KEAP1-NEH2 COMPLEX
1070, 2ghsA, 0.5476, 4.02, 0.083, 289, 265, CRYSTAL STRUCTURE OF A CALCIUM-BINDING PROTEIN REGUCALCIN (AGR_C_1268) FROM AGROBACTERIUM TUMEFACIENS STR. C58 AT 1.55 A RESOLUTION
1071, 4zy3A, 0.5475, 3.91, 0.057, 285, 263, CRYSTAL STRUCTURE OF KEAP1 IN COMPLEX WITH A SMALL CHEMICAL COMPOUND K67
1072, 4iqkA, 0.5474, 3.86, 0.061, 285, 262, CRYSTAL STRUCTURE OF CPD 16 BOUND TO KEAP1 KELCH DOMAIN
1073, 5f72C, 0.5472, 3.88, 0.061, 285, 263, DE NOVO DESIGN AND CRYSTALLOGRAPHIC VALIDATION OF ANTIBODIES TARGETING A PRE-SELECTED EPITOPE
1074, 3zgdB, 0.5472, 3.93, 0.057, 285, 263, CRYSTAL STRUCTURE OF A KEAP1 MUTANT
1075, 3adeA, 0.5472, 3.85, 0.061, 289, 262, CRYSTAL STRUCTURE OF KEAP1 IN COMPLEX WITH SEQUESTOSOME- 1/P62
1076, 6gy5A, 0.5471, 3.73, 0.061, 285, 261, CRYSTAL STRUCTURE OF THE KELCH DOMAIN OF HUMAN KLHL20 IN COMPLEX WITH DAPK1 PEPTIDE 
1077, 4in4C, 0.5470, 3.87, 0.073, 289, 262, CRYSTAL STRUCTURE OF CPD 15 BOUND TO KEAP1 KELCH DOMAIN
1078, 6fmpA, 0.5468, 3.90, 0.061, 285, 262, KEAP1 - PEPTIDE COMPLEX 
1079, 5x54A, 0.5468, 3.87, 0.061, 285, 262, CRYSTAL STRUCTURE OF THE KEAP1 KELCH DOMAIN IN COMPLEX WITH A TETRAPEPTIDE
1080, 3vngA, 0.5467, 3.91, 0.057, 288, 262, CRYSTAL STRUCTURE OF KEAP1 IN COMPLEX WITH SYNTHETIC SMALL MOLECULAR BASED ON A CO-CRYSTALLIZATION
1081, 4l7dB, 0.5466, 3.81, 0.046, 285, 259, STRUCTURE OF KEAP1 KELCH DOMAIN WITH (1S2R)-2-{[(1S)-5-METHYL-1-[(1- OXO-13-DIHYDRO-2H-ISOINDOL-2-YL)METHYL]-34-DIHYDROISOQUINOLIN- 2(1H)-YL]CARBONYL}CYCLOHEXANECARBOXYLIC ACID
1082, 4ascA, 0.5466, 3.90, 0.061, 307, 261, CRYSTAL STRUCTURE OF THE KELCH DOMAIN OF HUMAN KBTBD5
1083, 3zgcB, 0.5465, 3.86, 0.069, 285, 262, CRYSTAL STRUCTURE OF THE KEAP1-NEH2 COMPLEX
1084, 5fvmD, 0.5463, 4.29, 0.066, 299, 271, CRYO ELECTRON MICROSCOPY OF A COMPLEX OF TOR AND LST8
1085, 5fvmC, 0.5463, 4.29, 0.066, 299, 271, CRYO ELECTRON MICROSCOPY OF A COMPLEX OF TOR AND LST8
1086, 3qz4A, 0.5461, 4.52, 0.097, 302, 277, CRYSTAL STRUCTURE OF AN ENDO-14-BETA-XYLANASE D (BT_3675) FROM BACTEROIDES THETAIOTAOMICRON VPI-5482 AT 1.74 A RESOLUTION
1087, 2wozA, 0.5459, 3.94, 0.069, 307, 261, THE NOVEL BETA-PROPELLER OF THE BTB-KELCH PROTEIN KRP1 PROVIDES THE BINDING SITE FOR LASP-1 THAT IS NECESSARY FOR PSEUDOPODIA EXTENSION
1088, 3qz4B, 0.5457, 4.52, 0.094, 302, 277, CRYSTAL STRUCTURE OF AN ENDO-14-BETA-XYLANASE D (BT_3675) FROM BACTEROIDES THETAIOTAOMICRON VPI-5482 AT 1.74 A RESOLUTION
1089, 4iflX, 0.5456, 3.96, 0.049, 285, 263, CRYSTAL STRUCTURES OF APO KEAP1 KEAP1-PEPTIDE AND KEAP1-COMPOUND COMPLEXES
1090, 2fluX, 0.5456, 3.85, 0.065, 285, 262, CRYSTAL STRUCTURE OF THE KELCH-NEH2 COMPLEX
1091, 4l7cC, 0.5455, 3.86, 0.061, 286, 261, STRUCTURE OF KEAP1 KELCH DOMAIN WITH 2-{[(1S)-2-{[(1R2S)-2-(1H- TETRAZOL-5-YL)CYCLOHEXYL]CARBONYL}-1234-TETRAHYDROISOQUINOLIN-1- YL]METHYL}-1H-ISOINDOLE-13(2H)-DIONE
1092, 5nkpB, 0.5453, 3.98, 0.057, 289, 263, CRYSTAL STRUCTURE OF THE HUMAN KLHL3 KELCH DOMAIN IN COMPLEX WITH A WNK3 PEPTIDE
1093, 4n1bB, 0.5450, 3.78, 0.051, 284, 257, STRUCTURE OF KEAP1 KELCH DOMAIN WITH(1S2R)-2-[(1S)-1-[(1-OXO-23- DIHYDRO-1H-ISOINDOL-2-YL)METHYL]-1234-TETRAHYDROISOQUINOLINE-2- CARBONYL]CYCLOHEXANE-1-CARBOXYLIC ACID
1094, 4ch9B, 0.5447, 3.92, 0.065, 286, 261, CRYSTAL STRUCTURE OF THE HUMAN KLHL3 KELCH DOMAIN IN COMPLEX WITH A WNK4 PEPTIDE
1095, 2xn4B, 0.5447, 3.74, 0.058, 286, 258, CRYSTAL STRUCTURE OF THE KELCH DOMAIN OF HUMAN KLHL2 (MAYVEN)
1096, 5yy8A, 0.5439, 3.69, 0.062, 272, 259, CRYSTAL STRUCTURE OF THE KELCH DOMAIN OF HUMAN NS1-BP
1097, 4chbB, 0.5438, 3.90, 0.061, 286, 261, CRYSTAL STRUCTURE OF THE HUMAN KLHL2 KELCH DOMAIN IN COMPLEX WITH A WNK4 PEPTIDE
1098, 5nkpA, 0.5433, 3.83, 0.066, 286, 259, CRYSTAL STRUCTURE OF THE HUMAN KLHL3 KELCH DOMAIN IN COMPLEX WITH A WNK3 PEPTIDE
1099, 2xn4A, 0.5432, 3.81, 0.062, 286, 260, CRYSTAL STRUCTURE OF THE KELCH DOMAIN OF HUMAN KLHL2 (MAYVEN)
1100, 4chbA, 0.5430, 3.91, 0.061, 286, 261, CRYSTAL STRUCTURE OF THE HUMAN KLHL2 KELCH DOMAIN IN COMPLEX WITH A WNK4 PEPTIDE
1101, 3j77SA, 0.5428, 4.09, 0.071, 318, 266, 
1102, 1v04A, 0.5418, 4.01, 0.053, 332, 266, SERUM PARAOXONASE BY DIRECTED EVOLUTION
1103, 5o9zD, 0.5414, 4.26, 0.056, 302, 269, CRYO-EM STRUCTURE OF A PRE-CATALYTIC HUMAN SPLICEOSOME PRIMED FOR ACTIVATION (B COMPLEX)
1104, 4ch9A, 0.5414, 4.00, 0.068, 286, 263, CRYSTAL STRUCTURE OF THE HUMAN KLHL3 KELCH DOMAIN IN COMPLEX WITH A WNK4 PEPTIDE
1105, 3jcrD, 0.5414, 4.26, 0.056, 302, 269, 3D STRUCTURE DETERMINATION OF THE HUMAN*U4/U6.U5* TRI-SNRNP COMPLEX
1106, 3dr2A, 0.5414, 3.76, 0.062, 299, 259, STRUCTURAL AND FUNCTIONAL ANALYSES OF XC5397 FROM XANTHOMONAS CAMPESTRIS: A GLUCONOLACTONASE IMPORTANT IN GLUCOSE SECONDARY METABOLIC PATHWAYS
1107, 5ndvYE, 0.5411, 4.23, 0.067, 318, 268, struct.pdbx_descriptor              
1108, 3qeeB, 0.5411, 4.27, 0.056, 299, 268, THE STRUCTURE AND FUNCTION OF AN ARABINAN-SPECIFIC ALPHA-12- ARABINOFURANOSIDASE IDENTIFIED FROM SCREENING THE ACTIVITIES OF BACTERIAL GH43 GLYCOSIDE HYDROLASES
1109, 4d6vA, 0.5408, 4.12, 0.056, 313, 266, CRYSTAL STRUCTURE OF SIGNAL TRANSDUCING PROTEIN
1110, 5juoWA, 0.5404, 4.14, 0.060, 318, 266, 
1111, 5dgvID, 0.5404, 4.13, 0.068, 318, 266, 
1112, 5i4lID, 0.5403, 4.13, 0.079, 318, 267, 
1113, 5tgmID, 0.5402, 4.16, 0.068, 318, 266, 
1114, 2z2oA, 0.5401, 4.08, 0.053, 298, 263, CRYSTAL STRUCTURE OF APO VIRGINIAMYCIN B LYASE FROM STAPHYLOCOCCUS AUREUS
1115, 5fciID, 0.5398, 4.18, 0.071, 318, 266, 
1116, 3dr2B, 0.5396, 3.75, 0.062, 297, 258, STRUCTURAL AND FUNCTIONAL ANALYSES OF XC5397 FROM XANTHOMONAS CAMPESTRIS: A GLUCONOLACTONASE IMPORTANT IN GLUCOSE SECONDARY METABOLIC PATHWAYS
1117, 4u4qID, 0.5395, 4.17, 0.064, 318, 266, 
1118, 3qefB, 0.5395, 4.26, 0.060, 297, 267, THE STRUCTURE AND FUNCTION OF AN ARABINAN-SPECIFIC ALPHA-12- ARABINOFURANOSIDASE IDENTIFIED FROM SCREENING THE ACTIVITIES OF BACTERIAL GH43 GLYCOSIDE HYDROLASES
1119, 2z2oD, 0.5395, 4.11, 0.053, 295, 263, CRYSTAL STRUCTURE OF APO VIRGINIAMYCIN B LYASE FROM STAPHYLOCOCCUS AUREUS
1120, 2z2oC, 0.5395, 4.10, 0.053, 299, 263, CRYSTAL STRUCTURE OF APO VIRGINIAMYCIN B LYASE FROM STAPHYLOCOCCUS AUREUS
1121, 5ndwAF, 0.5394, 4.13, 0.086, 316, 267, struct.pdbx_descriptor              
1122, 5datID, 0.5394, 4.17, 0.075, 318, 266, 
1123, 2fp8B, 0.5393, 3.90, 0.065, 303, 261, STRUCTURE OF STRICTOSIDINE SYNTHASE THE BIOSYNTHETIC ENTRY TO THE MONOTERPENOID INDOLE ALKALOID FAMILY
1124, 4u55ID, 0.5392, 4.15, 0.079, 318, 267, 
1125, 2fp9B, 0.5392, 3.93, 0.069, 305, 262, CRYSTAL STRUCTURE OF NATIVE STRICTOSIDINE SYNTHASE
1126, 5dc3ID, 0.5391, 4.17, 0.068, 318, 266, 
1127, 2vaqA, 0.5389, 4.02, 0.068, 305, 263, STRUCTURE OF STRICTOSIDINE SYNTHASE IN COMPLEX WITH INHIBITOR
1128, 2z2oB, 0.5387, 4.06, 0.049, 293, 263, CRYSTAL STRUCTURE OF APO VIRGINIAMYCIN B LYASE FROM STAPHYLOCOCCUS AUREUS
1129, 2qc5A, 0.5384, 3.99, 0.065, 298, 262, STREPTOGRAMIN B LYASE STRUCTURE
1130, 5fcjHA, 0.5383, 4.10, 0.064, 318, 265, 
1131, 3qeeA, 0.5383, 4.28, 0.064, 297, 266, THE STRUCTURE AND FUNCTION OF AN ARABINAN-SPECIFIC ALPHA-12- ARABINOFURANOSIDASE IDENTIFIED FROM SCREENING THE ACTIVITIES OF BACTERIAL GH43 GLYCOSIDE HYDROLASES
1132, 3qefA, 0.5382, 4.26, 0.068, 296, 266, THE STRUCTURE AND FUNCTION OF AN ARABINAN-SPECIFIC ALPHA-12- ARABINOFURANOSIDASE IDENTIFIED FROM SCREENING THE ACTIVITIES OF BACTERIAL GH43 GLYCOSIDE HYDROLASES
1133, 6g18g, 0.5380, 4.22, 0.075, 313, 266, CRYO-EM STRUCTURE OF A LATE HUMAN PRE-40S RIBOSOMAL SUBUNIT - STATE C 
1134, 3j6yAC, 0.5380, 4.21, 0.079, 318, 267, 
1135, 5tbwUD, 0.5378, 4.18, 0.079, 318, 267, struct.pdbx_descriptor              ? 
1136, 5ndgID, 0.5378, 4.06, 0.076, 313, 263, struct.pdbx_descriptor              
1137, 3v1sA, 0.5377, 3.89, 0.069, 302, 260, SCAFFOLD TAILORING BY A NEWLY DETECTED PICTET-SPENGLERASE AC-TIVITY OF STRICTOSIDINE SYNTHASE (STR1): FROM THE COMMON TRYP-TOLINE SKELETON TO THE RARE PIPERAZINO-INDOLE FRAMEWORK
1138, 4u50HA, 0.5376, 4.18, 0.086, 318, 267, 
1139, 6d90EC, 0.5374, 4.29, 0.068, 313, 266, struct.pdbx_descriptor              Ribosome 
1140, 1zgkA, 0.5374, 3.97, 0.047, 281, 258, 1.35 ANGSTROM STRUCTURE OF THE KELCH DOMAIN OF KEAP1
1141, 4u4qHA, 0.5373, 4.18, 0.086, 318, 267, 
1142, 4aowC, 0.5373, 4.24, 0.075, 305, 266, CRYSTAL STRUCTURE OF THE HUMAN RACK1 PROTEIN AT A RESOLUTION OF 2.45 ANGSTROM
1143, 3v1sB, 0.5373, 3.87, 0.066, 302, 259, SCAFFOLD TAILORING BY A NEWLY DETECTED PICTET-SPENGLERASE AC-TIVITY OF STRICTOSIDINE SYNTHASE (STR1): FROM THE COMMON TRYP-TOLINE SKELETON TO THE RARE PIPERAZINO-INDOLE FRAMEWORK
1144, 5meiVD, 0.5372, 4.18, 0.086, 318, 267, 
1145, 3j81g, 0.5371, 4.39, 0.067, 318, 269, CRYOEM STRUCTURE OF A PARTIAL YEAST 48S PREINITIATION COMPLEX
1146, 1rwiA, 0.5371, 3.32, 0.036, 256, 247, EXTRACELLULAR DOMAIN OF MYCOBACTERIUM TUBERCULOSIS PKND
1147, 2fp9A, 0.5368, 3.89, 0.069, 305, 260, CRYSTAL STRUCTURE OF NATIVE STRICTOSIDINE SYNTHASE
1148, 4iygB, 0.5366, 3.84, 0.062, 302, 259, STRUCTURE OF STRICTOSIDINE SYNTHASE IN COMPLEX WITH 2-(1H-INDOL-3-YL)- N-METHYLETHANAMINE
1149, 4iygA, 0.5366, 3.89, 0.066, 302, 259, STRUCTURE OF STRICTOSIDINE SYNTHASE IN COMPLEX WITH 2-(1H-INDOL-3-YL)- N-METHYLETHANAMINE
1150, 3japJA, 0.5366, 4.42, 0.063, 318, 269, 
1151, 4aowA, 0.5364, 4.25, 0.075, 305, 266, CRYSTAL STRUCTURE OF THE HUMAN RACK1 PROTEIN AT A RESOLUTION OF 2.45 ANGSTROM
1152, 6f0tB, 0.5363, 3.18, 0.078, 251, 245, CRYSTAL STRUCTURE OF PIZZA6-SFW
1153, 5m1jN, 0.5363, 4.27, 0.060, 318, 266, 
1154, 2vaqB, 0.5363, 3.93, 0.065, 305, 260, STRUCTURE OF STRICTOSIDINE SYNTHASE IN COMPLEX WITH INHIBITOR
1155, 2v91A, 0.5362, 3.91, 0.069, 302, 260, STRUCTURE OF STRICTOSIDINE SYNTHASE IN COMPLEX WITH STRICTOSIDINE
1156, 6f0tA, 0.5361, 3.26, 0.069, 251, 246, CRYSTAL STRUCTURE OF PIZZA6-SFW
1157, 3wwaA, 0.5361, 3.21, 0.082, 251, 245, CRYSTAL STRUCTURE OF THE COMPUTATIONALLY DESIGNED PIZZA7 PROTEIN AFTER HEAT TREATMENT
1158, 2v91B, 0.5361, 3.91, 0.069, 302, 260, STRUCTURE OF STRICTOSIDINE SYNTHASE IN COMPLEX WITH STRICTOSIDINE
1159, 2fpcB, 0.5359, 3.95, 0.069, 302, 261, STRUCTURE OF STRICTOSIDINE SYNTHASE THE BIOSYNTHETIC ENTRY TO THE MONOTERPENOID INDOLE ALKALOID FAMILY
1160, 2z2pA, 0.5358, 4.02, 0.050, 293, 262, CRYSTAL STRUCTURE OF CATALYTICALLY INACTIVE H270A VIRGINIAMYCIN B LYASE FROM STAPHYLOCOCCUS AUREUS WITH QUINUPRISTIN
1161, 2fp8A, 0.5358, 3.93, 0.069, 302, 260, STRUCTURE OF STRICTOSIDINE SYNTHASE THE BIOSYNTHETIC ENTRY TO THE MONOTERPENOID INDOLE ALKALOID FAMILY
1162, 2z2pB, 0.5356, 4.02, 0.053, 293, 262, CRYSTAL STRUCTURE OF CATALYTICALLY INACTIVE H270A VIRGINIAMYCIN B LYASE FROM STAPHYLOCOCCUS AUREUS WITH QUINUPRISTIN
1163, 4imbB, 0.5355, 3.86, 0.062, 301, 258, STRUCTURE OF STRICTOSIDINE SYNTHASE IN COMPLEX WITH 2-(1-METHYL-1H- INDOL-3-YL)ETHANAMINE
1164, 4imbA, 0.5355, 3.89, 0.069, 301, 259, STRUCTURE OF STRICTOSIDINE SYNTHASE IN COMPLEX WITH 2-(1-METHYL-1H- INDOL-3-YL)ETHANAMINE
1165, 3ww9A, 0.5355, 3.25, 0.061, 251, 247, CRYSTAL STRUCTURE OF THE COMPUTATIONALLY DESIGNED PIZZA6 PROTEIN
1166, 6g5hg, 0.5354, 4.17, 0.068, 314, 264, CRYO-EM STRUCTURE OF A LATE HUMAN PRE-40S RIBOSOMAL SUBUNIT - MATURE 
1167, 6g53g, 0.5354, 4.17, 0.068, 314, 264, CRYO-EM STRUCTURE OF A LATE HUMAN PRE-40S RIBOSOMAL SUBUNIT - STATE E 
1168, 6g51g, 0.5354, 4.17, 0.068, 314, 264, CRYO-EM STRUCTURE OF A LATE HUMAN PRE-40S RIBOSOMAL SUBUNIT - STATE D 
1169, 2fpcA, 0.5352, 3.92, 0.073, 302, 260, STRUCTURE OF STRICTOSIDINE SYNTHASE THE BIOSYNTHETIC ENTRY TO THE MONOTERPENOID INDOLE ALKALOID FAMILY
1170, 6f0sA, 0.5350, 3.31, 0.060, 251, 248, CRYSTAL STRUCTURE OF PIZZA6-SYW
1171, 3jamg, 0.5347, 4.31, 0.056, 318, 267, CRYOEM STRUCTURE OF 40S-EIF1A-EIF1 COMPLEX FROM YEAST
1172, 6f0qB, 0.5345, 3.28, 0.081, 251, 246, CRYSTAL STRUCTURE OF PIZZA6-AYW
1173, 4aowB, 0.5343, 4.25, 0.075, 301, 265, CRYSTAL STRUCTURE OF THE HUMAN RACK1 PROTEIN AT A RESOLUTION OF 2.45 ANGSTROM
1174, 6f0tC, 0.5330, 3.29, 0.061, 251, 247, CRYSTAL STRUCTURE OF PIZZA6-SFW
1175, 3ow8A, 0.5330, 3.94, 0.062, 293, 259, CRYSTAL STRUCTURE OF THE WD REPEAT-CONTAINING PROTEIN 61
1176, 3j7rEC, 0.5329, 4.18, 0.049, 313, 263, 
1177, 3j7pDC, 0.5329, 4.18, 0.049, 313, 263, 
1178, 1rwlA, 0.5329, 3.43, 0.040, 254, 248, EXTRACELLULAR DOMAIN OF MYCOBACTERIUM TUBERCULOSIS PKND
1179, 2fpbA, 0.5328, 3.88, 0.054, 299, 259, STRUCTURE OF STRICTOSIDINE SYNTHASE THE BIOSYNTHETIC ENTRY TO THE MONOTERPENOID INDOLE ALKALOID FAMILY
1180, 6gqvAC, 0.5326, 4.33, 0.064, 318, 266, struct.pdbx_descriptor              
1181, 4v6iA, 0.5324, 4.32, 0.060, 319, 265, 
1182, 6fecOA, 0.5323, 4.34, 0.071, 313, 266, struct.pdbx_descriptor              
1183, 6f0qA, 0.5322, 3.30, 0.061, 251, 246, CRYSTAL STRUCTURE OF PIZZA6-AYW
1184, 3janHC, 0.5319, 4.21, 0.046, 313, 263, 
1185, 3jajIC, 0.5319, 4.21, 0.046, 313, 263, 
1186, 4v7rPC, 0.5316, 4.18, 0.057, 313, 264, 
1187, 3qedD, 0.5316, 4.37, 0.057, 297, 265, THE STRUCTURE AND FUNCTION OF AN ARABINAN-SPECIFIC ALPHA-12- ARABINOFURANOSIDASE IDENTIFIED FROM SCREENING THE ACTIVITIES OF BACTERIAL GH43 GLYCOSIDE HYDROLASES
1188, 4u4oID, 0.5314, 4.49, 0.067, 318, 270, 
1189, 5obmDF, 0.5312, 4.16, 0.061, 318, 262, struct.pdbx_descriptor              
1190, 3qedC, 0.5310, 4.38, 0.064, 295, 265, THE STRUCTURE AND FUNCTION OF AN ARABINAN-SPECIFIC ALPHA-12- ARABINOFURANOSIDASE IDENTIFIED FROM SCREENING THE ACTIVITIES OF BACTERIAL GH43 GLYCOSIDE HYDROLASES
1191, 5it7BC, 0.5309, 4.43, 0.045, 318, 269, 
1192, 4u3uID, 0.5309, 4.15, 0.046, 318, 262, 
1193, 4u50ID, 0.5308, 4.16, 0.057, 318, 263, 
1194, 3jaqJA, 0.5308, 4.58, 0.063, 318, 270, 
1195, 4u4rID, 0.5307, 4.18, 0.057, 318, 263, 
1196, 1rwiB, 0.5306, 3.36, 0.037, 254, 245, EXTRACELLULAR DOMAIN OF MYCOBACTERIUM TUBERCULOSIS PKND
1197, 3qedB, 0.5305, 4.35, 0.057, 297, 264, THE STRUCTURE AND FUNCTION OF AN ARABINAN-SPECIFIC ALPHA-12- ARABINOFURANOSIDASE IDENTIFIED FROM SCREENING THE ACTIVITIES OF BACTERIAL GH43 GLYCOSIDE HYDROLASES
1198, 3j80g, 0.5305, 4.52, 0.063, 318, 270, CRYOEM STRUCTURE OF 40S-EIF1-EIF1A PREINITIATION COMPLEX
1199, 2fpbB, 0.5305, 3.91, 0.047, 299, 258, STRUCTURE OF STRICTOSIDINE SYNTHASE THE BIOSYNTHETIC ENTRY TO THE MONOTERPENOID INDOLE ALKALOID FAMILY
1200, 5tgaHA, 0.5304, 4.51, 0.063, 318, 270, 
1201, 4u3mID, 0.5303, 4.20, 0.057, 318, 263, 
1202, 5lybID, 0.5302, 4.20, 0.061, 318, 263, 
1203, 4u3nID, 0.5300, 4.41, 0.052, 318, 269, 
1204, 4v88ID, 0.5299, 4.18, 0.053, 318, 263, 
1205, 4u4zID, 0.5299, 4.17, 0.053, 318, 263, 
1206, 5tgaID, 0.5298, 4.22, 0.053, 318, 264, 
1207, 5mqfF, 0.5298, 4.23, 0.057, 307, 262, CRYO-EM STRUCTURE OF A HUMAN SPLICEOSOME ACTIVATED FOR STEP 2 OF SPLICING (C* COMPLEX)
1208, 5fcjID, 0.5298, 4.13, 0.050, 318, 261, 
1209, 4u6fID, 0.5298, 4.15, 0.057, 318, 262, 
1210, 4u4nHA, 0.5298, 4.53, 0.063, 318, 270, 
1211, 3qedA, 0.5298, 4.37, 0.064, 290, 264, THE STRUCTURE AND FUNCTION OF AN ARABINAN-SPECIFIC ALPHA-12- ARABINOFURANOSIDASE IDENTIFIED FROM SCREENING THE ACTIVITIES OF BACTERIAL GH43 GLYCOSIDE HYDROLASES
1212, 3frxC, 0.5298, 4.11, 0.062, 302, 259, CRYSTAL STRUCTURE OF THE YEAST ORTHOLOGUE OF RACK1 ASC1.
1213, 4v6xB, 0.5297, 4.23, 0.046, 313, 263, 
1214, 4u56ID, 0.5297, 4.49, 0.056, 318, 270, 
1215, 4u4uID, 0.5297, 4.23, 0.053, 318, 264, 
1216, 4kzzg, 0.5297, 4.23, 0.046, 313, 263, RABBIT 40S RIBOSOMAL SUBUNIT IN COMPLEX WITH MRNA INITIATOR TRNA AND EIF1A
1217, 4kzyg, 0.5297, 4.23, 0.046, 313, 263, RABBIT 40S RIBOSOMAL SUBUNIT IN COMPLEX WITH EIF1 AND EIF1A.
1218, 4kzxg, 0.5297, 4.23, 0.046, 313, 263, RABBIT 40S RIBOSOMAL SUBUNIT IN COMPLEX WITH EIF1.
1219, 5dgeHA, 0.5296, 4.51, 0.059, 318, 271, 
1220, 4u52ID, 0.5294, 4.55, 0.063, 318, 271, 
1221, 5dgeID, 0.5293, 4.46, 0.056, 318, 269, 
1222, 5ndvYB, 0.5291, 4.20, 0.061, 317, 262, struct.pdbx_descriptor              
1223, 4u4yID, 0.5291, 4.25, 0.053, 318, 264, 
1224, 5lybHA, 0.5290, 4.51, 0.056, 318, 270, 
1225, 5k0ym, 0.5290, 4.35, 0.068, 313, 265, M48S LATE-STAGE INITIATION COMPLEX PURIFIED FROM RABBIT RETICULOCYTES LYSATES DISPLAYING EIF2 TERNARY COMPLEX AND EIF3 I AND G SUBUNITS RELOCATED TO THE INTERSUBUNIT FACE
1226, 4v7hQ, 0.5289, 4.03, 0.062, 313, 259, 
1227, 5on6DF, 0.5288, 4.47, 0.056, 318, 269, struct.pdbx_descriptor              
1228, 1trjA, 0.5288, 4.48, 0.079, 314, 266, HOMOLOGY MODEL OF YEAST RACK1 PROTEIN FITTED INTO 11.7A CRYO-EM MAP OF YEAST 80S RIBOSOME
1229, 5tbwWD, 0.5287, 4.17, 0.057, 318, 262, struct.pdbx_descriptor              ? 
1230, 4v8zG, 0.5287, 4.53, 0.052, 318, 271, 
1231, 4v8yG, 0.5287, 4.53, 0.052, 318, 271, 
1232, 4v88HA, 0.5287, 4.53, 0.052, 318, 271, 
1233, 4uerR, 0.5287, 4.53, 0.052, 318, 271, 40S-EIF1-EIF1A-EIF3-EIF3J TRANSLATION INITIATION COMPLEX FROM LACHANCEA KLUYVERI
1234, 5meiCF, 0.5286, 4.21, 0.053, 318, 263, 
1235, 5dgfID, 0.5286, 4.23, 0.057, 318, 263, 
1236, 5dgfHA, 0.5286, 4.22, 0.053, 318, 262, 
1237, 5dgvHA, 0.5285, 4.59, 0.063, 318, 271, 
1238, 4u4nID, 0.5285, 4.03, 0.066, 318, 259, 
1239, 3e5zA, 0.5285, 3.85, 0.078, 287, 255, X-RAY STRUCTURE OF THE PUTATIVE GLUCONOLACTONASE IN PROTEIN FAMILY PF08450. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET DRR130.
1240, 4u51ID, 0.5284, 4.20, 0.057, 318, 263, 
1241, 2z2nA, 0.5284, 4.14, 0.046, 289, 260, CRYSTAL STRUCTURE OF SELENOMETHIONINE SUBSTITUTED VIRGINIAMYCIN B LYASE FROM STAPHYLOCOCCUS AUREUS
1242, 4u53ID, 0.5283, 4.32, 0.064, 318, 266, 
1243, 5it9g, 0.5282, 4.14, 0.046, 318, 260, STRUCTURE OF THE YEAST KLUYVEROMYCES LACTIS SMALL RIBOSOMAL SUBUNIT IN COMPLEX WITH THE CRICKET PARALYSIS VIRUS IRES.
1244, 6faig, 0.5280, 4.52, 0.063, 317, 269, STRUCTURE OF A EUKARYOTIC CYTOPLASMIC PRE-40S RIBOSOMAL SUBUNIT
1245, 5ndgHA, 0.5280, 4.44, 0.063, 318, 268, struct.pdbx_descriptor              
1246, 5fciHA, 0.5280, 4.49, 0.063, 318, 269, 
1247, 5mc6P, 0.5279, 4.19, 0.057, 318, 261, 
1248, 5datHA, 0.5279, 4.28, 0.042, 318, 264, 
1249, 5tgmHA, 0.5277, 4.28, 0.053, 318, 264, 
1250, 5ndwBF, 0.5277, 4.23, 0.046, 318, 262, struct.pdbx_descriptor              
1251, 4u4rHA, 0.5277, 4.22, 0.057, 318, 262, 
1252, 4u4zHA, 0.5275, 4.25, 0.061, 318, 263, 
1253, 4u4oHA, 0.5274, 4.20, 0.046, 318, 262, 
1254, 4u3nHA, 0.5273, 4.26, 0.061, 318, 263, 
1255, 3e5zB, 0.5273, 3.88, 0.075, 287, 255, X-RAY STRUCTURE OF THE PUTATIVE GLUCONOLACTONASE IN PROTEIN FAMILY PF08450. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET DRR130.
1256, 4u56HA, 0.5272, 4.26, 0.065, 318, 263, 
1257, 4u51HA, 0.5272, 4.35, 0.053, 318, 265, 
1258, 4u4uHA, 0.5272, 4.25, 0.042, 318, 263, 
1259, 5dc3HA, 0.5270, 4.24, 0.057, 318, 262, 
1260, 4u53HA, 0.5269, 4.28, 0.057, 318, 263, 
1261, 4u3mHA, 0.5268, 4.26, 0.057, 318, 262, 
1262, 5obmZB, 0.5267, 4.14, 0.042, 318, 261, struct.pdbx_descriptor              
1263, 5i4lHA, 0.5267, 4.28, 0.057, 318, 263, 
1264, 5lksPB, 0.5266, 4.45, 0.071, 313, 266, 
1265, 4u3uHA, 0.5265, 4.29, 0.057, 318, 263, 
1266, 5oa1V, 0.5264, 4.12, 0.047, 288, 256, RNA POLYMERASE I PRE-INITIATION COMPLEX
1267, 4u52HA, 0.5264, 4.27, 0.061, 318, 263, 
1268, 4u6fHA, 0.5263, 4.21, 0.042, 318, 262, 
1269, 5lzyEC, 0.5261, 4.22, 0.038, 313, 261, 
1270, 5nuvA, 0.5260, 4.06, 0.058, 301, 257, STRUCTURE OF THE WD40-DOMAIN OF HUMAN ATG16L1
1271, 3jagFC, 0.5260, 4.24, 0.042, 313, 261, 
1272, 4u4yHA, 0.5257, 4.33, 0.053, 318, 264, 
1273, 5lzzFC, 0.5256, 4.23, 0.042, 313, 261, 
1274, 3jaiFC, 0.5255, 4.32, 0.050, 313, 262, 
1275, 5lzxFC, 0.5252, 4.23, 0.042, 313, 261, 
1276, 5lzvFC, 0.5252, 4.24, 0.038, 313, 261, 
1277, 5lzuEC, 0.5251, 4.24, 0.038, 313, 261, 
1278, 4u55HA, 0.5251, 4.38, 0.053, 318, 266, 
1279, 5lzwFC, 0.5250, 4.23, 0.042, 313, 261, 
1280, 5lzsEC, 0.5249, 4.29, 0.038, 313, 262, 
1281, 3jahFC, 0.5249, 4.27, 0.042, 313, 261, 
1282, 2ojhA, 0.5248, 3.51, 0.049, 269, 247, THE STRUCTURE OF PUTATIVE TOLB FROM AGROBACTERIUM TUMEFACIENS
1283, 5lztFC, 0.5246, 4.30, 0.042, 313, 262, 
1284, 5aj0DC, 0.5245, 4.26, 0.042, 314, 261, 
1285, 5on6WD, 0.5239, 4.09, 0.069, 318, 260, struct.pdbx_descriptor              
1286, 3j6xAC, 0.5239, 4.32, 0.068, 318, 263, 
1287, 4v5oAA, 0.5224, 4.36, 0.045, 338, 264, 
1288, 4v92IA, 0.5223, 4.35, 0.057, 315, 263, 
1289, 4btsVC, 0.5223, 4.40, 0.049, 338, 263, 
1290, 4btsLB, 0.5223, 4.41, 0.049, 338, 263, 
1291, 4btsFE, 0.5223, 4.40, 0.049, 338, 263, 
1292, 4btsBA, 0.5223, 4.40, 0.049, 338, 263, 
1293, 1npeA, 0.5223, 3.27, 0.067, 263, 240, CRYSTAL STRUCTURE OF NIDOGEN/LAMININ COMPLEX
1294, 5flxg, 0.5221, 4.32, 0.046, 314, 261, MAMMALIAN 40S HCV-IRES COMPLEX
1295, 4v5oJB, 0.5220, 4.38, 0.045, 338, 264, 
1296, 3ow8C, 0.5219, 4.13, 0.047, 300, 257, CRYSTAL STRUCTURE OF THE WD REPEAT-CONTAINING PROTEIN 61
1297, 3ow8D, 0.5218, 4.12, 0.047, 300, 257, CRYSTAL STRUCTURE OF THE WD REPEAT-CONTAINING PROTEIN 61
1298, 3frxB, 0.5217, 4.20, 0.062, 306, 258, CRYSTAL STRUCTURE OF THE YEAST ORTHOLOGUE OF RACK1 ASC1.
1299, 3frxD, 0.5216, 4.21, 0.062, 306, 258, CRYSTAL STRUCTURE OF THE YEAST ORTHOLOGUE OF RACK1 ASC1.
1300, 5a2qg, 0.5215, 4.36, 0.050, 314, 261, STRUCTURE OF THE HCV IRES BOUND TO THE HUMAN RIBOSOME
1301, 3frxA, 0.5214, 4.14, 0.062, 303, 257, CRYSTAL STRUCTURE OF THE YEAST ORTHOLOGUE OF RACK1 ASC1.
1302, 6ek0QB, 0.5212, 4.36, 0.046, 313, 261, struct.pdbx_descriptor              
1303, 4ujeKA, 0.5212, 4.31, 0.042, 314, 261, 
1304, 4ujdEC, 0.5212, 4.31, 0.042, 314, 261, 
1305, 4ujcEC, 0.5212, 4.31, 0.042, 314, 261, 
1306, 4d61g, 0.5212, 4.31, 0.042, 314, 261, CRYO-EM STRUCTURES OF RIBOSOMAL 80S COMPLEXES WITH TERMINATION FACTORS AND CRICKET PARALYSIS VIRUS IRES REVEAL THE IRES IN THE TRANSLOCATED STATE
1307, 4d5lg, 0.5212, 4.31, 0.042, 314, 261, CRYO-EM STRUCTURES OF RIBOSOMAL 80S COMPLEXES WITH TERMINATION FACTORS AND CRICKET PARALYSIS VIRUS IRES REVEAL THE IRES IN THE TRANSLOCATED STATE
1308, 3jb9L, 0.5210, 4.36, 0.054, 293, 261, CRYO-EM STRUCTURE OF THE YEAST SPLICEOSOME AT 3.6 ANGSTROM RESOLUTION
1309, 5juuWA, 0.5203, 4.69, 0.059, 318, 270, 
1310, 3j78SA, 0.5203, 4.37, 0.068, 318, 263, 
1311, 5oa3g, 0.5197, 4.39, 0.050, 314, 260, HUMAN 40S-EIF2D-RE-INITIATION COMPLEX
1312, 6gqbAC, 0.5195, 4.47, 0.072, 318, 265, Cryo-EM reconstruction of yeast 80S ribosome in complex with mRNA; tRNA and eEF2 (GDP+AlF4/sordarin)  
1313, 5jupWA, 0.5189, 4.32, 0.065, 318, 262, 
1314, 5jutWA, 0.5184, 4.40, 0.057, 318, 264, 
1315, 5c0pA, 0.5184, 4.36, 0.112, 279, 259, THE CRYSTAL STRUCTURE OF ENDO-ARABINASE FROM BACTEROIDES THETAIOTAOMICRON VPI-5482
1316, 6gq1AC, 0.5181, 4.71, 0.063, 318, 270, Cryo-EM reconstruction of yeast 80S ribosome in complex with mRNA; tRNA and eEF2 (GMPPCP/sordarin)  
1317, 5jusWA, 0.5181, 4.35, 0.069, 318, 262, 
1318, 6d9jDC, 0.5179, 4.52, 0.042, 313, 265, struct.pdbx_descriptor              Ribosome 
1319, 6az1g, 0.5178, 4.10, 0.059, 300, 254, CRYO-EM STRUCTURE OF THE SMALL SUBUNIT OF LEISHMANIA RIBOSOME BOUND TO PAROMOMYCIN
1320, 5wlcDA, 0.5171, 5.02, 0.047, 362, 276, struct.pdbx_descriptor              
1321, 6g5ig, 0.5167, 4.57, 0.042, 314, 263, CRYO-EM STRUCTURE OF A LATE HUMAN PRE-40S RIBOSOMAL SUBUNIT - STATE R 
1322, 5xyig, 0.5166, 4.25, 0.074, 305, 257, SMALL SUBUNIT OF TRICHOMONAS VAGINALIS RIBOSOME
1323, 5t2cZB, 0.5145, 4.55, 0.042, 313, 262, 
1324, 3ow8B, 0.5145, 4.12, 0.059, 292, 253, CRYSTAL STRUCTURE OF THE WD REPEAT-CONTAINING PROTEIN 61
1325, 4v7rU, 0.5142, 4.60, 0.080, 313, 262, 
1326, 3odtA, 0.5141, 4.27, 0.082, 293, 257, CRYSTAL STRUCTURE OF WD40 BETA PROPELLER DOMAIN OF DOA1
1327, 3odtB, 0.5132, 4.21, 0.078, 293, 256, CRYSTAL STRUCTURE OF WD40 BETA PROPELLER DOMAIN OF DOA1
1328, 3rfhD, 0.5129, 4.14, 0.103, 307, 253, CRYSTAL STRUCTURE OF THE YEAST RACK1 DIMER IN SPACE GROUP P21
1329, 3rfhB, 0.5128, 3.93, 0.108, 290, 249, CRYSTAL STRUCTURE OF THE YEAST RACK1 DIMER IN SPACE GROUP P21
1330, 3rfhA, 0.5128, 4.03, 0.108, 291, 250, CRYSTAL STRUCTURE OF THE YEAST RACK1 DIMER IN SPACE GROUP P21
1331, 3rfgA, 0.5086, 4.00, 0.109, 288, 248, CRYSTAL STRUCTURE OF THE YEAST RACK1 DIMER IN SPACE GROUP P63
1332, 3rfgB, 0.5085, 4.01, 0.109, 288, 248, CRYSTAL STRUCTURE OF THE YEAST RACK1 DIMER IN SPACE GROUP P63
1333, 4q1uA, 0.5083, 4.16, 0.056, 328, 250, SERUM PARAOXONASE-1 BY DIRECTED EVOLUTION WITH THE K192Q MUTATION
1334, 3sreA, 0.5080, 4.18, 0.056, 329, 250, SERUM PARAOXONASE-1 BY DIRECTED EVOLUTION AT PH 6.5
1335, 3rfhC, 0.5076, 3.99, 0.109, 288, 247, CRYSTAL STRUCTURE OF THE YEAST RACK1 DIMER IN SPACE GROUP P21
1336, 4hhoA, 0.5074, 4.17, 0.056, 326, 250, SERUM PARAOXONASE-1 BY DIRECTED EVOLUTION WITH THE H115W MUTATION
1337, 5vycSE, 0.5064, 4.72, 0.049, 313, 263, 
1338, 5vycRA, 0.5064, 4.72, 0.049, 313, 263, 
1339, 5vycJD, 0.5064, 4.72, 0.049, 313, 263, 
1340, 5vycI, 0.5064, 4.72, 0.049, 313, 263, 
1341, 5vycBG, 0.5064, 4.72, 0.049, 313, 263, 
1342, 5vycAC, 0.5064, 4.72, 0.049, 313, 263, 
1343, 4ug0RB, 0.5064, 4.72, 0.049, 313, 263, 
1344, 3eweC, 0.5046, 4.16, 0.053, 255, 245, CRYSTAL STRUCTURE OF THE NUP85/SEH1 COMPLEX
1345, 4rusF, 0.5038, 3.10, 0.053, 237, 228, CARP FISHELECTIN HOLO FORM
1346, 4hhqA, 0.5038, 4.11, 0.057, 323, 247, SERUM PARAOXONASE-1 BY DIRECTED EVOLUTION WITH THE H115Q AND H134Q MUTATIONS
1347, 4rusA, 0.5037, 3.14, 0.057, 237, 229, CARP FISHELECTIN HOLO FORM
1348, 4ruqB, 0.5028, 3.18, 0.048, 237, 229, CARP FISHELECTIN APO FORM
1349, 4rusE, 0.5026, 3.17, 0.052, 237, 229, CARP FISHELECTIN HOLO FORM
1350, 4rusD, 0.5021, 3.14, 0.053, 237, 228, CARP FISHELECTIN HOLO FORM
1351, 3eweA, 0.5020, 3.89, 0.050, 255, 241, CRYSTAL STRUCTURE OF THE NUP85/SEH1 COMPLEX
1352, 4rusC, 0.5014, 3.10, 0.053, 236, 227, CARP FISHELECTIN HOLO FORM
1353, 4ruqA, 0.5004, 3.18, 0.053, 236, 228, CARP FISHELECTIN APO FORM
